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Abstract 
Relief from pain and distressing symptoms associated with a life limiting illness is an issue relevant 
to all Canadians.  Provision of high quality care for persons nearing the end of life may improve the 
health and quality of life of the person and affects the health and well-being of members of their informal 
support network including family, friends, and caregivers.  Palliative care, a person-centered approach to 
care for persons faced with a life limiting illness and their informal support network, focuses on the ‘total 
person’ or ‘whole self’ addressing the multifaceted complex needs of each person on an individualized 
basis.  Palliative care is recognized by the World Health Organization (WHO) to be “achieved through 
prevention and relief of suffering by means of early identification, comprehensive assessment, and 
treatment of pain and physical, psychosocial, or spiritual problems” (World Health Organization [WHO], 
2010).  The palliative care philosophy prioritizes self-determination of the person and supports their 
engagement in the care planning and decision making process across the illness trajectory. 
Approximately one fifth of persons who die annually experience unrelieved suffering (Doyle & 
Woodruff, 2013).  Persons nearing the end-of-life face can face a wide range of challenges that may 
include: uncontrollable pain and physical symptoms, unresolved and emotionally distressing psycho-
social issues, and fear of one’s own mortality and of an unknown future.  Nearly two thirds of Canadians 
who die each year may benefit from palliative care (Canadian Hospice Palliative Care Association 
[CHPCA], 2010), however only approximately one in eight of those persons are able to access palliative 
care services (Carstairs & Beaudoin, 2000).   
Comprehensive clinical assessment supports clinicians to make evidence-informed decisions and 
promotes a person-centered approach to care planning. The interRAI Palliative Care assessment 
instrument (interRAI PC) is a comprehensive standardized assessment instrument, designed for use by 
facility and community based palliative care services, with applications that include care planning, 
outcome measurement, quality monitoring, and resource allocation (Hirdes et al., 1999; Steel, et al., 2003; 
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Gray, et al., 2009; Hirdes et al., 2008).  Using pilot data gathered from the interRAI PC, this thesis 
examines the potential use of interRAI PC assessment data, and in particular how evidence from the 
interRAI PC Clinical Assessment Protocols (CAPs) has the potential to inform individualized care plan 
development for persons with a life limiting illness. 
This thesis begins with a scoping literature search that describes palliative care in a Canadian context 
and explores care planning with the interRAI PC.  This is followed by three research based chapters 
(Chapters 6, 7, and 8) that include analysis based on pilot data gathered between 2006 and 2011 using the 
interRAI PC assessment instrument.  Community dwelling persons with a life limiting illness receiving 
palliative home care services in six geographic locations across Ontario, Canada, were included in these 
analyses.  Persons with a life limiting illness residing in institutional or hospice facilities, or in 
jurisdictions outside of Ontario, were excluded.  Analyses were performed using SAS Version 9.2 with an 
alpha level of p< 0.05 for all statistical tests unless otherwise stated.  The University of Waterloo’s Office 
of Research Ethics granted ethics clearance for this research (ORE# 19424) November 29
th
, 2013. 
The first research chapter (Chapter 6) describes how clinicians may use the interRAI PC Clinical 
Assessment Protocols (CAPs) to inform care planning.  It includes an overview of the suite of eight CAPs 
and provides a background description of the CAP development process.  Discussion addresses the 
unique distributional characteristics of each CAP and describes a hierarchical triggering structure. 
Following, chapter six which provides an overview of the interRAI PC CAPs from a broad 
perspective; chapter seven (the second research chapter) takes a more in-depth focus investigating the 
Dyspnea CAP.  Dyspnea was selected as the symptom of focus because it is the one of the most 
commonly triggered CAPs affecting nearly half of the sample palliative home care population used in this 
thesis and is reported to be one of the most distressing symptoms affecting both the person faced with a 
life limiting illness and their informal caregivers (Ng &von Gunten, 1998; Potter, Hami, Bryan, & 
Quigley, 2003; Dellon et al., 2010; Kroenke, Johns, Theobald, Wu, & Tu 2013).  Chapter seven examines 
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the Dyspnea CAP and describes the prevalence of dyspnea.  This chapter demonstrates the relationship 
between dyspnea and prognosis as well as other clinical factors.  Moreover, how the presence of dyspnea 
changes over time is examined and person-level characteristics, some of which are potentially amenable 
to change, that affect the risk for dyspnea over time are identified. In addition, risk and protective factors 
for persons who over time developed new dyspnea symptoms and for those who recovered from dyspnea 
are examined. 
Recognizing that a hallmark of the palliative care philosophy is its aim to provide the highest 
quality of care and support for both the person nearing the end of life and members of their care network 
including their informal caregivers, the third research chapter (Chapter 8) examines distress experienced 
by both the caregiver and the care recipient as a unit of care.  As quality palliative care may increase 
satisfaction with care, improve global quality of life for client and their caregiver, reduce physical 
symptoms like dyspnea, decrease signs of depression or anxiety, and improve access to health care 
resources (Kane, Bernstein, Wales, Leibowitz, & Kaplan, 1984; Melin-Johansson, Axelsson, Gaston-
Johansson, & Danielson, 2010) the association between the presence of dyspnea and distress experienced 
by members of the caregiver-client unit of care is examined to illustrate how dyspnea relates to distress, a 
major problem affecting over half of the caregiver-client units of care. 
Together, findings from this thesis show that if one or more interRAI PC CAPs are triggered then 
the clinician should take notice.  Data from the interRAI PC and more specifically from the interRAI PC 
CAPs examined in this thesis provide evidence on their potential to inform greater understanding of the 
complex needs of palliative home care clients.  Better understanding of the interRAI PC CAPs and 
identification of patterns in CAP triggering structure suggest symptoms where clinicians may focus 
increased attention.  To address the accumulative complex needs of persons who are faced with a life-
limiting illness and the needs of their caregivers, resource allocation focused on evidence gathered from a 
comprehensive standardized assessment instrument should be prioritized.  
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1.  Introduction and Overview 
From the local to regional, national, and global levels, the value of palliative care to address the needs 
of persons faced with a life limiting illness and to improve health and well-being is gaining increased 
attention.  Provision of the highest quality care for persons nearing the end of life is as an important 
public health priority (Emanuel, Fairclough, Wolfe, & Emanuel, 2004; World Health Organization 
[WHO], 2004).  It is commonly accepted that provision of palliative care services improves both the 
quality of living and dying for persons faced with a life limiting illness and for their family, friends, and 
caregivers (the persons faced with a life limiting illness’ informal support network). Palliative care is a 
person-centered approach recognized by the World Health Organization (WHO) to be “achieved through 
prevention and relief of suffering by means of early identification, comprehensive assessment, and 
treatment of pain and physical, psychosocial, or spiritual problems” (World Health Organization [WHO], 
2010). Palliative care prioritizes self-determination for persons faced with a life limiting illness not only 
in control over their own life, but also to function as an active informed participant in their treatment and 
care planning process.  Palliative care focuses on the ‘total person’ or ‘whole self’.  While pain and 
symptom management for the person faced with a life limiting illness is a well-known focus, quality 
palliative care simultaneously recognizes the need to support families and caregivers.  Palliative care 
services have been found to lead to improved survival, (Connor, Pyenson, Fitch, Spence, & Iwasaki, 
2007) and increased satisfaction with care for both the persons faced with a life limiting illness and for 
their informal support network (Kane, Bernstein, Wales, Leibowitz, & Kaplan, 1984; Brumley et al., 
2007).  With appropriate timing of referral, quality palliative care may lead to a reduction of unnecessary 
health care resource utilization (Tulskyc & Steinhauserc, 2007; Kamal, Currow, Ritchie, Bull, & 
Abernethy, 2012). 
The International Association for Hospice and Palliative Care (IAHPC) notes that of the more than 52 
million people who die in the world each year about one fifth are likely to die with unrelieved suffering 
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(Doyle & Woodruff, 2013).  The IAHPC emphasizes that in all regions of the world “people are living 
and dying in unrelieved pain, with uncontrolled physical symptoms, with unresolved psychosocial and 
spiritual problems, and in fear and loneliness” (Doyle & Woodruff, 2013).  The WHO has prioritized 
raising global awareness of the value of palliative care in the relief of pain and suffering among persons 
faced with a life limiting illness, regardless of geographic location (Sepúlveda, Marlin, Yoshida, & 
Ullrich, 2002).  It is estimated that of the more than 252,000 persons who die in Canada each year 
(Statistics Canada, 2011), nearly two thirds may benefit from palliative care (Canadian Hospice Palliative 
Care Association [CHPCA], 2010).  However, in Canada, it has been found that less than 15% of persons 
with a need for palliative care are able to access services (Carstairs & Beaudoin, 2000).   
The first palliative care programs in Canada were developed in Montreal, Quebec and Winnipeg, 
Manitoba during the mid-1970s in response to the unmet needs of dying persons.  During these early 
beginnings, palliative care across Canada was primarily a grass roots movement, reliant on charitable or 
local funding and lacked a clear united direction.   More recently, with the leadership of the Canadian 
Hospice Palliative Care Association (CHPCA), palliative care in Canada has evolved into an increasingly 
united movement with a growing shared voice, which advocates for access to palliative care for all 
persons faced with a life limiting illness (CHPCA, 2005).  Palliative care continues to be limited by a lack 
of clear national funding policy strategy and remains an uninsured service under the Canada Health Act 
(CHA).  A 2005 Senate Commission noted that despite advances in the palliative care movement since 
1995, progress had been slow.  A 2010 Senate of Canada report highlighted the current Canadian reality 
of unequal access to palliative care services, inconsistencies in type and quality of service provision 
across the country, and that the majority of persons faced with a life limiting illness are unable to access 
high quality palliative care services to meets their needs as they progress towards the end of life 
(Carstairs, 2010).  
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With support from informal care networks in combination with community based palliative services, 
dying at home is becoming increasingly accessible to more persons with a life limiting illness.  Grant, 
Elk, Ferrell, Morrison, and von Gunten, (2009) reported on the challenges for persons at end of life to 
achieve their preferred place of death.  Disparities in preferences at the end of life and actual outcomes 
were evident as Grant et al. found that although the vast majority of persons expressed the wish for a 
home death more than half died in hospital and a quarter died in a nursing home (2009). Palliative care 
services, allocated to meet person-specific need at the appropriate time in the preferred setting, are critical 
to support persons faced with a life limiting illness who prefer a home death.  Yet, it is also important to 
recognize that not all persons faced with a life limiting illness prefer a home death.  Yamasaki et al., 
(2008) found that only half of study participants wished for a home death, and this preference differed 
significantly by gender. Community based palliative home care has been found to have a positive impact 
on quality of life and reduce health care expenditures for persons faced with a life limiting illness and 
their informal support network (Pereira & Bruera, 2001).  Palliative home care programs have also been 
shown to improve quality of life, reduce physical symptoms, reduce psychological distress, and improve 
accessibility to formal care providers (Melin-Johansson, Axelsson, Gaston-Johansson, & Danielson, 
2010).   
Palliative care promotes person-specific care where resources and supports are tailored to meet need 
on a case-by-case basis.  Comprehensive clinical assessment is a key tool that clinicians must use to 
provide an evidence-informed, person-centered approach to care planning. The interRAI Palliative Care 
assessment instrument (interRAI PC) is a comprehensive assessment instrument designed for use by 
facility and community based palliative care services, including those that specifically target persons with 
a life limiting illness. The applications of the interRAI PC and related interRAI instruments include care 
planning, outcome measurement, quality monitoring, and resource allocation (Hirdes et al., 1999; Steel, et 
al., 2003; Gray, et al., 2009; Hirdes et al., 2008).  Using pilot data gathered from the interRAI PC, this 
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thesis examines how data from the interRAI PC has the potential use to inform individualized care plan 
development for persons faced with a life limiting illness. This thesis begins with a scoping literature 
search to describe palliative care in a Canadian context.  The nature of services and target populations for 
palliative care are defined and its key components outlined.  Dyspnea, a major challenge in symptom 
management that commonly affects persons with a life limiting illness is explored with greater depth.  An 
overview of care planning with attention to care planning in palliative care is provided in chapter three, 
followed by introduction to the interRAI suite of assessment instruments in chapter four. A discussion of 
how clinicians may use the interRAI PC Clinical Assessment Protocols (CAPs) to inform care planning 
follows.  The strengths and limitations of the interRAI PC are compared and contrasted to three other 
prominent palliative care assessment instruments described in section 4.4; the Palliative Performance 
Scale (PPS), the Edmonton Symptom Assessment System (ESAS), and the Liverpool Care Pathway 
(LCP).  The study rationale described shows gaps in current knowledge from a Canadian context and 
introduces the data source and measures to be used in the three research chapters (Chapters 6, 7, and 8).  
The three research chapters, each formatted as articles for publication, focus on the potential use of the 
interRAI PC CAPs beginning with a broad overview of the eight interRAI PC CAPs.  This is followed by 
a more in-depth investigation into the Dyspnea CAP and finally a focus on the relationship between the 
Dyspnea CAP and distress experienced within the caregiver-care recipient unit of care. 
1.1 Literature Review Strategy 
The literature search was performed between September 2012 and March 2013 using the SCOPUS, 
PubMed, CINAHL, and Google Scholar databases.  Various combinations of the following MeSH 
keywords were used: “Palliative care”, “Terminal care”, “Hospice” “Clinical Protocol”, “Patient Care 
Planning”, “Community Health Planning”, Patient Care Management”, “Nursing Assessment”, “Health 
Care”, “Risk Adjustment”, “Standard of Care”, “Symptom Assessment”, “Geriatric Assessment’, 
“Nursing Assessment”, “Quality Assurance, Health Care”, “Best Practice Guideline” and “Gold 
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Standard”.  Other search words and combinations used included:  “End of Life”, “interRAI”, and 
“Clinical Assessment Protocol”.  Articles published in non-English languages were excluded as were 
articles published prior to 1995.  Articles that focused on children and youth, under the age of 18, were 
excluded.  Publication year limitation criteria were removed if an article was identified as being 
important.   
For selected papers forward checking of articles citing the paper and backward checking of articles 
cited was performed using functions in SCOPUS.  As key authors were identified, their names were 
searched in Google Scholar and SCOPUS databases to ascertain any related articles.  This process 
continued until saturation was reached and no new articles were identified.  Federal publication databases 
were searched to identify senate and policy documents vital to the development of palliative care services 
in Canada. 
For inclusion, studies must have met the following criteria:  1) focus primarily on palliative care for 
persons faced with a life limiting illness, 2) examine palliative care clinical assessment protocols, care 
planning, practice guidelines, OR palliative care symptoms and treatments, 3) apply predominately to the 
Canadian context, and 4) be applicable for persons over the age of 18.   
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2.  Background 
Palliative care recognizes that self-determination and the rights of the person with a life limiting 
illness and when appropriate, the needs of their informal support network, are the foundation to identify 
need, choose individualized goals of care, and direct treatment.  IAHPC identifies that the goals of 
palliative care are: 
• To provide relief from pain and other physical symptoms; 
• To provide psychosocial and spiritual care; 
• To support and help the support network during the persons illness trajectory and through the 
bereavement process; and 
• To maximize the quality of life of the person with a life limiting illness and their support network. 
(Doyle & Woodruff, 2013)   
 
Palliative care prioritizes the importance of quality of life (QOL) and personal choice, recognizing that 
desire for a cure and the preference to receive aggressive or life-prolonging treatments are not 
incompatible with palliative care’s priority for pain and symptom management and for peace and dignity 
through all stages of the illness trajectory (National Consensus Project [NCP], 2013). To address the 
complex needs on a case-by-case basis, palliative care should be provided by multidisciplinary teams 
whom are equipped with all necessary tools to the address the context of the person faced with a life 
limiting illness.  Effective palliative care depends on leadership, collaboration, coordination, and 
communication (NCP, 2013). In some cases, palliative teams may be led by a physician with a strong 
medical focus aimed at relief of distressing physical symptoms such as pain or dyspnea, but others may be 
led by a social worker focused on examining the financial and psycho-social issues faced by the person 
with a life limiting illness and members of the informal support network.  In the United States, social 
workers are integral members to the multidisciplinary palliative care teams, and are required to be 
available by Medicare regulations (Gwyther et al., 2005).  For most teams, a diverse range of health and 
community care providers and supports will be required ranging from physicians, medical specialists, and 
nurses to social workers, spiritual care workers, and volunteers.  The multidisciplinary team approach to 
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palliative care aims to respond to the ‘whole person’ needs, preferences, values, and beliefs in a manner 
that is collaborative, personalized and culturally appropriate (NCP, 2013).   
2.1 Defining Palliative Care 
The origin of the term palliative care is rooted in the word ‘palliate’, derived from the Latin word 
palliatius, which means to ‘cloak or cover’ (McCusker et al., 2013).  This creates a comforting image of 
surrounding the person with a cozy blanket, wrapping them in support to decrease pain and distressing 
symptoms (NCP, 2013).  Numerous terms and definitions of care of persons with a life limiting illness 
exist including palliative care, hospice care, hospice palliative care, supportive care, end-of-life care, 
supportive end-of-life care, and terminal care.  The meanings of each term may vary by time, context, 
language, and location of application.  Yet, although they are individually defined, these terms are often 
used interchangeably.  For the purpose of this thesis, palliative care will be defined as a philosophy of 
care that stresses alleviation of suffering and aims “to improve the quality of living and of dying” 
(Government of British Columbia, 2006; CHPCA, 2013).  Palliative care seeks to improve QOL through 
“the prevention and relief of suffering by means of early identification and impeccable assessment and 
treatment of pain and other problems, physical, psychosocial and spiritual” (WHO, 2010).  In addition, 
palliative care: 
• Provides relief from pain and other distressing symptoms; 
• Affirms life and regards dying as a normal process; 
• Intends neither to hasten nor postpone death; 
• Integrates the psychological and spiritual aspects of patient care; 
• Offers a support system to help patients live as actively as possible until death and to help the    
family cope during the patients illness and in their own bereavement; 
• Uses a team approach to address the needs of patients and their families including bereavement 
counseling if indicated; 
• Will enhance QOL and may also positively influence the course of the illness; and 
• Is applicable early in the course of illness, in conjunction with other therapies that are intended to 
prolong life, such as chemotherapy or radiation therapy, and includes those investigations needed 
to better understand and manage distressing clinical complications. (WHO, 2010) 
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The focus of palliative care is multidisciplinary providing a wide range of care services addressing the 
practical, physical, psychological, social, spiritual, and holistic needs of each person (Doyle & Woodruff, 
2013).  Palliative care aims to alleviate current symptoms and distress, prevent subsequent issues before 
they develop, and help the person find meaning, purpose, and growth over the course of the illness 
trajectory (CHPCA, 2005). Palliative care may be the total focus of care or it may be provided as a 
secondary focus in conjunction with disease modifying curative treatments.   
CHPCA recognizes seven core values of palliative care:  
1. The intrinsic value of each person as autonomous and unique;  
2. The value of life, the natural process of death, and the fact that both provide opportunities for 
personal growth and self-actualization;  
3. The need to address suffering, expectations, needs, hopes, and fears of both the person with a life 
limiting illness and their support network;  
4. Care is only provided when the patient and/or family is prepared to accept it;  
5. Care is guided by QOL as defined by the person with a life limiting illness  
6. The therapeutic relationship be based on dignity and integrity; and  
7. A unified response to suffering strengthens communities (CHPCA, 2005). 
In its definition of palliative care, the WHO recognizes palliative care may enhance the QOL of the 
person and “positively influence the course of illness” (2010).   It is important that potential disparity 
between the subjective perspective of the person with a life limiting illness and the objective view of 
those surrounding the person (including both formal care providers and the person’s informal support 
network) may exist (Randall, Downie, & Downie, 1999 pp. 250; Kaasa and Loge, 2003).  Recognition of 
the person’s subjective assessment of QOL and support that promotes its attainment through self-
determination is a foundation principle of the palliative care philosophy. 
The perceived change in life trajectory after diagnosis with a life limiting illness can be perceived as a 
serious threat to the viability of the person’s hopes, dreams and aspirations for the future.  When a person 
is faced with a life limiting illness, it may be the first time that the person challenged to address in realist 
terms the fact that that they will die.  This change may affect the person’s self-perception of health and 
QOL, as well as challenge their perceived role in society and relationships with others. These challenges 
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may be negative (examples: financial insecurity and decreased or lost productivity (Covinsky et al., 1994; 
Albert, Williams, Legowski, & Remis, 1998)) or may be more positive in the form of opportunities for 
personal growth, motivation to resolve unfinished business or reconcile past relationships, promote 
recognition of inner resilience, and drive a desire to resolve conflicts and attain inner peace (CHPCA, 
2013b).  Palliative care encourages enhancing self-empowerment through personal choice.  Palliative care 
support may assist the person to adjust their expectations for change in their life trajectory and assist them 
to prioritize issues and need on an individualized basis.  Palliative care recognizes the importance of self-
determination and choice as the driving force in identification of need and in development of a plan for 
care. 
2.1.1 Defining Dying 
For the purpose of this thesis, the term dying will refer to active dying in the final days or hours 
during the terminal phase. When a person is actively dying, the goals of care and methods in which they 
are addressed should adapt to the volatile and unpredictable changes in distressing symptoms during the 
terminal phase (Heidrich, 2007). Physicians, trained within a medical model that promotes the importance 
to ‘cure patients’ and provide ‘aggressive and life-saving’ treatments whenever possible, may feel 
conflicted and hesitant to label a person as ‘actively dying’ if any hope for improvement remains 
(McCusker et al., 2009).  This reluctance to refer to palliative care by physicians due to the perception by 
the physician that they have ‘failed’ creates a barrier for persons to be referred to or to receive care from 
palliative care services. 
It is well established that dying persons are at increased risk to experience distressing symptoms.  
Multiple complex symptoms require a plan of action, subject to continuous adjustment, to address 
treatment challenges and promote QOL as persons near the end of life (Fürst, & Doyle, 2004; Heidrich, 
2007).  Common signs and symptoms, as detailed by Heidrich (2007) and the NCP (2013), that indicate 
the person with a life limiting illness may be in the dying stage include: delirium, increased periods of 
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sleep, lethargy, or fatigue, decreased food and liquid consumption, abnormal breathing patterns or 
dyspnea, inability to heal or recover from wounds or infections, increased swelling, or severe agitation 
with hallucinations or changes in personality (Heidrich, 2007; NCP, 2013). 
2.1.2 Challenges to Defining Palliative Care 
  Misunderstanding of the meaning of palliative care, the depth of its benefits, and breath of its 
applicability creates substantial barriers to access palliative care.  Historically, in Canada, it has been the 
case that palliative care has been access predominantly by persons with cancer in the final stages of life.  
In a 2003 report by the Ontario Association of Community Care Access Centers (OACCAC), it was noted 
that 80 to 85% of patients who accessed palliative care teams had a diagnosis of cancer (Ontario 
Association of Community Care Access Centers [OACCAC], 2003 in Dudgeon et al., 2007).  Incorrect 
beliefs that palliative care is only useful for persons who are actively dying, for persons who no longer 
respond to curative treatment, or whose death is imminent, can also result in limited access to or 
effectiveness of palliative care services.  In the final stages of the end-of-life, dying may be complex 
requiring increased levels of specialized palliative care.  However, the scope of palliative care is not 
limited to the later stages of the illness trajectory. Palliative care is often misunderstood as solely 
beneficial for persons with a cancer diagnosis, resulting in its under-utilization by persons with non-
cancer diagnoses. 
Recognizing that the term palliative care may be a barrier, global efforts to clarify the definition, 
scope, and utility of palliative care are underway.  The WHO (2010) has focused on mass global 
education campaigns and publications to broaden understanding of the ideology of palliative care.  In 
Canada, CHPCA emphasizes the broad applicability of palliative care to all persons with a life limiting 
illness (CHPCA, 2013a).  As a result, the term palliative care has been receiving wider recognition as 
more than simply pain relief in the final days and hours of life when hope for a cure is lost.  Palliative 
care is applicable to any person with a life limiting illness during any stage of the illness. Therefore, use 
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of the phrase ‘life limiting illness’ as used in this thesis rather than ‘terminal disease’ widens the scope 
and applicability to a more diverse range of persons. This broad definition of palliative care enables 
clinicians to apply palliative care principles in multiple settings, earlier in the illness trajectory and tailor 
care planning to address needs of persons with a life limiting illness on a case-by-case level.   
Palliative care applies to persons who are dying as described above and persons who are predicted to 
be nearing the end of their life, but also to persons faced with the possibility or reality of life limiting 
illness from the time of evaluation or diagnosis, early in the disease trajectory.  Palliative care may benefit 
persons with a life limiting illness not traditionally perceived as a ‘terminal illness’ but instead have an 
illness or condition that results in reduced life expectancy such as multiple sclerosis, cerebral palsy, or 
muscular dystrophy.  Persons with progressive neurological conditions are a specific subpopulation with 
complex health needs that may benefit from palliative care not typically recognized as being within the 
scope of palliative care (Kristjanson, Aoun, & Oldham, 2006).  As there is no known cure for the majority 
of progressive neurological conditions, treatments that address the effects of the condition (e.g., pain, 
symptom management, support) fit well within a palliative care philosophy.  From the onset of symptoms 
through potentially lengthy periods of diagnosis to an ongoing response to deterioration across the disease 
trajectory, persons with a progressive neurological condition and members of their informal support 
network may benefit from education and support from a palliative care provider.  The definition of 
palliative care clearly states that it is appropriate for persons with a life limiting illness, such as persons 
with progressive neurological conditions, who may benefit from and should have access to palliative care 
at any time during the illness trajectory. 
When a person is diagnosed with a life limiting illness, it not only affects the person faced with a life 
limiting illness but also the lives of his/her informal support network including family, friends, caregivers, 
or co-workers (CHPCA, 2005).  CHPCA estimates that death affects the health, wellbeing, and QOL of 
over 1.25 million Canadians each year, an average of five persons per death (2010).  Effective palliative 
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care depends on a strong informal support network to respond to the needs of persons with a life limiting 
illness.  Palliative care also recognizes the impact caregiving and bereavement has on members of the 
informal support network. Palliative care includes access to caregiver-focused resources in addition to 
collaboration with and support from health professionals.  Palliative care may assist members of the 
informal support network across the illness trajectory and during bereavement.   
2.2 Palliative Care in Canada 
Dame Cicely Saunders, founder of St. Christopher’s Hospice in the United Kingdom, the world’s first 
hospice center, conceived the modern idea of the hospice movement in the mid-1960s (Saunders, 1996).  
During the 1970s the first Canadian palliative care programs were initiated at two teaching hospitals in 
Montreal and in Winnipeg.  Dr. Balfour Mount, a physician influenced by his relationship with Dr. 
Saunders, opened the Royal Victoria Palliative Care Unit in Montreal, Quebec. Dr. Mount coined the 
term ‘palliative care’ as it is now used in the contemporary context in Canada (Seely, Scott, and Mount, 
1997). In 1991, the Canadian Palliative Care Association, presently known as the Canadian Hospice 
Palliative Care Association (CHPCA), a national organization dedicated to palliative care was established 
(CHPCA, 2013).  Since then, issues regarding health care for the persons with a life limiting illness have 
attracted increasing attention from the general public, researchers, clinicians, and policy makers across 
Canada.  
In recognition of lack of a formal policy on palliative care and in response to national attention from 
the Rodriguez Supreme Court Challenge (Government of Canada, 1993), the Special Senate Committee 
on Euthanasia and Assisted Suicide was struck.  In 1995, the Senate Committee released the pivotal 
report:  “On Life and Death:  Final Report” in which they noted the right to euthanasia or assisted suicide 
could not be adequately addressed without first examining access to palliative care in Canada.  This report 
gained national attention highlighting the disarray in co-ordination and lack of understanding of palliative 
care among health care professionals.  More importantly, this report raised awareness that Canadians were 
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dying with unrelieved pain and suffering (Special Senate Committee on Euthanasia and Assisted Suicide, 
1995).  In 2000, the Senate Commission released a follow-up report “Quality End-Of-Life Care:  The 
Right of Every Canadian,” which found minimal progress had been made and brought attention to the 
unmet needs of informal caregivers, the need for improved access to home care and medications, and the 
importance to increase education and research capacity (Senate Commission, 2005; Health Canada, 
2005). Palliative care programs remained unevenly distributed, with limited capacity, across Canada 
(Carstairs & Beaudoin, 2000).  Publicity from the Kirby and Romanow reports fueled a national 
campaign advocating for increased access to palliative care for persons with life limiting illnesses and 
emphasizing the important role for palliative home care services to assist persons to remain in the 
community and to die at home (Kirby & LeBreton, 2002; Romanow, 2002; Williams et al., 2010).  In 
2005, the Senate Commission’s report “Still Not There.  Quality End-Of-Life Care:  A Progress Report” 
recognized significant advancements in policy since 2000 with development of the Canadian Strategy on 
Palliative and End-of-Life Care.  However, it noted continued disparities in accessibility and emphasized 
that without federal leadership, the ‘patchwork’ of available palliative care services would continue 
(Senate Commission, 2005). 
2.2.1 Accessing Palliative Care Services 
Currently, palliative care is offered in almost every sector of the Canadian health care system, from 
acute care and complex continuing care hospitals, to long-term care facilities (LTC) and community 
based home care (Dudgeon et al., 2007).  On a provincial level, the Ontario Association of Community 
Care Access Centers (OACCAC) (2003) recognized palliative care lacked “coordination, integration, and 
consistency” which resulted in great difficulty for persons with a life limiting illness and their informal 
support network to navigate palliative care services.  Although palliative care is recognized by both health 
care professionals and the Canadian public as a valuable compassionate support for persons faced with a 
life limiting illness, without political advocacy and pressure, provincial and federal support, and health 
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care policy reform, palliative care is projected to remain on the periphery of the Canadian health care 
system (Health Canada, 2007; Williams et al., 2010).  Canada does not yet have legislation to mandate 
provision of palliative care for dying persons under the CHA. Because the current focus of the Canadian 
health care system is on ‘cure’ in the medical sense rather than ‘care’ as promoted in palliative care the 
provinces and territories are not required by law, under the CHA, to provide care oriented services like 
palliative care. 
2.2.2 Ontario’s Health Care Structure 
As the three research chapters (Chapters 6, 7, and 8) of this thesis utilize data gathered from the 
province of Ontario, it is important to understand the background context of Ontario’s health care 
structure.  In Ontario, the first points of access to community based care are the fourteen Community Care 
Access Centers (CCAC’s) located in various regions across the province (Figure 2.1.).  The goal of each 
CCAC is to coordinate specialized supports for persons under its jurisdiction and to connect those 
requiring care with available services and resources in the person’s home or within the respected 
community.  Each CCAC has been tasked with the following responsibilities: 
• Assess and determine eligibility for professional health services, homemaking, and personal 
support services to be provided in community, client’s homes, or schools; 
• Assess and determine eligibility for the professional health and personal support services for 
children attending school or being home schooled; 
• Develop service plans; 
• Inform and refer members of the community to available services; 
• Through a procurement process, purchase home care services from providers; 
• Manage admissions to long-term care facilities; 
• Co-ordinate delivery of CCAC provided home care services.  (CCAC Client Services Policy 
Manual, 2007. Chapter 1, pp. 15) 
 
In Ontario, palliative care consultation services and palliative care education are recognized as 2 of the 15 
key community support services provided to persons by the CCAC in the geographic region in which they 
reside. 
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Figure 2.1. Map of Community Care Access Center (CCAC) Districts, Ontario, Canada. 
 
Source:  Copyright permission received from Digital Strategy Lead, OACCAC, Jan. 17, 2014. 
 
The Ministry of Health funds the CCAC’s through Local Health Integration networks.  Eligibility for 
services including nursing, personal support, and palliative care, are determined by CCAC policy and rely 
on both clinical judgment and established criteria.  Established criteria, outlined in the Community Care 
Access Centre’s Client Services Policy Manual (2007) include but are not limited to:  Being eligible for 
the Ontario Health Insurance Plan (OHIP) (having residency in Ontario), having a recognized need for at 
least one professional service (e.g. nursing, physiotherapy, or occupational therapy), and the ability to 
receive care in a setting which ensures the safety, space, and privacy of both the care provider and care 
recipient.  Community based services may be temporary/periodic or ongoing/long-term (CCAC Client 
Services Policy Manual, 2007, Chapter 1, pp. 3).  Among all specified professional health services, 
maximum service provision is specified, only for nursing services, under the Long-term Care Act 
regulation number 386/99 (CCAC Client Services Policy Manual, 2007).  These regulations allow special 
exceptions for persons who are palliative with complex or intensive needs to access additional personal 
support of homemaking services above suggested maximum service provisions based on special 
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circumstances.  Although not a focus of the current thesis, CCACs may coordinate funding support for 
residential hospices within their associated jurisdictions. 
An important clarification in eligibility criteria for CCAC support is that “the person can only access 
the services that are available within the person’s CCAC catchment area (e.g., in some cases, not all 
services may be available within the area)” (CCAC Client Services Policy Manual, Chapter 3, pp. 2).  
This may result in geographic variation not only in service availability, funding, and allocation, but also 
in client referrals.  Although there may be a recognized need for a program, a client may not be referred 
because there is no program to refer the client too. Provincial eligibility criteria for CCACs in Ontario 
state that availability of services may affect client referrals for services.  This is important when 
addressing palliative care needs and examining what population is assessed for services throughout the 
province of Ontario.  As palliative care is an uninsured service under the Canada Health Act, variation in 
program and resource availability is common.  Provision of palliative care services are based on annual 
budgetary decisions at the regional level.  As an optional or add-on service, it is important to recognize 
some CCACs may be unable in times of fiscal constraint to fund and support specialized palliative care 
programs.  
When a person is referred to a CCAC for service, a case manager assesses the person’s needs, 
evaluates their service/resource eligibility, develops a plan of care in conjunction with the person’s 
identified goals of care, and arranges for and coordinates service/resource delivery.  The case manager is 
a point of information for the person and their informal support network to discuss availability of service 
options to meet desired and perceived need both at the current time of assessment and in the person’s 
anticipated future.  When appropriate, the case manager may also recommend and facilitate admission to 
a LTC or residential hospice facility.  Since spring 2012, when a person is referred to a CCAC and 
recognized as potentially benefitting from palliative home care services, the case manager will assess the 
needs of the person using the interRAI Palliative Care Assessment instrument (interRAI PC) (OACCAC, 
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2012).  Information gathered during the interRAI PC assessment is then used to inform creation of a care 
plan and conduct goal setting with the client. 
 It is important to note that while it is not the focus of this thesis, volunteer based and fee-for-
service private companies offer a variety of palliative care focused services in Ontario, Canada.  Persons 
who wish to purchase extra services from a private company such as additional homemaking services 
through a home care company, or who seek care from a private free-standing non-government funded 
hospice are able to do so throughout the province of Ontario.  The ability for persons to seek these added 
services depends foremost on the financial capacity of the person, the availability of the services to meet 
their required needs, and the ability to find the resources to meet their perceived needs.  For the purpose 
of this thesis, any reference to community based palliative home care services will be limited to those 
funded by the LHINs and allocated through the CCACs in Ontario, Canada. 
2.3 Trajectories of Death 
Critical to discussions of palliative care are issues related to disease diagnosis and more specifically, 
as is discussed later in this thesis, in terms of persons with a cancer versus non-cancer diagnosis.  
Therefore, section 2.3 examines differing ways persons die and provides descriptions of characteristic 
patterns of clinical and functional decline associated with major illness or disease as persons near the end 
of life (Lorenz et al., 2008). Four distinct trajectories of death: cancer; organ system failure; frailty and 
dementia; and sudden or unknown death, are useful to understand the roles of disease and difficulties of 
prognosis at end of life.  Persons with cancer are most often high functioning until late in the disease 
trajectory while persons with frailty and dementia may continue to function with low levels of functional 
abilities and experience a slow progressive prolonged decline.  Persons with organ systems failure tend of 
experience a gradual decline interrupted over time by illness exacerbations. Trajectory of death analysis 
in 2001-2002 in Alberta found that terminal illness (primarily cancer) accounted for 29% of deaths, organ 
system failure accounted for 26.9% of deaths, frailty and dementia accounted for 26.7% of deaths, sudden 
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deaths accounted for 6.3% of deaths, and the cause of death could not be determined in the remaining 
13.8% of cases (Fassbender, Fainsinger, Carson, & Finegan, 2009). Since sudden or unknown deaths are 
not believed to require palliative care prior to death they are not discussed further.  To elucidate patterns 
the majority of persons who are assumed to be able to benefit from palliative care may follow towards 
death, focus will be placed on the three chronic illness trajectories of death: cancer, organ system failure, 
and frailty and dementia. 
2.3.1 Cancer Trajectory  
The cancer trajectory, as shown in Figure 2.2, is characterized by a variable period after diagnosis 
where the person with a cancer maintains comfort and function. From the time of diagnosis through early 
and mid-stages of the illness trajectory, persons with cancer may experience a continued period of high 
functional status where most symptoms are managed (NCP, 2013).  As the illness progresses, there is a 
tipping point where the person’s health status begins to progressively decline and symptoms may become 
uncontrolled or overwhelming.  From this point, the health of the person with a cancer may deteriorate 
rapidly as he/she approaches death (Lynn & Adamson, 2003).  After reaching the tipping point, persons 
characteristically follow a pattern of decline which clinicians are often able to predict.  Therefore 
clinicians may be able to with reasonable reliability predict a prognosis in the few months preceding death 
(Shugarman, Lorenz, & Lynn, 2005).  
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Figure 2.2. Cancer Illness Trajectory of Death. 
  
Source: Lynn, J. & Adamson, D.M.  (2003) Living Well at the End of Life. Adapting Health Care to 
Serious Chronic Illness in Old Age. Washington: Rand Health, pp. 11. 
Note: Copyright permission not required for noncommercial purposes 
 
 Research used to inform current palliative care practice focuses almost exclusively on the needs 
of persons with a cancer diagnosis (McClement, 2006).  “At the moment, there is only one model for 
palliative care in Canada: The cancer model” (S. Baxter, personal communication, March 1, 2010).  
Because benefits of palliative care for persons with a cancer diagnosis and their informal support network 
during the rapid decline phase preceding death are well recognized, palliative care has been best shown to 
benefit persons with cancer during the final months before death (Shugarman, Lorenz, & Lynn, 2005; 
Lorenz, Shugarman, & Lynn, 2006).  Less than 30% of total deaths in Canada each year are related to 
cancer (Public Health Agency of Canada, 2007; Public Health Agency of Canada, 2013).  Yet people with 
cancer account for more than 90% of those receiving palliative care (Canadian Heart Health Strategy and 
Action Plan, 2009).  This reflects provincial comparisons where persons with cancer receive 80-85% of 
palliative care services in Ontario yet account for only one third of persons who die (Seow, King, & 
Vaitonis, 2008), and international comparisons where persons with a cancer diagnosis receive up to 90% 
of palliative care services in the UK (Eve, Smith, & Tebbit, 1997), in the United States (Hogan, Lunney, 
Gabel & Lynn, 2001) and in Australia (Australia P.C., 1998). 
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Strict reliance on disease-specific eligibility guidelines (in particular the common entry criteria of a 
prognosis of less than three or six months to live) often result in the systematic exclusion for access to 
palliative care among persons dying from non-cancer diagnoses (Zerzan, Stearns, & Hanson, 2000).  
Gaudette et al. (2002) found that while all palliative programs accepted persons with a cancer diagnosis, 
not all accepted persons with other life limiting illnesses.  Palliative care policies in Canada commonly 
target those persons with a life limiting illness whom clinicians expect are likely to die within a six month 
time period (Fassbender, Fainsinger, Carson, & Finegan, 2009). Potential cost savings through reduction 
of unnecessary treatments drives this rationale that accessibility to palliative care be based on an average 
six-month decline in functional status frequently experienced among persons with advanced stage 
terminal cancer (Teno, Weitzen, Fennel, & Mor, 2001; Lunney, Lynn, Foley, Lipson, & Guralnik, 2003).  
2.3.2 Organ Systems Failure Trajectory 
The organ systems failure trajectory shown in Figure 2.3. is characterized by a saw tooth pattern, 
where periods of general stability are interrupted by sharp downward inflections reflecting exacerbations 
and acute illnesses. Persons diagnosed with congestive heart failure, chronic obstructive pulmonary 
disease, or renal failure, are examples of chronic diseases that commonly follow the organ systems failure 
trajectory towards death.  During an exacerbation, medical interventions may improve the person’s health 
status however after recovery the person usually does not typically return to the level of their pre-episode 
level of function.  Therefore, the trajectory exhibits an overall slow downward slope.   
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Figure 2.3. Organ Systems Failure Trajectory of Death. 
  
Source: Lynn, J. & Adamson, D.M.  (2003) Living Well at the End of Life. Adapting Health Care to 
Serious Chronic Illness in Old Age. Washington: Rand Health, pp. 11. 
Note: Copyright permission not required for noncommercial purposes 
 
Chronic diseases, such as diseases of the circulatory system and respiratory systems, excluding 
cancer, account for nearly half of all deaths annually in Canada (Statistics Canada, 2005).  Although 
recognized as potentially benefitting from palliative care, persons with life limiting chronic illnesses often 
do not receive palliative care (Love & Sawatzky, 2007). Criteria for palliative care referral, such as a six-
month prognosis, systematically exclude persons with non-cancer diagnoses creating a major barrier to 
service access and utilization.  The inability to accurately prognosticate the end stage of chronic (non-
cancer) diseases currently results in the denial of access to palliative programs for many persons with a 
life limiting illness and their informal support networks.  This often includes inaccessibility to palliative 
care hospital based care, institutional and community hospice programs, as well as many provincial 
palliative home care programs.. 
Chronic disease prognostication can be extremely difficult. Ongoing medical care is often successful 
to prevent or reduce severity of exacerbations and to extend survival (McAlister, Stewart, Ferrua, & 
McMurray, 2004) however, death may occur suddenly from an unexpected complication or exacerbation 
(Lorenz, Shugarman, & Lynn, 2006).  Many persons with chronic diseases such as COPD or heart failure 
often have a prognosis of two to six months, even in their last week of life (Ostchega, Harris, Hirsch, 
   22 
Parsons & Kingstong, 2000; Schron et al., 2002; Shugarman, Lorenz, & Lynn, 2005).  Clinical prediction 
prognostic criteria for seriously ill patients with advanced chronic illnesses have been found to be 
ineffective and have poor discrimination (Fox et al., 1999; Coventry, Grande, Richards, & Todd, 2005).  
In contrast to the rapid linear decline experienced by many persons with a cancer diagnosis, those 
diagnosed with cardiovascular disease or heart failure may experience an erratic course of disease decline 
with periods of relative stability interrupted by episodes of acute decompensation (Goodlin, 2005; 
McClung, 2007). Due to prognostic uncertainty, health care providers may focus solely on life prolonging 
or lifesaving treatments and fail to recognize the progressive life-limiting nature of the disease.  This in 
turn results in failure to recognize the benefits of or need for palliative care (Love & Sawatzky, 2007).  
Palliative care for persons with organ system failure is often perceived as conflicting with the goals of 
chronic disease management (Gott et al., 2009). The Canadian Action Heart Health Strategy and Action 
Group recognized that cardiovascular care emphasized acute intervention and end of life care planning 
guidelines for cardiac care were lacking (2009).  In a medical setting which prioritizes “optimizing 
medical management, prolonging life, and reducing or eliminating classical cardiac symptoms”, clinicians 
may feel uncomfortable discussing palliative care and end of life planning (Howlett et al. 2010, page 
137).  Some clinicians may perceive referral to palliative care services as a personal failure to ‘cure’ the 
patient.  This represents a fundamental misperception of palliative care as being in conflict with the goals 
of chronic disease management.  Instead, clinicians should recognize palliative care as being symbiotic 
with the chronic disease model, able to work alongside curative or life prolonging treatments to improve 
the health and QOL of the person with a life limiting illness.  
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2.3.3 Dementia and Frailty Trajectory 
Persons who do not fit within the cancer or organ system failure trajectories may die from dementia 
or generalized frailty (Lynn & Adamson, 2003).   People with dementia or frailty experience a slow and 
progressive decline (shown in Figure 2.4.).  Over many years prolonged dwindling is characterized by 
multimorbidity and progressive physical and cognitive impairment.  Eventually persons with dementia or 
frailty become unable to care for themselves and will require extensive personal care for an extended 
period of time imposing significant demands on both formal care services and their informal support 
network (Shugarman, Lorenz, & Lynn, 2005). Estimates of median length of survival from time of 
diagnosis to death range from seven to eight years (Sachs, Shega, & Cox-Hayley, 2004).  Cary et al. 
(2007) found one-year mortality for frail persons to be 13% and three-year mortality 35%. Persons with 
dementia or frailty are at increased risk to die with uncontrolled pain and suffering (Teno, 2001).  
Although it is documented that persons with dementia or frailty (Singer, Martin & Kelner, 1999), and 
formal and informal caregivers, often prefer palliative care (Hughes, Robinson, & Volicer, 2005) they are 
often not referred to palliative care services, fail to receive optimal pain and symptom management and 
are likely to receive unnecessary life prolonging treatment such as artificial hydration or feeding tubes at 
the end of life (Sachs, Shega, & Cox-Hayley, 2004). 
Persons with dementia or frailty may not be perceived as suffering from a life-limiting condition and 
therefore are not referred to palliative care services.  Often persons with dementia or frailty are 
recognized to die from other diagnoses such as pneumonia or heart failure.  If a diagnosis of dementia or 
characteristics of frailty are recognized as a cause of death, they are more likely to be perceived as a 
secondary predisposing or contributing factors rather than the primary cause of death (Sachs, Shega, & 
Cox-Hayley, 2004).  Similar to challenges in prognostication mentioned previously for persons on the 
organ systems failure trajectory, differentiation of a terminal event from an exacerbation for persons with 
dementia or frailty is challenging.  
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Figure 2.4. Dementia and Frailty Trajectory of Death. 
  
Source: Lynn, J. & Adamson, D.M.  (2003) Living Well at the End of Life. Adapting Health Care to 
Serious Chronic Illness in Old Age. Washington: Rand Health, pp. 11. 
Note: Copyright permission not required for noncommercial purposes 
 
In addition, due to the highly unstable nature of both dementia and frailty, persons with dementia or 
frailty may require periods of palliative pain and symptom management during an acute exacerbation 
from which their health condition may improve.  Their health condition may then stabilize to a point 
where they cease to require palliative pain and symptom management.  As will be shown in the Trajectory 
Model of Care (Figure 2.6.), the need for palliative care is projected to increase over time and that 
benefits from aggressive or curative treatments will decrease.  The system for palliative care services is 
not structured to address the needs of persons with frailty and dementia who may benefit from periodic 
palliative care in which services start and stop as required.  For example, palliative care may be beneficial 
to address uncontrollable pain during an exacerbation but then no longer required or reduced during 
periods of relative stability when the pain is controlled.  In this case, the “revolving door” complicates the 
design, coordination, and delivery of palliative care (Tilly & Fok, 2008). 
2.3.4 Alternative Trajectory 
It must be noted that the four trajectories (cancer, organ system failure, dementia/frailty, and sudden 
death) are theoretical guides and there are always exceptions.  With advancements in cancer treatments, 
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some types of cancer have become a chronic illness following other illness trajectories making them 
increasingly challenging to prognosticate.  Some cancers, such as prostate cancer, may result in long-term 
disability rather than a short-term decline and follow the organ system trajectory. Conditions including 
strokes may follow the cancer trajectory with a short period of quick decline while diseases such as 
HIV/AIDS may fit multiple trajectories depending on the phase or co-morbidities experienced. Persons 
with a progressive neurological condition may also fit both the organ systems failure trajectory and the 
dementia and frailty trajectory.  And finally, any person may fall victim to a sudden death or unexpected 
trauma. 
2.4 Models of Palliative Care 
The IAHPC advocates that there is no “right or wrong” or one size fits all model of palliative care 
(Doyle & Woodruff, 2013).  In Canada, there are three prevailing models of care:  the Transition Model 
of Care (Figure 2.5.) and the Trajectory Model of Care (Figure 2.6.) as postulated by Lynn and Adamson 
(2003), which describe the dying process, and the CHPCA Square of Care (SoC) (2005; Figure 2.7.), used 
to organize and direct the steps in the process of providing palliative care. 
  
   26 
Figure 2.5. Transition Model of Care. 
  
Source: Lynn, J. & Adamson, D.M.  (2003) Living Well at the End of Life. Adapting Health Care to 
Serious Chronic Illness in Old Age. Washington: Rand Health, pp. 10. 
Note: Copyright permission not required for noncommercial purposes 
In the Transition Model of Care (Figure 2.5.) there is a specific point in the disease trajectory when 
the care needs of the person change from a curative or aggressive medical treatment focus, to hospice care 
focus where the person is recognized as ‘terminally ill’ with limited expectations for survival.  Curative 
treatment is stopped, a comfort plan initiated until the point of death, which marks the end of care.  
Eligibility requirements for programs fitting in the Transition Model of Care may include: 
• Request comfort and symptom management and refuse any curative or aggressive treatment; 
• Have clearly stated advance directives including a do not resuscitate order (DNR) refusing any 
extraordinary measures 
• Person has a specified limited prognosis (e.g. less than 3 months) 
 
These criteria conflict with the definition of palliative care and limit access for a large number of persons 
with a life limiting illness.  They reinforce misperceptions that palliative care is appropriate only when all 
other options have failed, is beneficial only for persons at the end of life or who are actively dying, and is 
not to be provided at the same time as curative or aggressive treatment. 
 In contrast, the Trajectory Model of Care (Figure 2.6.) recognizes that over the course of an 
illness, persons may simultaneously require varying amounts of disease modifying curative treatment and 
palliative symptom management and incorporates a period of palliative care for family bereavement after 
death.  The diagonal line indicates that as the person progresses towards death they will require increased 
   27 
levels of palliative care and symptom management and decreasing amounts of curative and active care.   
The Trajectory Model of Care does not require a limited prognosis like the Transition Model of Care and 
instead, expands to include persons with a life limiting illness and their informal support network. 
Figure 2.6. Trajectory Model of Care. 
  
Source: Lynn, J. & Adamson, D.M.  (2003) Living Well at the End of Life. Adapting Health Care to 
Serious Chronic Illness in Old Age. Washington: Rand Health, pp. 10. 
Note: Copyright permission not required for noncommercial purposes 
The ‘Square of Care’ (SoC) utilizes a bottom up approach based on recognition of cultural and ethnic 
diversity to marry the strengths of the Transition Model of Care and the Trajectory Model of Care (Figure 
2.7.) (CHPCA, 2005). The SoC provides a foundation to address the individuality of person-specific need 
for palliative care in relation to the availability of services.  It is based on two interacting dimensions.  
The SoC takes a holistic approach emphasizing consideration of multiple aspects of patient need and 
disease management, all highly relevant concerns to be addressed by clinicians during the care planning 
process (Shahidi, Bernier, & Cohen, 2009).  Care provision is organized from assessment and decision 
making through care planning and delivery to address common issues including disease management, 
physical, psychological, social, spiritual, practical, end of life/death management, and loss/grief domains.  
Ferris et al., (2002) note the value of standardized needs assessment to gather evidence to inform care 
planning, identify need, and set the goals of care with the person faced with a life limiting illness and 
when appropriate also with their informal support network.  
   28 
Figure 2.7. CHPCA Square of Care. 
  
 
Source: Ferris, F. D., Balfour, H. M., Bowen, K., Farley, J., Hardwick, M., Lamontagne, C., … 
West, P.  (2004). In: A Model to Guide Hospice Palliative Care.  Canadian Hospice Palliative Care 
Association, Ottawa, Canada, pp. 112.  
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As persons with a life limiting illness progress across the illness trajectory it is important they be able 
to access the appropriate level of care to match their needs in the right place at the right time (O’Brien, 
2003). Early phases may be characterized by allocation of both curative treatments and palliative care in 
the form of focused pain and symptom management or psychological counseling to reduce anxiety as 
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promoted in the Trajectory Model of Care.  As the illness progresses, the need for palliative care usually 
changes and tends to increase while availability of cure oriented intervention options often decrease. Over 
time, the person with a life limiting illness may reach a point where they no longer benefit from or desire 
curative or aggressive treatments and wish to set comfort oriented symptom management goals of care as 
advocated in the Transition Model of Care.  In contrast, the SoC advocates use of a person-driven 
approach where the self-defined needs of the person drive resource allocation within the context of 
available resources at any time across the illness trajectory.  Only the SoC prioritizes persons with a life 
limiting illness access the level of care matched to their individualized needs at the right time irrespective 
of prognosis or preference for cure oriented treatment.  
2.5 Overview of Symptoms Common among Persons Receiving Palliative Care 
  Resources focused on directing and informing symptom management for persons with a life 
limiting illness are diverse.  CHPCA recognizes eight key domains of issues associated with illness and 
bereavement, outlined in Figure 2.8. (CHPCA, 2005), which illustrate the wide range of symptoms 
experienced by persons with a life limiting illness.  The examples listed in each the domain do not 
represent an exhaustive list.  The symptom experience of persons with a life limiting illness as they near 
the end of life may differ by context (diagnosis, prognosis, and care setting); symptoms may intensify, 
subside, or disappear over time while new symptoms may appear, (Heidrich, 2007).  
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Figure 2.8. CHPCA Domains of Palliative Care. 
 
Source: Ferris, F. D., Balfour, H. M., Bowen, K., Farley, J., Hardwick, M., Lamontagne, C., … 
West, P.  (2004). In: A Model to Guide Hospice Palliative Care.  Canadian Hospice Palliative Care 
Association, Ottawa, Canada, pp. 15.  
Copyright Permission Granted Monday January 27
th
, 2014 from Sharon Baxter, Executive Director 
of the Canadian Hospice Palliative Care Association (CHPCA).  
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A founding principle of palliative care is ‘pain and symptom management’.  Among persons requiring 
palliative care, pain is often the most frequently reported symptom (Doyle & Woodruff, 2013). Pain and 
symptom management must address multiple complex issues as recognized and prioritized by the person 
with a life limiting illness on a case-by-case basis.  Common to textbook or print publications on 
palliative care which address symptom management is a primary emphasis detailing in-depth pain 
management followed by follow-up sections highlighting a plethora of other symptoms.  In the Palliative 
Care Manual 2
nd
 Edition released by the IAHPC (Doyle & Woodruff, 2013), pain and its management are 
the clear focus.  Pain is the first symptom addressed and is discussed in its own chapter accounting for 
approximately one third of the manual (45/150 pages).  In contrast, the chapter on symptom control that 
emphasizes multiple respiratory (breathlessness, cough, terminal respiratory congestion), gastrointestinal 
(nausea and vomiting, bowel obstruction, constipation), and constitutional (anorexia, weight loss, 
weakness and fatigue, neurological—confusion/delirium/ terminal restlessness) symptoms key for 
clinicians to address are all contained and described in less than one quarter of the manual (35/150 pages) 
(Doyle &Woodruff, 2013).  The IAHPC manual also contains a separate section on guidelines of care for 
psychosocial issues including psychological distress, depression, anxiety, and spiritual/existential distress 
(Doyle &Woodruff, 2013), which accounts for only 15 pages. In contrast, the Oxford Handbook of 
Palliative Care (Fürst & Doyle, 2004) first describe the management of pain followed by a long list of 
individual symptoms including cachexia, anorexia, fatigue, sweating, fever, and the symptoms grouped 
into respiratory, gastrointestinal, genitourinary, and skin conditions. Fürst and Doyle (2004) include 
sections specific to head and neck cancers, endocrine and metabolic complications in advanced cancer, 
neurologic problems in advanced cancer, and sleep disorders.  They provide specific reference to disease 
specific issues such as AIDS in adults, renal failure, or palliative care in non-malignant respiratory 
disease. These examples highlight an imbalance in the amount of information and emphasis placed on 
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pain in comparison to other physical and psychological issues and symptoms experienced by persons 
nearing the end of life in the context of palliative care. 
 In their study measuring the prevalence and patterns of symptoms among 400 persons receiving 
palliative care, Potter, Hami, Bryan and Quigley, (2003) found that the five most prevalent symptoms 
were pain, anorexia, constipation, weakness, and dyspnea.  Ng and von Gunten (1998) found the most 
common symptoms among 100 patients admitted to an acute hospice palliative care unit to be:  pain, 
constipation, nausea, vomiting, anorexia, confusion, dyspnea, weakness, insomnia, and depression.  In a 
study of somatic symptoms among cancer patients with pain and/or depression, Kroenke, Johns, 
Theobald, Wu, & Tu, (2013) found high prevalence of symptoms at baseline where 15 of the 22 
symptoms they were investigating were present among more than 50% of their respondents.  The most 
prevalent of the 22 symptoms included:  fatigue, sleep problems, pain, memory problems, dry mouth, 
shortness of breath, gastrointestinal problems, and numbness.  Kroenke et al. (2013) also noted that 
differences in prevalence of symptoms differed when compared to other studies by Esther Kim, Dodd, 
Aouizerat, Jahan, & Miaskowski, (2009) and Teuuissen et al. (2007) yet all three studies reported fatigue 
as the most common symptom.  In order of highest prevalence, fatigue was followed by pain, lack of 
appetite, dry mouth, constipation, insomnia, and shortness of breath in Teuuissen et al. (2007) and 
followed by dry mouth, insomnia, pain, drowsiness, lack of appetite, dyspepsia, numbness, and shortness 
of breath in the study by Esther Kim, Dodd, Aouizerat, Jahan, & Miaskowski, (2009).  
With the diversity of symptoms experienced at end of life and each symptom’s unique relationship to 
both disease diagnosis and illness trajectory, a person specific plan of care addressing the symptoms 
perceived as most distressing by the person is warranted.  If one or more issues perceived as central to the 
experience of the person with a life limiting illness are not addressed, they can snowball and result in 
increased symptom complexity, distress and more severe complications (CHPCA, 2005).  Failure to 
address distressing symptoms can be a barrier to goal attainment and to the ability of the person with a 
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life limiting illness to adapt their perceptions of healthiness and find meaning or value.  Moreover, 
unaddressed and uncontrolled symptoms are highly disturbing for members of the person’s informal 
support network and can be a source of increased stress and anxiety. 
2.5.1 Dyspnea 
Dyspnea, also referred to as shortness of breath or breathlessness, is one of the most frequently 
reported and highly distressing symptoms affecting persons nearing end of life (Ng and von Gunten, 
1998; Potter, Hami, Bryan and Quigley, 2003; Kroenke, Johns, Theobald, Wu, & Tu, 2013).  The 
American Thoracic Society (1999) defines dyspnea as: 
a subjective experience of breathing discomfort that consists of qualitatively distinct  
sensations that vary in intensity, is derived from interactions among multiple  
physiological, psychological, social, and environmental factors, and may induce  
secondary physiological and behavioral responses. 
 
Dyspnea may be “acute or chronic, progressive, recurrent, paroxysmal, or episodic” (Wilkins, Dexter, & 
Heuer, 2009, page 41) depending on the frequency, symptom features, and experiences of the person.  
Subtypes of dyspnea include orthopnea, platypnea, and trepopnea.  Dyspnea may be referred to as 
orthopnea if the shortness of breath occurs solely when the person is in a reclining position or is lying 
down (Wilkins, Dexter, & Heuer, 2009).  To obtain relief from orthopnea, the person may use pillows to 
elevate their upper body.  Clinicians commonly refer to orthopnea as ‘two- or three- pillow orthopnea’ 
depending on how many pillows are used by the person to obtain symptom relief (Wilkins, Dexter, & 
Heuer, 2009).  Orthopnea commonly occurs among persons with congestive heart failure (Wilkins, 
Stoller, & Scanlan, 2003).  If dyspnea is present solely in the upright position, dyspnea may be referred to 
as platypnea.  Platypnea, the opposite of orthopnea, is often relieved when the person changes to a 
recumbent position (Wilkins, Dexter, & Heuer, 2009).  Platypnea is an uncommon symptom and may be 
hereditary or occur in relation to chronic liver disease (hepatopulmonary syndrome) (Wilkins, Stoller, & 
Scanlan, 2003).  Trepopnea is when dyspnea occurs when the person is lying in one lateral position but 
   34 
not the other; meaning the dyspnea may occur when the person is lying down on either their left or right 
side, but not both (Wilkins, Dexter, & Heuer, 2009). Wilkins, Dexter, and Heuer (2009) note that 
trepopnea is most commonly associated with chest disorders that affect only one side of the body and 
provide examples where this may occur including unilateral lung disease, unilateral pleural effusion, and 
unilateral airway obstruction. 
The subjective nature of dyspnea means that it is experienced both physically (body) and cognitively 
(mind) (Booth, Moosavi, & Higginson, 2008).  Dyspnea directly affects functional ability and mobility.  
It can also cause anxiety and fear increasing the risk of social isolation (Bredin, et al., 1999; Parshall et 
al., 2012).  It can be physically and psychologically distressing for the person and for members of their 
informal support network.  Despite its high prevalence and severity of distress, attention to dyspnea in the 
literature is lacking (Dudgeon & Rosenthal, 1996; Currow, Smith, Davidson, Newton, Agar, & 
Abernethy, 2010).  Dyspnea may be described in different ways including:  ‘tightness in their chest’, 
‘feelings of suffocation’, ‘air hunger’, increased difficulty to breath’, or ‘increased effort to breath’ 
(Wilkins, Dexter, & Heuer, 2009).  Accordingly, dyspnea has been selected as the symptom of focus of 
this thesis to not only illustrate potential benefits of care planning using data gathered from a 
comprehensive assessment instrument (interRAI PC) but also in order to expand current understanding 
and awareness of this highly distressing symptom among persons with a life limiting illness and members 
of their informal support network. 
2.5.1.1 Prevalence 
Dyspnea is a complex and multifaceted symptom.  It may be challenging to address, as the level of 
severity shows no clear relation to pulmonary functioning or disease status (Booth, Moosavi, & 
Higginson, 2008).  With no clearly accepted ideal measurement scale for dyspnea (Dorman, Byrne, & 
Edwards, 2007) and no universally recognized evaluation criteria (Bruera, Sweeney, & Ripamonti, 2002), 
estimated prevalence rates for dyspnea vary greatly from 3 to 25% in the general population (Michelson 
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& Hollrah, 1999) to 16 to 80% among persons with a life limiting illness (Ng & von Gunten 1998; 
Watson, Lucas, Hoy, & Wells, 2009). Prevalence rates vary by both disease diagnosis and point in illness 
trajectory (expected time toward death).  It is one of the most common symptoms experienced by up to 
95% of persons with COPD, up to 70% of persons with advanced cancer and over 85% of persons with 
cardiac failure and motor neuron disease (Oliver, 2005; Solano, Gomez, & Higgenson, 2006).  In their 
review of published studies, Solano, Gomez, & Higgenson (2006) noted prevalence of dyspnea ranges 
from 54 to 85% for persons with AIDS, 69-82% for persons with heart disease, and 11 to 62% for persons 
with renal disease. 
Edmonds, Karlsen, Khan, & Addington-Hall (2001) found that in the final year of life, 94% of 
persons with chronic lung disease (CLD) experienced dyspnea compared to 78% of persons with lung 
cancer.  Moreover, they note the prevalence of dyspnea was 91% for persons with CLD and 69% for 
those with lung cancer in the final week of life (Edmonds, Karlsen, Khan, & Addington-Hall, 2001).  The 
prevalence of dyspnea also ranged within disease diagnosis.  In an international multi-site study of 
persons with cancer receiving palliative treatment, Vainio and Auvinen, (1996) reported the overall 
prevalence of dyspnea (19%) ranged greatly by cancer diagnosis from only 6% for persons with head and 
neck cancer to 46% of persons with lung cancer.   In the last six weeks of life it is estimated that 70% of 
persons receiving palliative care experienced dyspnea and this increases to 90% during the active dying 
phase (Tarzian, 2000). 
Development of and experiences with dyspnea vary greatly by disease trajectory.  Persons following a 
chronic disease trajectory (e.g. persons with COPD) may not experience dyspnea early in the illness 
trajectory even though there is substantial impairment to their respiratory system.  The person may be 
more likely to develop dyspnea gradually and increase in severity as the person progresses across the 
illness trajectory towards death.  It is usually not until the advanced stages of the disease when persons 
with COPD are likely to develop severe dyspnea (Booth, Moosavi, & Higginson, 2008).  Booth et al. 
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(2008) notes how this gradual progression experienced by persons with COPD is contrasted by the 
experience of persons with cancer who more often experience episodic dyspnea characterized by rapid 
progression and increasing severity in the final weeks and days prior to death.  Moreover, the duration 
that persons with COPD may experience dyspnea for is often longer compared to persons with cancer 
(Edmonds, 2001).  
2.5.1.2 Pathophysiology 
The pathophysiology of dyspnea is multifactorial and not fully understood yet in the scientific and 
medical world.  As the cause may involve single or multiple organ systems, it is important to first isolate 
which organ system is involved (example: respiratory, cardiovascular, neither system, or both systems) 
and then conduct follow-up diagnostic testing as needed.   
Thomas and von Gunten (2002) aim to simplify understanding of the complexity of the 
pathophysiology of dyspnea organized through three important components:  Work of Breathing; 
Chemical; and Neuromechanical Dissociation.  Work of breathing refers to greater effort needed to 
breathe when there is increased resistance (e.g. COPD) or when there is muscle deconditioning or 
weakness (e.g. ALS).  Thomas and von Gunten (2002) note that the most important factor is this 
“increased respiratory work”.  Chemical refers to hypoxaemia (“subnormal oxygenation of arterial 
blood”; Dirckx, 2005) and hypercapnia (“abnormally increased arterial carbon dioxide tension”; Dirckx, 
2005).  In contrast to general perceptions, hypercapnia is believed to be more important for persons with 
dyspnea than hypoxaemia (Thomas & von Gunten, 2002).  Moreover, Thomas notes that the majority of 
persons with cancer do not exhibit dyspnea related to hypoxaemia.  Neuromechanical dissociation refers 
to discordance between the brain’s perception of required respiratory function and the sensory feedback it 
receives regarding the actual existing respiratory function.  This discordance may lead to dyspnea 
(O’Donnell & Webb, 1993).  Accordingly, clinicians may understand dyspnea in relation to these three 
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factors of pathophysiology viewed as independent factors or clinicians may conceptualize dyspnea as an 
inter-related interaction between more than one of these factors. 
Sorenson (2000) categorized dyspnea into four different groups:  Physiologic, pathologic, neurologic, 
or psychogenic.  These categories assist to organize understanding of the diverse range of potential causes 
(Figure 2.9.). Wilkins, Dexter, and Heuer (2009) provide an expanded list including the following clinical 
types of dyspnea:  Physiologic, pulmonary (restrictive and obstructive), cardiac, circulatory, chemical, 
central, and psychogeneic.  They note that each clinical type of dyspnea is associated with a specific list 
of conditions or features depicted by different signs and symptoms (Wilkins, Dexter, & Heuer, 2009, 
pp.36). 
 
Figure 2.9. General Classifications of Dyspnea.  
  
Source: Sorenson, H. M. (2000). Dyspnea assessment. Respiratory care, 45(11), 1331. 
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In general the most common causes for dyspnea include asthma, pneumonia, myocardial ischemia, 
and deconditioning (Porter & Kaplan, 2012).  However, for persons with COPD or cardiac disorders the 
most common cause of dyspnea is disease exacerbation (Porter & Kaplan, 2012).  Other factors 
associated with increased prevalence of dyspnea include:  advanced age, low socio-economic status, 
history of smoking, morbid obesity, and gender (female) (Michelson & Hollrah, 1999).  The wide range 
of possible causes for dyspnea is known to vary based on the acuity of the onset of the symptoms.  The 
Merck Manual for Health Care Professionals (Porter & Kaplan, 2012) lists some causes and risk factors 
for development of dyspnea broken down by the type of dyspnea:  acute (occurs almost immediately 
following the event), sub-acute (occurs within a few hours or days following the event), and chronic 
(occurs within a few hours or up to years following the event).  Causes of acute dyspnea may include but 
are not limited to:   
• Pulmonary causes:  
 Pneumothorax; 
 Pulmonary embolism; 
 Asthma, bronchospasm, or reactive airway disease; 
 Foreign body inhalation; 
 Toxin-induced airway damage. 
• Cardiac causes: 
 Acute myocardial ischemia or infarction; 
 Papillary muscle dysfunction or rupture; 
 Heart failure. 
• Other causes:   
 Diaphragmatic paralysis; 
 Anxiety disorder causing hyperventilation (Porter & Kaplan, 2012). 
 
Causes of sub-acute dyspnea may include but are not limited to: 
• Pulmonary causes:   
 Pneumonia; 
 COPD exacerbation. 
• Cardiac causes: 
 Angina; 
 Coronary artery disease; 
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Causes of chronic dyspnea may include but are not limited to: 
• Pulmonary causes:   
 Obstructive lung disease; 
 Restrictive lung disease; 
 Interstitial lung disease; 
 Pleural effusion. 
• Cardiac causes: 
 Heart failure; 
 Stable angina; 
 Coronary artery disease; 
• Other causes: 
 Anemia; 
 Physical deconditioning (Porter & Kaplan, 2012). 
 
When addressing dyspnea experienced by persons with a life limiting illness, it is critical that the 
cause be identified where possible.  In addition to the causes for acute, sub-acute, and chronic dyspnea as 
listed above potential causes of dyspnea specific for persons at end of life may include:  obstructing 
tumors, pulmonary embolism, pleural effusions, infections, anemia, arrhythmia, bronchospasm, 
pneumothorax, cardiac failure, abdominal ascites, and superior vena cava syndrome (Kristjanson 2006; 
McCusker et al., 2009).  In Figure 2.10., Thomas (2003) lists various causes of dyspnea in categories 
emphasizing the heterogeneity of causes of dyspnea in relation to cancer vs. non cancer diagnoses as well 
as direct vs. indirect causes related to cancer.  In addition it also provides a sub-list of causes of dyspnea 
known to be associated with cancer therapy in contrast to the diagnosis of cancer itself (Thomas, 2003). 
Wilkins, Dexter, and Heuer (2009) note that common causes of dyspnea range by the associated body 
system(s).  For example, they note that common causes of dyspnea for the neurologic system may 
include:  brain tumor, increased intracranial pressure, hypertensive encephalopathy, and some 
cardiovascular accidents; while common causes for the metabolic and endocrine system may include:  
toxins, uremia, hepatic coma, thyrotoxicosis, and myxedema (Wilkins, Dexter, & Heuer, 2009). 
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Figure 2.10. Causes of Dyspnea. 
  
Source: Thomas, L. A. (2003). Clinical management of stressors perceived by patients on 
mechanical ventilation. AACN Advanced Critical Care, 14(1), page 225. 
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Dyspnea may not always be directly attributed to somatic disease and may instead be exacerbated by 
factors such as fear or anxiety. Dyspnea may trigger a cycle of distress where the symptoms of dyspnea 
cause anxiety, which then elevates the symptoms of dyspnea thereby increasing further the psychological 
distress experienced by the person with a life limiting illness (Kristjanson, 2006).  Common 
psychological causes of dyspnea include severe anxiety and hyperventilation syndrome (Wilkins, Dexter, 
& Heuer, 2009). 
Table 2.1. illustrates a number of potentially treatable causes of dyspnea for persons with a life 
limiting illness matched to examples of treatment options (Cancer Care Ontario [CCO], 2010). Care 
planning should investigate person specific causes for dyspnea and tailor pharmacological and non-
pharmacological treatments where possible and desirable in accordance with established goals of care, co-
morbidities, and life expectancy of the person with a life limiting illness (McCusker et al., 2009; NHS 
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Lothian, 2009; CCO, 2010).  It is important for clinicians to recognize which causes may respond to 
treatment and which may not.  In the case where the cause may not respond to treatment then the goals of 
care should focus on reducing the symptom severity of dyspnea and educating the person on the 
progression of the symptom as the illness progresses. 
Table 2.1. Potentially Treatable Underlying Causes of Dyspnea.  
  
Source: Cancer Care Ontario.  (2010).  Cancer Care Ontario’s Symptom Management Guide-to-
Practice:  Dyspnea. Retrieved from: https://www.cancercare.on.ca/toolbox/symptools/ 
 
Permission received from Cancer Care Ontario, Communications division, Sept. 4th, 2013.   
“Table and information borrowed with permission from Cancer Care Ontario’s Symptom 
Management Guide-to-Practice: Dyspnea”.   
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2.5.1.3 Treatment Options 
 As the diagnosis of dyspnea is based on the subjective perceptions of the person, 
acknowledgement and acceptance of their self-report experience should be the foundation for any plan of 
care (CCO, 2010). Attention during assessment, care planning, and treatment phase should focus on 
minimizing physical and psychological distress to address the persons self-perceived QOL.  Treatment 
should first be based on a comprehensive assessment to clarify precipitating and alleviating factors on the 
individual or person level.   In the respiratory community, clinicians recognize that the vast majority (over 
75%) of information required about dyspnea can be ascertained through a comprehensive clinical 
assessment (Sorenson, 2000). During the initial assessment clinicians should discuss with the person their 
perceptions of dyspnea and then elucidate any abnormal experiences the person may have with their 
breathing.  This may assist the clinician to identify if dyspnea is present and inform further investigation 
into the source of the symptoms of dyspnea.  A detailed comprehensive patient history may also assist to 
identify any precipitating factors.  If a source of the dyspnea is identified, potential underlying conditions 
or reversible causes should be examined.  Table 2.2. lists of causes of dyspnea for persons with cancer 
and provides examples of specific management techniques to match the cause (Booth, Moosavi, & 
Higginson, 2008).  They illustrate the wide range of causes and strategies for client care of dyspnea.  The 
effects of current treatments should be determined and any associated symptoms affecting dyspnea 
addressed.  The clinician should also investigate whether the person is experiencing fear and anxiety 
associated with the dyspnea and to determine the effects on the person’s QOL and activities of daily 
living (ADLs).   
  
   43 
Table 2.2. Causes of Dyspnea in Advanced Cancer. 
 
Source: Reprinted by permission from Macmillan Publishers Ltd:  Nature Clinical Practice 
Oncology, Booth, S., Moosavi, S. H., & Higginson, I. J. (2008). The etiology and management of 
intractable breathlessness in patients with advanced cancer: a systematic review of 
pharmacological therapy. Nature Clinical Practice Oncology, 5(2), 90-100. 
 
Copyright Permission Granted Thursday, January 16, 2014 from Copyright Clearance Center’s 
RightsLink service for Nature Publishing Group (License Number 3222000329465). 
 
Management and treatment of dyspnea should be tailored to meet the needs identified by the person.  
A wide array of pharmacological and non-pharmacological interventions is available as will be discussed 
below; however, any potential benefits of the chosen approach must be weighed against potential burdens. 
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Available options may or may not be appropriate depending on symptom severity, estimated prognosis, 
and the identified goals of care of the person.  Effective treatment and management of dyspnea is 
difficult.  It is not always possible to relieve or alleviate the symptoms of dyspnea especially in the final 
weeks, days, and moments of life 
2.5.1.3.1 Non-Pharmacological Treatments 
Non-pharmacological interventions include counseling, breathing retraining, relaxation techniques, 
psychosocial support and coping and adaptation strategies (Bredin, et al., 1999; Corner, Plant, A'hern, & 
Bailey, 1996; Parshall et al., 2012).  Counseling should involve listening to the person describe their 
experiences surrounding dyspnea and also be directed to addressing the experiences of members of the 
person’s informal support network.  Any fears experienced by the person should be discussed and a care 
plan to address current symptoms and future episodes of dyspnea crafted.  Education should target both 
the current symptom experience associated with the dyspnea and also inform the person and their 
informal support network of situations and experiences which may occur over the future course of the 
illness.  Referral for follow-up to a physiotherapist, respiratory therapist, or social worker may be useful 
to support understanding of dyspnea and the plan of care.  Other strategies may include: keeping the room 
well-ventilated such as opening a window or having a cool fan, physiotherapy, positioning, acupuncture, 
acupressure, reducing the need for physical exertion, and education (Kristjanson, 2006; Booth, Moosavi, 
& Higginson, 2008).  Cognitive behavioral therapy interventions have been shown beneficial when 
provided for one to two month duration (CCO, 2010).  Relief from dyspnea may also be found in 
noninvasive positive pressure ventilation (NIPPV, also referred to as BiPAP).  NIPPV may assist in 
reducing the amount of effort required to breathe reducing the person’s reliance on opioids and thereby 
enabling the person to remain more wakeful and comfortable (Pinna, 2012). 
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2.5.1.3.2 Pharmacological Treatments 
The majority of persons with dyspnea at the end of life will require pharmacological treatment to 
address their symptoms (Jennings, 2002).  Pharmacological treatments used to manage dyspnea may 
include oxygen, sedatives, bronchodilators, steroids, opioids, and benzodiazepines (Kristjanson, 2006; 
NHS Lothian, 2009). Morphine may be effective to reduce symptoms of dyspnea among persons with 
advanced cancer and advanced lung disease (Mazzocato, Buclin, & Rapin, 1999; Qaseem et al., 2008).  
Low doses of sustained release oral morphine have been found useful in relieving dyspnea (Abernethy et 
al., 2003). Inhaled corticosteroids benefit patients who have lung cancer or who have dyspnea associated 
with an inflammatory component (for example: among persons with asthma or COPD) (McCusker et al., 
2009).  As the person’s illness progresses, need for medication may increase and the preferred method for 
medication may change from an oral to a subcutaneous route.  Oral and parenteral opioids are beneficial 
to treat dyspnea (Jennings, Davies, Higgins, Gibbs, & Broadley, 2002) however nebulized opioids, and 
phenothiazines are not recommended (CCO, 2010).  Benzodiazepines are not recommended to manage 
dyspnea but are often used to treat the anxiety associated with dyspnea (DiSalvo, Joyce, Tyson, Culkin, & 
Mackay, 2008). 
2.5.1.3.3 Special Considerations for Dyspnea Related to Palliative Care 
As dyspnea is a subjective experience, the gold standard for diagnosis should remain the person’s 
self-report.  Treatments should be designed to meet person-specific needs on a case-by-case basis.  For 
persons who are in the final stages of the disease trajectory or who have entered the actively dying phase, 
the priorities for treatment, care, and options for dyspnea may change substantially from the care plan 
crafted when expected prognosis was longer.  Booth, Moosavi, & Higginson (2008), emphasize that while 
both the prevalence and severity of dyspnea increase as a person nears death, evidence is lacking 
regarding the effectiveness of interventions to improve dyspnea.  The burden-benefit of dyspnea treatment 
should always be addressed especially when the person has entered the active dying phase.  Although not 
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discussed above, palliative sedation is an option for persons experiencing severe dyspnea and 
psychological distress in the final days and hours of life.  Much controversy surrounds the use of 
palliative sedation but that is not a focus of this thesis. 
Another key consideration when addressing potential treatment options is to recognize the challenges 
surrounding research and product testing.  Development and testing of pharmaceuticals can be difficult 
from both practical and ethical perspectives.  An interesting challenge for researchers and 
pharmacologists is the inability to conduct in vitro drug testing due to the lack of an animal model for 
breathlessness (Booth, Moosavi, & Higginson, 2008).  Development of Randomized Controlled Trials 
(RCTs) to test and develop pharmacological treatment may be ethically challenging among a complex 
population at the end of life.  With reduced functional abilities and anxiety, persons experiencing severe 
dyspnea may lack the physical capacity to perform clinical tests such as exercise or pulmonary function 
testing, or to remain still for an MRI (Booth, Moosavi, & Higginson, 2008).    Ethical concerns raised 
when conducting RCTs involving participants nearing the end of life include: vulnerability of a medically 
fragile or clinically complex participant population requiring palliative care, treatment allocation and use 
of placebos, and issues surrounding informed consent (Addington-Hall, Bruera, Higginson, & Payne, 
2009).  
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3.  Care Planning 
 A care plan is “a carefully prepared outline of care showing both identified needs and the means 
to address them” (Farflex, 2012).  It is an integral component of the care assessment, allocation, and 
management process and is key to ensuring care is directed to meet person-specific need.  A care plan 
should be initiated upon program admission and reviewed and adjusted regularly to respond to change in 
clinical status affecting progress toward the desired or predicted outcomes of care (Dirckx, 2005).  Care 
planning most often addresses a subset of defined problems on a person-by-person basis that require 
immediate medical nursing care interventions without which the problem may worsen (Carpenito-Moyet, 
2007).  The care planning process involves selection of the problem of focus, prioritization of the goals of 
care, identification of indicators to be addressed and selection of appropriate interventions (Caprentio-
Moyat, 2007). 
 Key components of the care planning process are prioritization, delegation, and critical thinking 
(Haugen & Galura, 2010).  Prioritization involves the identification of needs that necessitate a priority 
response in contrast to long-term issues that may be less urgent. The care plan to be developed should 
incorporate best practice guidelines that may include treatment with pharmacological, non-
pharmacological, complimentary or supportive care and prevention strategies, to avoid the onset of 
distressing symptoms and unwanted side effects.  The assessor then should delegate to whom and in what 
context the needs should be addressed.  Critical thinking is key to triangulate knowledge gathered from 
multiple sources and to ensure the plan of care will effectively address the identified needs of the person.   
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It is important that the care plan is an accurate representation of the persons preferred goals of care. 
CHPCA (2005) note comprehensive assessment of need and allocation of palliative care provision as 
required during the care process should be guided by nine important principles:   
1- Patient/family focused; 
2- High quality; 
3- Safe and effective; 
4- Accessible to all patients in a timely manner regardless of location of care; 
5- Adequate resourced to enable service or organization to function effectively; 
6- Collaborative;  
7- Knowledge-based and evidence informed recognizing importance of education; 
8- Advocacy-based; and 
9- Research focused on development, dissemination, and integration of knowledge. 
 
A care plan, as is suggested by Carpenito-Moyet (2007), may be organized by first defining the problem, 
outlining related factors such as pathophysiology, treatment-related issues and situational (personal, 
environmental).  Following, the care plan outlines key concepts including related factors and person 
specific considerations (e.g. Geriatric or end-of-life characteristics) and focuses the assessment criteria 
that incorporate both objective and subjective perspectives.  Subsequently, the goals should be clearly 
defined with a set of indicators and general interventions identified which are based upon an included 
rationale for each suggested intervention.  Clinicians may use pre-made care plans (e.g. Nursing Care 
Plans by Gulanick & Myers, 2011) as a framework and adjust them according to the person-specific 
needs of the client and their informal support network.   
3.1 Care Planning in Palliative Care 
 Dr. Saunders, founder of the hospice care movement, emphasized that “the goal of the palliative 
care planning process, based on a careful assessment of symptoms from the person with a life limiting 
illness’ perspective, [is] not to make a diagnosis and treat solely pain, but to treat pain in addition to all 
the other issues that add up to a general state of misery” (Saunders, 1996). This founding principle of 
addressing the needs of the ‘whole person’ remains a critical focus for palliative care (Cohen, 2009) and 
important component for care planning.  When care planning for persons with a life limiting illness, 
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clinicians combine their clinical judgment with a comprehensive assessment to ensure all major issues 
affecting the person with a life limiting illness and their informal support network are identified 
(Morrison & Meier, 2004). White, McMullan, & Doyle (2009) reported among persons receiving 
palliative care, the number of symptoms detected using systematic assessment was ten times higher than 
those volunteered during the patient assessment.  Moreover, they found that nearly two thirds of all 
symptoms experienced at the end of life not self-reported (White, McMullan, & Doyle, 2009). In the 
absence of detailed assessment, important symptoms that affect quality of life at the end of life may 
remain undetected (Homsi, et al., 2006; White, McMullan, & Doyle, 2009).  Heyland et al., (2010) note 
the potential for improved end of life care in a Canadian context through prioritization of better care 
planning and stronger communication between the person with a life limiting illness and their health care 
team.  Comprehensive clinical assessment should inform the care planning process to ensure that all 
symptoms experienced are discussed, support a person-driven goal setting and decision-making process, 
and improve communication between the person with a life limiting illness, their informal support 
network, and the care team. 
Care planning typically follows three phases:  intake, ongoing care, and closure (discharge) (CHPCA, 
2005).  Unique to care planning for persons with palliative care is the closure or discharge phase, which 
not only focuses upon death of the person but also should include the bereavement period for members of 
their informal support network.  Although it is possible for persons with a life limiting illness to improve 
and no longer require care, the vast majority will receive services, which increase in response to increased 
health complexity and symptom burden as the person progresses towards death.  The major focus of care 
planning for persons with a life limiting illness becomes pain and symptom management and maximizing 
QOL as they near end of life.   
Persons with a life limiting illness seek guidance from the health care system to: develop a plan of 
care which upholds self-determination in treatment options; inform risks and benefits of treatment 
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options; direct access to services; and recognize the effectiveness or futility of the plan of care (CHPCA, 
2005). Palliative care provides this guidance through a therapeutic client driven relationship between the 
person with a life limiting illness, their informal support network, and the health care team.  In Figure 3.1. 
the CHPCA illustrates six basic steps in a therapeutic encounter:  1-Assessment, 2-Information sharing, 3-
Decision-making, 4-Care planning, 5-Care delivery, and 6-Confirmation.  The therapeutic relationship 
prioritizes:  communication of treatment and care options; discussion of associated risks and benefits; and 
empowerment of the person with a life limiting illness to make informed choices and decisions at all 
stages during the therapeutic relationship (CHPCA, 2005).  
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Figure 3.1. Steps During a Therapeutic Encounter. 
  
Source:  Ferris, F. D., Balfour, H. M., Bowen, K., Farley, J., Hardwick, M., Lamontagne, C., 
Lundy, M., Syme, A., & West, P.  (2002). In: A Model to Guide Hospice Palliative Care.  Canadian 
Hospice Palliative Care Association, Ottawa, Canada, pp. 26. 
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Stage 4 of the therapeutic process in Figure 3.1. is the care planning stage.  Clinicians use the 
information they have gathered during the assessment through shared communication with, by, and about 
the person with a life limiting illness, and apply their own clinical judgment to inform decision making 
and care planning.  The clinician then formulates a client specific goal oriented care plan tailored to meet 
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the identified and prioritized needs of the person and their informal support network.  Often this done by 
nurses or trained case managers.  Nursing care plans typically begin with a defined diagnosis and identify 
how that diagnosis relates to other key issues (Haugen & Galura, 2010).  This initial step is also referred 
to as recognizing diagnostic clusters (Carpenito-Moyet, 2009).  Following, the clinician integrates both 
subjective and objective characteristics to identify risk factors for further decline or complication on a 
case-by-case basis.  In consultation with the client, desired outcomes should be matched with available 
interventions and a clear rationale provided to educate the person and their informal support network.  
Together with the person and their informal support network, a plan of care should be crafted based on 
the identified goals of care of the person and the recognized needs requiring care or intervention.  
The therapeutic relationship depends on an ongoing process of effective communication throughout 
three main phases of care (CHPCA, 2005).  Care planning during the intake phase establishes the initial 
approach identifying the person’s strengths, preferences and needs based on a collaborative dialogue 
between the clinical team, the person with a life limiting illness and their informal support network. The 
ongoing care phase promotes continuous revision of the care plan examining progress toward the person’s 
goals of care and any changes in clinical status.  Follow-up assessments track person-specific changes and 
may be used to evaluate outcomes including the effectiveness of interventions or treatments.  For 
example, if the person with a life limiting illness exhibited a pressure ulcer at initial assessment, the 
clinician may refer the person to a wound care program.  With consistent assessments, the clinician can 
monitor the person’s skin integrity and pressure ulcer status to determine whether adjustments are 
required to the approach to care. Baseline and follow-up assessments allow the clinician to evaluate 
whether change has occurred and provide evidence to inform an ongoing, collaborative approach to care 
planning in partnership with the person with a life limiting illness and their informal support network.  
Care planning in the final phase focuses on transitions to ensure continuity of care and optimal symptom 
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management for the person as they reach end of life and, for members of the informal support network, 
during the bereavement phase.  
Care planning for persons with a life limiting illness can be complex and involve issues where added 
sensitivity, patience, and understanding are needed.  While the priority for general care planning is 
usually outcomes based focusing on cure or rehabilitation of function to a previous level, care planning 
for persons receiving palliative care prioritizes maintenance or improvements in QOL through pain and 
symptom management.  Notwithstanding, clinicians must be careful to recognize that opportunities may 
arise for cure of some symptoms, especially when the expected prognosis is longer, and tailor the care 
plan accordingly.  Yet, even in the final moments of life, persons may still respond to treatment.  For 
example, dyspnea is one of the most distressing symptoms for persons with a life limiting illness and their 
caregivers (Ng and von Gunten, 1998; Potter, Hami, Bryan and Quigley, 2003; Kroenke, Johns, 
Theobald, Wu, & Tu, 2013).  It is highly prevalent and known to increase in severity as the person nears 
death (Booth, Moosavi, & Higginson, 2008).  Yet dyspnea should not be accepted as a normal part or 
expected part of the dying process.  Kuebler, Andry, and Davis (2007) note that in almost all cases, 
dyspnea will respond to intervention or treatment.  Therefore, while cure is not possible, symptom 
alleviation may remain an important and realistic goal of care for persons and treatment/management 
strategies aimed at reducing symptoms like dyspnea should be considered within the context of the 
burden/benefit ratio as well as the persons expected prognosis.    
Care planning for persons with a life limiting illness must address the treatment burden/benefit 
balance from the perspective and best interests of the person with a life limiting illness.  Clinicians must 
communicate available treatment and management options available throughout the care planning process 
and empower the person with the knowledge needed to determine whether treatments offered will cause 
added burden or distress.  In palliative care, it can be a challenging feat to balance the potential for 
treatment efficacy with futility in the context of expected prognosis.  Moreover, the burden that 
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undergoing a treatment may cause such as physical exertion, pain, or time must also be factored in.  
Specific to care planning at end of life is the need to balance quality versus quantity of life.  The care plan 
must address this quandary to ensure that the goals of the desired treatment are positioned within a 
realistic understanding.  It is important that decisions be made within the person’s individual cultural, 
religious, and spiritual context.  For example, persons from a Western culture may focus on prioritizing 
treatment addressing relief of pain and suffering while a person from a non-Western culture, who 
perceives the journey of pain and suffering before death as a test of faith, may not (Wold, 2008).  
Communication is key to unlock understanding between the clinician and the person and their informal 
support network during the care planning process to ensure that it is the goals of care of the person, which 
are being addressed, and not the goals recognized from within the socio-cultural perspective of the 
clinician.   
Another key consideration during the care planning process for persons with a life limiting illness is 
the role of the persons informal support network.  In community based palliative care, the responsibility 
for the majority of care often falls on the shoulders of the informal support network (Taube, 2005).  
Without adequate support, the magnitude and intensity of care provision necessitated to keep the person at 
home in the community as they progress along the illness trajectory may quickly overwhelm the person 
with a life limiting illness and his/her informal support network. Therefore, the care plan must include 
educational interventions to support and inform not only the person with a life limiting illness but also 
their informal support network with respect to current and projected expectations of need, level of care to 
be required, and availability of formal support services (Taube, 2005).  For example, the care needs for a 
person recently diagnosed with early stage dementia differ greatly from projected care needs in the later 
stages of the disease.  Awareness of future needs and illness progression, may empower the person with a 
life limiting illness to prepare and communicate preferred goals of care while they remain capable.  
   55 
4.  Introduction to the interRAI Suite of Assessment Instruments 
interRAI, an international not-for-profit research consortium of clinicians, researchers, health 
administrators, and health/social service professionals from over 35 countries in five continents, promotes 
“person-specific care” rather than “site specific care” (www.interrai.org) (Steel et al., 1999; Carpenter, 
Bernabei, Hirdes, Mor, & Steel, 2000; Bernabei et al., 2009).  The aim of interRAI is to enhance the 
health and well-being of vulnerable populations such as persons with a mental illness, frail older adults, or 
persons with disabilities, who require health care services in a variety of settings across the health care 
continuum.  The goal of interRAI “is to promote evidence-informed clinical practice and policy decisions 
through the collection and interpretation of high quality data about the characteristics and outcomes of 
persons served across the continuum of care” (interRAI Canada, 2013).  Each instrument offers multiple 
applications, including: CAPs for care planning to elucidate client needs; Outcome measures (scales such 
as the Activities of Daily Living Hierarchy or the Cognitive Performance Scale) to examine how the 
client is doing both at that moment and over time; and Quality indicators to assess quality of care and to 
benchmark how organizations may compare to others (e.g. across facilities, organizations, geographic 
regions). The interRAI suite of assessment instruments forms “an integrated system of health information 
linking person-specific data across the care continuum” (e.g. from home care and long-term care to acute 
and mental health services) (Hirdes et al., 1999; Hirdes et al., 2008; Gray et al., 2009).  
In Canada, the interRAI suite of assessment instruments are used in multiple care settings including:  
home care, assisted living, complex continuing care (CCC), LTC, acute care, inpatient and community 
mental health, and post-acute rehabilitation (Hirdes, 2006; Hirdes, Mitchell, Maxwell, & White, 2011).  
Clinicians may use full comprehensive assessments such as the RAI-HC for use in the home care setting 
or the MDS 2.0 for use in CCC and LTC, or may use shorter screening tools such as the interRAI Contact 
Assessment (Hirdes et al., 2010).  Different instruments have been adopted or mandated in various 
jurisdictions across Canada (Table 4.1.). 
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RAI 2.0 X X X X X   X X  X   X     
RAI-Home Care 
Assessment Instrument X X X X X   X   X   X     
RAI-Mental Health 
Assessment Instrument       * X *  *             
interRAI Community 
Mental Health         * *  *             
interRAI Emergency 
Screener for Psychiatry         *                 
interRAI Palliative Care 
Assessment Instrument   * *   X       X   X     
interRAI Intellectual 
Disability Instrument         *                 
interRAI Acute 
Care/Emergency 
Department Screener *     * *       *         
interRAI Contact 
Assessment       * X                 
interRAI Community 
Health Assessment         X                 
interRAI Assisted Living 
Assessment Instrument   *                       
interRAI Long-term Care 
Facility Instrument         X *                 
interRAI Subjective 
Quality of Life Assessment 
Instrument *   * * *       *         
 
*  denotes research/evaluation is underway   
X denotes instrument is mandated or recommended by the provincial government 
 
Adapted from:   
Hirdes, J.P. (2006). Addressing the health needs of frail elderly people: Ontario’s experience with an integrated health information 
system. Age and Ageing, 35, 329–331. 
Hirdes, J. P., Mitchell, L., Maxwell, C. J., & White, N. (2011). Beyond the ‘iron lungs of gerontology’: using evidence to shape the future 
of nursing homes in Canada. Canadian Journal on Aging, 30(3), 371. 
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While the focus of all interRAI instruments remains person specific care at an individual level, there 
are multiple benefits for organizations, researchers, health authorities, and policy makers to leverage these 
data to inform policy and organizational change at a systems level (Landi et al., 2000; Jones, Perlman, 
Hirdes, & Scott, 2010).  In addition to care planning, other uses of the interRAI suite of assessment 
instruments include:   
• Development of a resource use case mix system; 
• Targeting and evaluation of intermediate care; 
• Modeling of intermediate care service requirements; 
• Development of performance indicators for hospital service utilization; and 
• Benchmarking quality of care across care settings.  (Carpenter, 2006) 
4.1 interRAI Palliative Care Assessment Instrument (interRAI PC) 
The interRAI PC is a standardized assessment instrument developed to provide a comprehensive 
assessment of the strengths, preferences, and needs of all adults receiving palliative care (Steel et al., 
2003).  Two versions of the instrument, the full interRAI PC assessment (interRAI PC) and the shorter 
interRAI hospice form (interRAI PC-H), are designed to be used across the continuum of palliative care 
from community to residential or facility-based settings.  The full interRAI PC assessment includes more 
than 280 items covering 75 key areas which are grouped into 17 domains that include: identification and 
intake information, disease diagnosis, health conditions, oral status, nutritional status, skin condition, 
cognition, communication, treatments and procedures, mood, psychosocial wellbeing, functional status, 
continence, medications, responsibility and directives, social supports, and discharge information (Smith 
et al., 2010).  In contrast, the interRAI-PC-H is a shorter assessment designed for persons with a very 
limited prognosis (making it relevant to the final stage of care planning) and includes a subset of less than 
180 items from the full interRAI PC.   
 The interRAI PC is not a questionnaire but rather a “standardized minimum assessment tool” 
(Smith et al., 2009) that uses all sources of information including interviews of the person and caregivers, 
chart reviews, and interaction with other clinical team members. The assessments are to be completed by 
trained assessors and use a three-day observation period for most domains.  The breadth of items 
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collected inform a comprehensive evidence base, which when combined with clinical judgment, are 
useful to inform the development and implementation of care plans tailored to address the unique needs of 
persons with a life limiting illness.  Items contained in the interRAI PC have shown excellent inter-rater 
and test-retest reliability (Steel et al., 2003; Hirdes et al., 2008).  
In Canada, piloting of the interRAI PC and the process to develop the interRAI PC CAPs began in the 
winter/spring of 2004 (Smith, 2009).  Partly funded by the Ontario Ministry of Health and Long-term 
Care, data were initially collected from five Community Care Access Center’s (CCACs) in Ontario 
(Smith, 2009).  A sixth CCAC joined the pilot in the later years of the pilot.  An on-going feedback 
system was created between the interRAI Instrument and System Development (ISD) committee and case 
managers, clinicians, and decision makers involved in the pilot.  Focus groups were held with all pilot 
sites to gather feedback and face validity of the assessment form (Smith, 2009).  An assessor feedback 
form was used to inform which items to add, drop, or modify in order to meet the country specific needs 
of the Canadian population (Smith, 2009).  The interRAI PC was piloted, using different software 
supports, in numerous sites and care settings across Canada. Research grade software developed included 
a fillable pdf form for use in a paper-based format, a web-based assessment form, and an excel-form 
version (Smith, 2009).  Data were collected from: home care regions in Ontario, Manitoba, 
Saskatchewan, Alberta, British Columbia, and the Yukon; Complex Continuing Care facilities and 
hospitals in Ontario, Manitoba, and Alberta; and in Specialized Palliative Care hospice programs in 
Alberta, and Ontario.  International pilot sites for the instrument included the Czech Republic, Sweden, 
USA, Netherlands, Iceland, Germany, and Japan.  Interest has recently been expressed in New Zealand 
and South Korea. 
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4.2 interRAI Clinical Assessment Protocols (CAPs) 
 Clinical Assessment Protocols (CAPs) empower clinicians with knowledge to inform 
development of a person-specific, tailored plan of care. While the interRAI instruments enable care 
providers to address key factors such as aspects of function, health, and social support; the CAPS assist 
care providers investigate in greater depth areas where specific intervention may be warranted.  They 
enable clinicians to organize their clinical observations in a systematic manner to identify factors that 
influence clinical and other outcomes (Gray et al., 2009).  
Each CAP contains four core components:  Issue Statement, Goals of Care, Triggers, and Best 
Practice Guidelines.  The issue statement provides a clear rationale for why the specific CAP domain 
should be considered an important part of the palliative care services approach and how it impacts on the 
person with a life limiting illness’ life.  While the goals of care may vary by CAP, each focuses on 
resolving the problem, reducing risk of further decline, maximizing potential for improvement, or 
maintaining function to the best extent possible. CAP triggers use clinical decision support algorithms 
(available on the interRAI website www.interRAI.org) to link information gathered from the assessment 
to the specific problem referenced by the CAP.  Because CAPs identify problems or issues that may not 
have been previously identified by the clinician, they have been found to assist in the prevention of 
further decline, reduction of unnecessary hospital or emergency room visits, and can assist to delay or 
prevent admission to LTC (Carpenter, 2006). 
Assessment specific CAP manuals are available to accompany various instruments including the 
RAI-HC, the MDS. 2.0, RAI-MH and the interRAI-CMH.  The CAP manuals are a resource guide 
directing clinical interpretation and understanding of the CAPs.  Each CAP manual details background 
information to the problem of focus and providing guidance on the goals of treatment to be considered 
during the care planning process (Carpenter, 2006).  Within each CAP description, best practice 
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guidelines are summarized to assist clinicians to reflect on potential underlying issues to be considered 
during the care planning process.  
Previous versions of the interRAI suite of instruments included assessment specific care planning 
protocols such as the Resident Assessment Protocols (RAPs) (Fries, Morris, Bernabei, Finne‐Soveri, & 
Hirdes, 2007) to be used when care planning in LTC, and the Mental Health Assessment Protocols 
(MHAPs) (Martin et al., 2009) used when care planning for persons receiving community or in-patient 
mental health services.  Recently, RAPs and MHAPs have been revised into newly labeled CAPs to 
reflect interRAI’s emphasis on communication and compatibility of the suite of assessment instruments 
across care settings.  Over forty CAPs have been developed ranging from clinically oriented problems 
such as dyspnea and fatigue to psychosocial issues including depression and self-harm.  The interRAI PC 
CAPs are unique as they address issues framed within an end-of-life context, allowing for greater 
attention to symptoms that may or may not be appropriate to treat depending on estimated prognosis.  
4.3 interRAI Palliative Care Clinical Assessment Protocols (interRAI PC CAPs) 
The first generation of the interRAI PC CAPS (Steel et al., 2013e) use algorithms based on the items 
and scales in the interRAI PC assessment and they provide specific guidelines on eight CAP issues most 
relevant to persons with a life limiting illness with special consideration to the importance of estimated 
prognosis. Three types of CAPs: Performance (Fatigue and Sleep Disturbance CAPs); Clinical 
Complexity (Nutrition, Pressure Ulcers, Pain, and Dyspnea CAPs); and Cognition and Mental Health 
(Mood Disturbance and Delirium CAPs); each address how the clinical issue may affect the person.  An 
overview of the trigger levels for each CAP shown will be discussed in greater depth in the following 
sections. 
 The interRAI PC CAPs development process was a three phase multiyear initiative involving an 
international committee representing nine countries. The CAP development process was comprised of 
several tasks:  
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• A review of relevant scientific literature; 
• Analysis of existing interRAI data holdings to identify outcomes within sub-populations across 
multiple assessment periods; and 
• Summary of expert opinion by interRAI members and their associates (Gray et al., 2009). 
 
The first phase identified the key domains to be addressed by CAPs in palliative care through review 
of scientific and clinical practice publications.  Information was gathered from at least three different 
global regions to ensure the CAPs are able to inform palliative care internationally and are not country 
specific.  To represent the uniqueness of the Canadian context, resources were gathered in both French 
and English languages where available. In the second phase key informants and subject-matter experts 
were engaged to provide input on the components of the CAP through a series of consultations.  Feedback 
was useful to ensure face, content, and construct validity of the CAPs and to ensure that the CAP contents 
were clinically relevant to clinicians across the care continuum.  A 2010 meeting, involving Canadian and 
international experts, provided rigorous feedback for evaluation and revision to the CAPs. During phase 
three, triggers for the CAPs were developed using interRAI PC pilot data collected between 2006 and 
2009 from CCAC’s across Ontario.  This process resulted in development of an interRAI PC CAP manual 
(Available from www.interrai.org) that outlines all eight interRAI PC CAPs.  
4.3.1 Dyspnea CAP 
The Dyspnea CAP helps clinicians recognize persons with a life limiting illness experiencing dyspnea 
when performing regular activity (Steel, Morris, & Leff, 2013a).  The goals of care of focus on 
determining the severity of dyspnea symptoms and recognizing potential need for emergency 
intervention.  Persons with a life limiting illness who trigger the Dyspnea CAP exhibit moderate or worse 
dyspnea at rest or when performing normal daily activities.  Steel, Morris, & Leff (2013a) estimate that 
nearly 45% of palliative home care clients trigger the Dyspnea CAP of which almost half continue to 
trigger at follow-up.  The Dyspnea CAP guidelines highlight strategies to identify onset and severity of 
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dyspnea symptoms and to investigate possible causes of the symptoms.  In addition, the Dyspnea CAP 
guidelines provide information on treatment options and education. 
4.3.2 Delirium CAP 
The Delirium CAP helps clinicians identify persons experiencing delirium in palliative care settings.  
The goals of care highlight the importance of identifying and treating any underlying causes, monitoring 
and addressing symptoms, preventing future complications, and maximizing quality of life (Steel, Inouye, 
Morris, Murphy, & Marcantonio, 2013b).  Persons who trigger the Delirium CAP exhibit of one or more 
of the following symptoms that are different from the person’s usual functioning: Easily distracted; 
Episodes of disorganized speech; Mental function varies over the course of the day; or Acute changes in 
mental status. Steel, Inouye, Morris, Murphy, & Marcantonio (2013b) estimate that less than 15% of 
palliative home care clients trigger the Delirium CAP.  The Delirium CAP guidelines highlight key 
considerations and strategies for addressing symptoms of delirium.   
4.3.3 Fatigue CAP 
The Fatigue CAP is one of the most commonly triggered CAPs for persons with a life limiting illness.  
It identifies two groups whose QOL may be affected by symptoms of fatigue:  (1) Persons who are 
currently experiencing severe fatigue, and (2) Those at risk of experiencing severe fatigue (Olsen, Steel, 
Ljunggren, Steel, & Smith, 2013).  An estimated 43% of palliative home care clients experience severe 
fatigue and are unable to conduct some or all of their normal daily activities (Olsen, Steel, Ljunggren, 
Steel, & Smith, 2013).  In contrast, persons at risk of experiencing severe fatigue exhibit two or more of 
the following characteristics:  limited prognosis, recent fall, acid reflux, nausea, dry mouth, excessive 
sweating, thirst, memory problem, or exhibits signs of anxiety, depression, or activity withdrawal. Olsen, 
Steel, Ljunggren, Steel, & Smith, (2013) note up to 30% of the palliative home care population trigger at 
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risk for fatigue.  Fatigue CAP guidelines inform clinicians of issues specific to the trigger level group and 
suggest strategies to identify possible causes and to assist in symptom reduction.   
4.3.4 Pressure Ulcer CAP 
 The Pressure Ulcer CAP (PU CAP) helps clinicians determine the level of risk of developing a 
pressure ulcer and educate about methods for prevention to reduce potential risk (Steel et al., 2013c).  
This CAP is the least likely of all eight interRAI PC CAPs to be triggered among palliative home care 
clients.  The overall goals highlight the importance to treat existing pressure ulcers appropriately.  The PU 
CAP triggers are based on presence of a pressure ulcer and on the presence of the following protective 
characteristics:  absence of pain; absence of other skin ulcers; minimal care needed for personal hygiene; 
minimal assistance needed with bed mobility or transferring to the toilet; or bowel continent.  If a person 
exhibits five or more protective factors and has a pressure ulcer then they would trigger the PU CAP as 
likely to improve.  Steel et al. (2013c) found less than 5% of the palliative home care clients trigger the 
PU CAP as likely to improve, of which over 80% no longer have a pressure ulcer present at follow-up.  
Persons with four or fewer of the protective factors and a pressure ulcer present at the time of assessment 
trigger the PU CAP as difficult to improve.  Steel et al. (2013c) estimate that of the 7% of palliative home 
care clients trigger as difficult to improve, of whom 56% no longer have a pressure ulcer at follow-up.  
The PU CAP guidelines address considerations for existing pressure ulcers, describe strategies for 
pressure ulcer management, and suggest approaches for prevention of pressure ulcers. 
4.3.5 Mood Disturbance CAP 
The Mood Disturbance CAP helps clinicians identify and address any immediate effects of depression 
or anxiety on the person’s health and wellbeing and to recognize underlying symptoms and conditions 
(Smith, Rabinowitz, Hirdes, Morris, Stewart, Constantino, & Steel, 2013).  The goal of the Mood 
Disturbance CAP is to improve the person’s psychological well-being and support their engagement in 
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the decision making process.  Persons with a single mood symptom trigger the first level of the Mood 
Disturbance CAP while persons with multiple symptoms trigger at higher risk.  Mood symptoms focus on 
feelings of anxiety and sadness, whether the person is expressing a wish to die at the time of assessment, 
and on the ability to find pleasure in usual activities.  Smith, Rabinowitz, Hirdes, Morris, Stewart, 
Constantino, & Steel (2013) estimate that one third of palliative home care clients trigger the Mood 
Disturbance CAP of which an equal proportion trigger with a single mood symptom or multiple mood 
symptoms.  Over half of the persons who trigger either level will no longer have the symptom(s) at 
follow-up (Smith, Rabinowitz, Hirdes, Morris, Stewart, Constantino, & Steel (2013).   The Mood 
Disturbance CAP guidelines assist clinicians to identify best practice approaches to address the mood 
symptoms, determine the nature of the disorder, and to outline potential treatment and monitoring 
considerations.  
4.3.6 Nutrition CAP 
The Nutrition CAP identifies persons who are experiencing anxiety about not eating, could benefit 
from optimized energy and protein intake, or who may require intervention to alleviate hunger (Steel, 
Morris, Sorby, & Steel, 2013d).  The goals of the Nutrition CAP focus on educating the person and the 
informal support network about nutrition specific issues and conditions.  Persons who have a BMI less 
than 20 trigger the Nutrition CAP and are divided into two groups depending on whether they have 
recently lost weight. Steel, Morris, Sorby, & Steel, (2013d) estimate that 17% of palliative home care 
clients exhibited both low BMI and recent weight loss while 11% had low BMI but had not experienced 
recent weight loss.  The Nutrition CAP guidelines focus on symptom management and provide 
information about food and fluid intake specific to prognosis.  
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4.3.7 Pain CAP 
The Pain CAP, based on the Palliative Pain Index, combines multiple levels of pain ranging from no 
pain to severe, horrible, or excruciating pain (Won et al., 2010). The goals of the Pain CAP are to relieve 
suffering where possible, identify any underlying causes, optimize comfort and treatment efficacy, and 
closely monitor for any adverse events.  Persons who trigger the Pain CAP at a high priority indicate 
presence of severe, horrible, or excruciating pain.  Persons who trigger the Pain CAP at a medium priority 
exhibit mild to moderate pain with breakthrough pain.   Won et al. (2013) estimate that about 20% of 
palliative home care clients trigger each Pain CAP group respectively.  Guidelines for the Pain CAP focus 
in detail on assessment and management strategies. 
4.3.8 Sleep Disturbance CAP 
The Sleep Disturbance CAP helps clinicians determine and understand the nature of the sleep 
disturbance and identify any underlying causes (Ljunggren, Olson, Smith, Steel, Hirdes, & Morris, 2013).  
Goals of the Sleep Disturbance CAP are to reduce the sleep disturbance and maximize comfort and 
functioning.  Two groups of persons may trigger the Sleep Disturbance CAP, those with a high potential 
to improve and those with a moderate potential to improve.  Potential to improve is based on presence of 
a list of reversible issues.  If the person exhibits difficulty sleeping and has two or more of the reversible 
issues as listed in the interRAI PC CAP manual, then they will trigger at a high potential to improve.  
Those who trigger with moderate potential to improve also have difficulty sleeping but exhibit one or no 
reversible issues. Ljunggren, Olson, Smith, Steel, Hirdes, & Morris (2013) found that 17% of persons 
trigger the Sleep Disturbance CAP with high potential to improve of which 78% did not have a sleep 
problem at follow-up.  In addition, they note that of the 13% who triggered with moderate potential to 
improve, 48% did not have a sleep problem at follow-up. 
   66 
4.4 Other Care Planning Tools 
The current processes of care planning differ greatly by geographic region and by means.  In Canada, 
a wide variety of tools are available, in addition to the interRAI PC, to inform the care planning process.  
In some regions, multiple assessment tools are used to inform the care planning process while in other 
regions, a single tool may be used.  For example, on their website www.palliative.org, the Edmonton 
Regional Health Authority (ERHA) in Edmonton, Alberta, Canada lists 11 different assessment tools and 
guidelines developed by the Edmonton Zone Palliative Care Program (2013a) in addition to a list of 
references for other assessment tools that may be used.  Some tools are symptom specific such as the 
Constipation Score (http://www.palliative.org/NewPC/proffesionals/tools/const_score.html), or the 
CAGE Questionnaire (Ewing, 1984), while others such as the Edmonton Symptom Assessment System-
Revised (ESAS-r) (Watanabe et al., 2011), address multiple symptoms.  During the care planning process, 
a clinician in the ERHA may use a variety of these tools, as they perceive necessary to identify the needs 
of the person with a life limiting illness.  The tools used differ for each client.  This may allow for shorter 
assessments when less information is perceived necessary by the clinician to inform their judgment during 
the care planning process.  This can reduce the burden on the client as they may not need to spend as 
much time to be assessed.  It allows the clinician increased freedom to choose what information they 
gather and the means in which to do so. However, when different assessment tools are used on a case-by-
case basis, comparisons between persons with a life limiting illness, even among the same clinicians 
caseload, may be challenging.  This style of care planning process, which may use a large variety of 
different assessments to complete one care plan for each person with a life limiting illness, is contrasted 
by the process conducted in Hamilton, Ontario, Canada where a case manager completes only the 
interRAI PC and the Palliative Performance Scale (PPS). In Hamilton, all persons with a life limiting 
illness are measured using the same tools allowing for comparison within the caseload and across the 
health region.  Use of a standardized method of data collection creates a strong evidence base useful to 
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inform regional policy as it allows for recognition of regional variation, benchmarking, and identification 
of population specific needs.   
To understand the diversity in care planning tools available, an overview of some key tools used in 
various settings to assess the needs of persons receiving palliative care will be provided.  The PPS, ESAS, 
ESAS-r, and the Liverpool Care Pathway (LCP) are well-known tools used in different contexts.  A brief 
description of each tool is followed by comparison of its strengths and weaknesses in contrast to the 
interRAI PC. 
4.4.1 Palliative Performance Scale (PPS)  
The Palliative Performance Scale (PPS)
1
 was developed by the Victoria Hospice Society, British 
Columbia as a variant of the Karnofsky Performance Scale (Crooks, Waller, Smith, & Hahn, 1991) to 
assess change in functional status and to measure the degree of decline across the illness trajectory (CCO, 
2005a).  The PPS measures overall performance to provide a ‘best guess’ estimation of prognosis (CCO, 
2005b).  The PPS is divided into 11 levels, organized into three stages: stable, transitional, and end-of-
life.  Levels, measured at 10% increments ranging from 100% to 0% where a higher score reflects better 
functioning and 0 represents death, have been found to be valid measure of survival (Morita, Tsunoda, 
Inoue, & Chihara, 1999; Younis et al., 2009).  Harris et al. (2013) describe the range of the five domains 
of the PPS as follows: “ambulation (bed-bound to full), activity (unable to work to normal), self-care 
(completely dependent to completely independent), intake (mouth care only to full diet), and level of 
consciousness (drowsy or coma to fully alert)” (page 414).  Scoring proceeds in this order so that the first 
categories (e.g., ambulation, activity) are given the greatest weights. In clinical settings, the PPS is 
gaining in popularity among clinicians  (Fainsinger, Demoissac, Cole, Mead-Wood, & Lee, 2000) to aid 
in planning care (Barbera et al., 2010), and for communication (Anderson, Downing, Hill, Casorso, & 
                                                     
 
1
 The PPS tool may be viewed at Palliative Performance Scale (PPSv2) version 2 [PDF] online. 
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Lerch, 1996; CCO, 2005b).  It is short, quick to complete, and simple for clinicians to understand with 
minimal instruction. The PPS is used to estimate prognosis in homogeneous as well as minority 
populations (Harrold et al., 2005; Downing et al., 2007; Weng et al., 2009) and to assess needs for home 
care services (Anderson, Downing, Hill, Casorso, & Lerch, 1996; Ma et al., 2010). However, recent 
concerns have been raised that some PPS scores exhibit a high likelihood of overestimation of estimated 
prognosis (Selby et al., 2011).  
Compared to the interRAI PC, the PPS form is much shorter, briefer and may be perceived as more 
user friendly due to its simplicity.  It also provides a limited scope of information on the person with a life 
limiting illness and no information on their informal support network for clinicians.  The PPS fails to 
inform clinicians of psychological, social, or spiritual issues important to person with a life limiting 
illness and does not address informal caregivers, loss and grief, end of life care, death management, nor 
advanced directives.  The PPS is limited to functional and cognitive functioning of the person faced with 
a life limiting illness and provides minimal information for care planning in stark contrast to the over 280 
items covering 75 key areas grouped into 17 domains captured by the interRAI PC.  The interRAI PC 
contains the Changes in End Stage Signs and Symptoms (CHESS) Scale, which has been validated and 
shown to predict health instability in community and residential populations and shown to be a reliable 
predictor of estimated prognosis in nursing home and home care settings  (Hirdes, Frijters, & Teare, 2003; 
Armstrong, Stolee, Hirdes, & Poss, 2010; Hjaltadóttir, Hallberg, Ekwall, & Nyberg, 2011; Tjam, et al., 
2012). 
4.4.2 Edmonton Symptom Assessment System (ESAS) and the Edmonton Symptom Assessment 
System Revised (ESAS-r) 
 The Edmonton Symptom Assessment System (ESAS) is a validated screening tool to screen to 
identify presence and severity of symptoms (Barbera et al., 2010).  It is designed to identify if the person 
with a life limiting illness requires further more detailed assessment and/or possible intervention (Barbera 
et al., 2010).  It focuses on nine symptoms common in palliative care:  pain, tiredness, drowsiness, 
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nausea, lack of appetite, depression, anxiety, shortness of breath, and wellbeing (Bruera, Kuehn, Miller, 
Selmser, & Macmillan, 1991).  Like the PPS, the ESAS is limited to the person with a life limiting illness 
and does not include items on informal caregiver’s situation or of caregiver distress.  A tenth domain 
however does allow for persons to report an additional symptom of their choosing.   This self-report 
subjective assessment may be used to identify changes frequently and can be used on a monthly, weekly, 
or daily basis depending on the person’s changing care needs. Symptom distress is scored using a visual 
analogue scale where zero represents the absence of the symptom and ten represents the worst possible 
severity. Chang, Hwang, and Feuerman (2000) validated the ESAS against the Memorial Symptom 
Assessment Scale (MSAS), the Functional Assessment Cancer Therapy survey (FACT), and the 
Karnofsky Performance Status (KPS).  In addition, a review by Watanabe, Nekolaichuk, Beaumont, 
Johnson, Myers, & Strasser (2011) lists over 10 studies that evaluated the reliability, validity, or 
sensitivity and/or specificity of the ESAS. 
 In a revised version of the ESAS, the ESAS-r
2
, the visual analogue scale has been replaced with 
an 11-point numerical scale (Edmonton Zone Palliative Care Program, 2013b).  In the ESAS-r, the person 
is required to circle the specific number on the same scale of zero to ten indicating symptom severity. The 
ESAS-r also includes definitions of key terminology reducing ambiguity and confusion found in the 
original version of the ESAS.  The ESAS-r retains the original symptom items in a revised order. 
Watanabe, Nekolaichuk, Beaumont, Johnson, Myers, & Strasser (2011) found that the ESAS-r was easier 
for patients and clinicians to understand and complete and more user friendly.  
 If the person with a life limiting illness is unable or refuses to complete the ESAS or the ESAS-r, 
then it is possible for a member of their informal support network to complete it as a proxy.   
Nekolaichuk, Bruera, Spachynski, MacEachern, Hanson, & Maguire, (1999) found significant differences 
                                                     
 
2
 The ESAS-r tool may be viewed at Edmonton System Assessment System Revised (ESAS-r) 
[PDF] online 
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in patient and physician/nurse proxy reporting using the ESAS.  They found that physicians were more 
likely to rate symptom severity lower while nurse’s ratings were closer.  Moreover, they also found that 
these differences in ratings failed to improve over time and recommended further research was needed 
into proxy reporting.  In contrast, Resnizky and Bentur (2007) found moderate to high correlation (0.458 
fatigue ~ 0.787 shortness of breath) between informal caregiver proxy reporting and suggested that proxy 
reporting is reliable.  
 In contrast to all other tools, the ESAS and the ESAS-r may be completed directly by the person 
with a life limiting illness without any direction or in consultation with a health care professional.  It is 
very quick to complete and recognized as user friendly.  Unlike the interRAI PC that uses a trained 
assessor to gather information from multiple sources, the ESAS and the ESAS-r focus solely on self-
report (or proxy report when necessary).  This modular approach reduces the amount of assessment 
burden required as the client is able to report on their on perceptions without taking the time to complete 
objective measures or answer questions and interact with a clinician.  In contrast to the simplicity in data 
collection of the ESAS and ESAS-r, the interRAI PC is much more time and labour intensive involving 
data gathering and triangulation of findings from multiples sources.  The first source is to ask the person 
directly and to observe non-verbal cues such as facial expressions or body movements.  In addition, the 
assessor then gathers information from persons who know the client (including family, friends, and other 
health care professionals) and consults available medical records.  Using multiple sources of information 
beginning with the person enables the clinician to gain a comprehensive description of the individual 
person.    
The interRAI PC includes all domains gathered by the ESAS and the ESAS-r with the exception of 
the opportunity to report an ‘other’ symptom.  While the interRAI PC does not allow for any adjustments 
to the assessment forms on a local level, clinicians are able to write notes to be included with the 
assessment in the assessment record.  The interRAI PC addresses five of the nine ESAS and the ESAS-r 
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domains [pain, tiredness (fatigue), lack of appetite (nutrition), depression, and shortness of breath 
(dyspnea)]; with great depth through symptom specific interRAI PC CAPs.  The ESAS and the ESAS-r 
gather self-report information but do not provide guidance to clinicians on how that information may be 
used to inform care planning.  This differs greatly from the interRAI PC that is a ‘complete symptom 
assessment’ which encompasses a wide range of symptoms to provide that ‘whole person’ picture to 
inform care planning. 
4.4.3 Liverpool Care Pathway for the Dying Patient (LCP) 
The Liverpool Care Pathway for the dying patient (LCP)
3
, developed in the UK for actively dying 
persons, aims to facilitate high quality end of life care and serve as a model of quality practice supporting 
care (Marie Curie Palliative care Institute, 2012).  The LCP focuses on symptoms and care when the 
person is dying in last days and hours of life.  The LCP provides guidance to clinicians on care planning 
domains including: comfort measures, anticipatory prescribing of medication, and discontinuation of 
inappropriate interventions (Watson, Lucas, Hoy, & Wells, 2009).  It is comprised of three sections:  
Initial assessment (identification of key goals of care, addressing pain and symptom management, and 
review of appropriate pain medication regimen); Ongoing care (team approach using four-hour 
observation window for symptom identification and timely response); and Care after death (identify 
support and education needs for informal support network).  The LCP emphasizes communication 
between the person, their informal support network and health care team, taking into special consideration 
the person’s physical, psychosocial and spiritual needs.  The LCP uses a standardized assessment strategy 
to facilitate and monitor treatments and evaluate person specific outcomes (Veerbeek et al., 2008).  
The LCP provides detailed person specific information to inform care planning over a variety of 
domains.  Like the interRAI PC, the LCP emphasizes a multidisciplinary team approach to care that 
                                                     
 
3
 The LCP tool may be viewed at Liverpool Care Pathway [PDF] online 
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incorporates the person and their informal support network.  However, in contrast to the interRAI PC, 
which can be used at any time during the illness trajectory from the point of diagnosis with a life-limiting 
illness, the LCP is specifically designed for persons who are dying.  To be eligible for the interRAI PC, 
the person must be recognized as having a need that may benefit from a palliative approach, while 
eligibility for the LCP is more narrowly based on consensus by the health care team that the patient is 
dying.  If deterioration has been occurring over a period of weeks to days, the LCP requires the person 
meet two of the following four criteria:  bed-bound, semi-comatose, only able to take sips of fluid, or 
unable to take tablets (Watson, Lucas, Hoy, & Wells, 2009).  While the LCP specifically applies to 
persons who are dying, it may not be appropriate to conduct the full interRAI PC at that time. The 
interRAI PC-H is a shorter assessment tool, appropriate for persons in the final stages at end-of-life.  The 
interRAI PC fits the mandate of palliative care that recognizes the value for information exchange 
between the person with a life limiting illness, their informal support network, and care providers to occur 
as early as possible in the illness trajectory.  The design of the LCP, and in particular eligibility 
requirements, may be more restrictive towards persons where prognosis is more clearly evident such as 
persons with advanced terminal cancer.  The criteria used to identify those who are actively dying may 
not apply in the same way to the non-cancer population.  In contrast, the interRAI PC is not disease 
specific and is easily used to assess all persons with a life limiting illness.  It may be possible for the 
interRAI PC-H and the LCP to work together in a complementary fashion to inform clinicians of the 
person with a life limiting illness’ needs across the illness trajectory however future research is needed.  
The interRAI PC, and more specifically use of the CHESS scale, may be useful to identify persons with a 
life limiting illness who may be nearing an actively dying phase and who may benefit from assessment 
using the LCP. 
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4.4.4 Summary Findings of Instruments Used in Care Planning 
Implementation of a standardized comprehensive assessment tool in palliative care may lead to:  
 
• Earlier identification; 
• Systematic documentation;  
• Enhanced communication; 
• Evidence informed care planning; and  
• Better management of symptoms (CCO, 2009). 
 
This may decrease unnecessary ER visits, hospitalizations, and length of stay.  To achieve these results, it 
is important that the screening and assessment tools to gather relevant person-specific information to 
ensure all domains important to the person with a life limiting illness are addressed.  Of all the tools 
discussed, the interRAI PC is the most comprehensive covering more domains recognized by the CHPCA 
(Figure 2.8.) than the PPS, ESAS, and LCP.  The clinical practice guidelines for quality palliative care, 
developed as a component of the National Consensus project in the United States identified eight areas 
paramount to quality whole person palliative care provision:   
1. Structure and Processes of Care; 
2. Physical Aspects of Care; 
3. Psychological and Psychiatric Aspects of Care; 
4. Social Aspects of Care; 
5. Spiritual, Religious, and Existential Aspects of Care; 
6. Cultural Aspects of Care; 
7. Care of Imminently Dying; and 
8. Ethical and Legal Aspects of Care.  (NCP, 2013) 
 
Of these common tools used to assess persons with a life limiting illness: the PPS, ESAS, ESAS-r, the 
LCP, and the interRAI PC, the interRAI PC is the only assessment instrument that addresses all of these 
aspects to care in-depth, for all persons with a life limiting illness regardless of estimated prognosis.  The 
interRAI PC is the only tool which meets four essential components necessary for care planning:  
universality, coordinated care, a broad range of services, and provision of care regardless of setting 
(Picard, 2010).  The interRAI PC assessment is appropriate to assess all persons with a life limiting illness 
regardless of disease diagnosis, trajectory, prognosis, or setting of care.  The interRAI PC is the only tool 
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to meet the definition of palliative care as defined by the WHO and provide both ‘impeccable assessment’ 
and support means for ‘early identification’ of need for palliative care for persons with a life limiting 
illness regardless of disease diagnosis or estimated prognosis. 
Due to the finite amount of palliative care resources available, it is important to use a standardized 
comprehensive assessment to direct resources toward persons with a life limiting illness with the greatest 
needs.  The PPS, ESAS, ESAS-r, and the LCP were all developed with a focus on persons diagnosed with 
cancer and have since begun to be tested for applicability to non-cancer populations.  In contrast, the 
interRAI PC was developed as a ‘person specific’ comprehensive clinical assessment to examine the 
needs of any person with a life limiting illness without discrimination or bias based on disease diagnosis.  
The interRAI PC is the only tool which informs care planning throughout the disease trajectory based on 
identified and expressed preferences, values, goals, needs, and circumstances of the patient and their 
caregivers.  In addition, only the interRAI PC is fully compatible with other interRAI instruments in 
widespread use in other sectors of the Canadian health care system. 
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5.  Study Rationale and Methodological Overview of Research 
5.1 Study Rationale 
The WHO (2010) emphasizes the use of  ‘early identification’ and ‘impeccable assessment’ to 
improve quality of life, and to prevent and relieve of suffering in palliative care. Through the use of high 
quality assessments, a standardized approach to palliative care can identify persons with a life limiting 
illness that may benefit from palliative care services early in the illness trajectory in a consistent manner.  
This enables care providers to identify issues pertinent to each individual situation, ensure the informal 
support network and formal care providers are matched with the skills to perform assigned duties, and to 
tailor a person-centered care plan that fits the needs of the person with a life limiting illness at the 
appropriate time in the desired setting.  Evidence informed decision-making utilizing data gathered from 
standardized assessments facilitates higher quality of person-centered care by ‘leveling the playing field’ 
(Pereira & Bruera, 2001).   
Standardized assessment and measurement through use of the interRAI PC provide systematic means 
to identify need at the individual person level and can be used at an aggregate level to create an evidence 
base to inform community, regional, and national standards and policies.  Using evidence to inform care 
planning enables clinicians to understand with greater acuity the strengths, preferences and needs of the 
person.  Leveraging of evidence from the interRAI PC will empower clinicians with knowledge to more 
accurately address and target resources to meet the needs of persons with a life limiting illness.  Palliative 
care in Canada has been described as a ‘patchwork-quilt’ of services and programs provided 
inconsistently by care providers across regional jurisdictions (Williams et al., 2010).  Access to palliative 
care in Canada is often based on “the luck of the draw” rather than basic entitlement (Carstairs, & 
Beaudoin, 2000, Part I A).  It is “variable, fragmented, and financed through different mechanisms” 
(Romanow, 2002, page 182), and it leads to very different roles to be filled by various palliative care 
providers (Gaudette et al., 2002). As a result of unequal access to the patchwork of available palliative 
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care services in Canada, less than one in eight Canadians who may benefit from palliative care are able to 
access care (Carstairs & Beaudoin, 2000).  There is a lack of information from a population level on how 
systematically collected comprehensive person level evidence may be used to inform clinical decision 
making for persons with life limiting illness’ in Canada.  Using information collected in a standardized 
comprehensive manner across jurisdictions will allow for investigation of regional differences in 
accessibility. 
5.2 Data Source 
The interRAI PC is a standardized assessment instrument developed for persons with a life limiting 
illness residing in multiple care settings and included more than 280 items on demographic information; 
covering 75 key areas grouped into 17 unique domains (Steel et al., 2003; Smith et al., 2010).  
Assessments with the interRAI PC in home care settings in Ontario are completed by trained assessors 
and use a three-day observation period for most domains.  Assessors consult multiple sources of 
information such as direct observation or communication with the person with a life limiting illness, the 
informal support network, and team of health care providers, and in consultation with available medical 
records, when completing the interRAI PC.   
Data gathered from interRAI PC provide a comprehensive description of the individual care needs of 
palliative clients, which when combined with clinical judgment, is useful to inform the development and 
implementation of person specific care plans.  The interRAI PC is considered both reliable and valid and 
the items contained within have excellent inter-rater and test-retest reliability for conducting population-
based research (Steel et al., 2003; Hirdes et al., 2008).  In a 12-country study, Hirdes et al. (2008) 
examined the psychometric properties and the reliability of five interRAI instruments including the 
interRAI PC.  Using interRAI PC data gathered from the Czech Republic, Iceland, Norway, Spain, and 
the United States, Hirdes et al (2008) found strong evidence to support the inter-rater reliability of the 
interRAI PC. Although Hirdes et al. (2008) did not report the specific reliability of individual mood and 
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dyspnea items, all items with weighted kappa’s of less than 0.40 were not retained with the exception of 
measures of volatile symptoms like fever.  Carpenter (2006) notes that each assessment instrument 
undergoes validity and reliability testing by a research and development team.  Prior to use, the 
instruments undergo international research and development testing where the instruments are tested 
against proven scientific evidence and undergo testing against available gold standards (Carpenter, 2006).  
Hirdes et al. (2002) note that criterion validity has been established for numerous outcome scales 
including the CPS, ADL-H, and DRS. Specific to the development of the interRAI PC, Gray (2009) notes 
that the extensive field testing of the interRAI PC focused on item response rates, inter-rater reliability, 
and included convergent validity within the outcome scales.   
 During the CAP development process of the interRAI PC, steps were taken to ensure face and 
content validity of the instrument, through widespread stakeholder consultation, evaluation of best-
practice guidelines, and pilot testing with clients receiving palliative care services. Examination of 
specified outcomes at follow-up assessment will enable further understanding of the importance of 
triggering the Dyspnea CAP and to elucidate any increased risks for negative events.  
A total of 7,168 interRAI PC assessments, collected between 2006 and 2011 were available for 
inclusion in the current analysis. A total of 399 assessments were excluded.  Persons who resided in the 
community and were assessed to receive community based palliative homecare services were selected as 
the focus of these research studies as they comprised the vast majority of persons on whom the interRAI 
PC assessments were completed.   Persons known not to reside in a private home/apartment/rented room 
at time of assessment (n=222) were excluded.  Residential and living status at time of assessment for 
those excluded from the current analysis included:  board and care (n=24), assisted living or semi-
independent living (n=113), mental health residence such as a psychiatric group home (n=5), group home 
for persons with physical disability (n=2), setting for persons with intellectual disability (n=4), homeless 
(n=5), long-term care facility (n=3), hospice facility (n=63), acute care hospital (n=2) and other (n=1).  As 
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provincial variation exists in both health care structure and palliative care provision, analysis was limited 
to persons who resided in the province of Ontario.  Persons who resided outside of the province of 
Ontario (n=38) were excluded from the analysis.  Persons aged under 18 (n=8) or for whom age was 
missing (n=130) were also excluded from the analysis.  Finally, assessments missing data for all eight 
CAPs were also excluded (n=6).  Some cases were missing more than one of the above items therefore a 
final total of 6,769 baseline assessments and 1,000 follow-up assessments of unique persons were 
available for inclusion in the current analyses.   
5.2.1.1 CCAC Pilot Data Location Descriptions 
Data for the current study were gathered from six pilot sites located across the province of Ontario.  
As shown in Figure 5.1, these sites ranged from a primarily metropolitan urban district of the Mississauga 
Halton CCAC to more rural and geographically dispersed districts such as the North West CCAC.  
Representation from geographic regions from the South (Erie St. Clair) to the North (North West and 
North East) aimed to provide a more generalizable pilot dataset.  Details of each CCAC follow. 
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Original Source:  OACCAC website.  Retrieved from: http://www.ccac-
ont.ca/Locator.aspx?EnterpriseID=15&amp;LanguageID=1&amp;MenuID=46 
 
Note:  Coloured areas denote CCAC’s that provided pilot data. 
 White areas denote CCACs not involved in piloting the interRAI PC. 
Note:   Map was altered by addition of colours by thesis author (S.F.) from its original form.  
 
Copyright permission received from Digital Strategy Lead, OACCAC, Jan. 17, 2014. 
 
5.2.1.1.1 Champlain CCAC 
The Champlain CCAC borders the North East and South East CCACs as well as the province of 
Quebec, and Vermont in the United States (Figure 5.1., Area #11).  The Champlain CCAC provides care 
primarily in urban centers (approximately 75%) while also serving rural and remote populations covering 
almost 18,000 km
2
.  They serve over 53,000 clients every year with an average of 23,000 clients served 
daily (Champlain CCAC, 2011). The CCAC is comprised of one head office, nine branch offices, and 
twenty-two satellite offices.  Approximately twenty percent of clients are non-native English speakers.  
The palliative program in the Champlain CCAC is partnered with Bruyere Continuing care and focuses 
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the palliative pain and symptom management consultation service to address the needs of both the 
palliative client and members of their informal support network.  The palliative care team employs a 
circle of care philosophy to care comprised of a diverse care team including physicians, case managers, 
pain and symptom management specialists, advanced practice nurses and others as necessary on an 
individualized basis (Champlain CCAC Website, 2013).  The Champlain CCAC regional palliative 
consultation team prioritizes caring, compassion, and expertise.  
Data included in the pilot data were gathered, by approximately 20 case managers, for all palliative 
home care clients across all offices throughout the pilot window.  Training of the case managers occurred 
over a 1-2 day period.  All case managers received in person basic training.  Identified champions 
received an extra half-day of intensive training.  From initial discussion to staff training and initiation of 
the pilot took approximately six months and evolved from initial discussions during the Champlain 
CCAC amalgamation process.  All case managers were registered nurses, a pre-requisite for membership 
on the palliative care team. 
Referral to palliative care services and thereby eligible for analysis with the interRAI PC, clients must 
have been recognized as having an estimated prognosis of six months or less.  Internal guidelines 
developed as a combination of best practice experiences and a literature search were established and used 
a gold standard question “Would you be surprised if they passed away in the next 6 months?”  This would 
result in a designation code of ‘palliative’ and referral by the physician or community case manager to the 
palliative team.  Once the person was referred, an interRAI PC assessment was completed. Data was 
collected using paper-based assessments, collected from 2006 to 2009.  Data were de-identified then 
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5.2.1.1.2 Erie St. Clair CCAC 
The Erie St. Clair CCAC comprises the southernmost CCAC region in Ontario (Figure 5.1., Area #1).    
In 2012-2013, the Erie St. Clair CCAC provided care to over 37,000 client through access of care services 
and offered information and advice to thousands more (Erie St. Clair CCAC, 2013).  The Erie St. Clair 
CCAC is divided into three districts:  Windsor-Essex, Chatham-Kent, and Sarnia-Lambton.  Data 
included in the pilot dataset were gathered from Windsor-Essex district, the most urban and ethnically 
diverse of the three regions.   
The palliative program in Erie St. Clair is comprised of 8 full time care coordinators and 3 full time 
nurse practitioners and works closely with the Hospice of Windsor.  Their palliative approach emphasizes 
the importance of an interdisciplinary approach to end of life care and actively integrates chaplains, social 
workers, and spiritual care providers into the care team of clinicians including the physician, nurse, and 
home care providers.  At any given time, there may be over 600 persons receiving palliative care services 
and resources offered by the Erie St. Clair CCAC.  The palliative care program has been provided for 
over four years in Windsor-Essex.  The Erie St. Clair CCAC prioritizes the goals of the client when 
determining allocation of services and resources to meet need.  Persons entering the palliative care 
program were initially assessed with either the RAI-HC (if coming from home care or not immediately 
recognized to require palliative care) or with the interRAI-PC (for those recognized to require palliative 
care services).  Re-assessment was to be conducted every 3 to 6 months or as needed should a significant 
change in the client’s needs occur.  While estimated prognosis, based on the PPS score, nurse judgment, 
or physician referral are all tools used on an ad hoc basis to inform referral to palliative based services in 
the Erie St. Clair CCAC region, there is no clear means for persons to be referred to the palliative care 
program.  In discussion with a key informant from the Erie St. Clair CCAC, it was made clear that if a 
client was actively receiving any kind of active curative care such as chemotherapy, they would not be 
eligible to receive palliative care support services.  Data was collected from 2006 to 2008 using paper-
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based assessments, which were de-identified and then scanned and entered into the data repository at the 
University of Waterloo. 
5.2.1.1.3 Hamilton-Norfolk-Haldimand-Brant CCAC 
 The Hamilton-Norfolk-Haldimand-Brant CCAC covers five regions including Hamilton, 
Haldimand-Norfolk, Niagara, Brant, and Burlington (Figure 5.1., Area #4).  In 2011-2012, the Hamilton-
Norfolk-Haldimand-Brant CCAC served 72,951 clients and members of their informal support network 
with an average of 794 high needs clients served per month (Hamilton-Norfolk-Haldimand-Brant CCAC, 
2012).  The Hamilton-Norfolk-Haldimand-Brant CCAC reported 7.5% of their expenditures were on 
palliative care clients (HNHB CCAC, 2013) down from 8.4% reported in 2011/2012 (Hamilton-Norfolk-
Haldimand-Brant CCAC, 2012).  Palliative care coordinators work with physicians and other service 
providers to address the physical, emotional and spiritual needs of the client and members of their 
informal support network and assist with admissions to hospice (Hamilton-Norfolk-Haldimand-Brant 
CCAC, 2013).   The Hamilton-Norfolk-Haldimand-Brant CCAC is comprised of approximately 65% 
urban and 35% rural areas. 
 The Hamilton-Norfolk-Haldimand-Brant CCAC was the first site, which began to collect pilot 
data using the interRAI PC.  Decisions to pilot the interRAI PC were an outcome for the palliative care 
integrated project collaborative from the Kingston group (J. Noble
4
, personal communication, December 
23, 2013).  From 2006 to 2008 the original pilot data was gathered on all palliative home care clients 
accessing services from the Hamilton branch.  In 2008, the pilot was extended to include all regions in the 
Hamilton-Norfolk-Haldimand-Brant CCAC.   Eligibility for referral to the palliative care was based on 
                                                     
 
4
 Janet Noble MSW, RSW, is the Director of Client Services for the Hamilton Branch of the 
Hamilton Niagara Haldimand Brant CCAC. 
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criteria sourced from Dr. Joanne Lynn, M.D.
5
, a hospice physician and health services researcher, and 
current director of the Center on Elder Care and Advanced Illness for Altarum Institute
6
.  Criteria for 
eligibility include that the assessor “would not be surprised if the person were to die within 12 months” or 
that the person “has pain and symptom issues that require palliative expertise including psycho-social 
care”  (J. Noble, personal communication, December 23, 2013).  Referral for the palliative care services 
may be determined by one of many sources including members of the person’s clinical team, home care 
service provider, tertiary care specialist, family doctor, or primary care clinician.  Clients may have been 
first assessed using the RAI-HC and then transferred to the palliative care team for follow-up assessment 
using the RAI-PC.  At time of assessment, the care coordinator employed their judgment to determine 
whether the referred client exhibited need for palliative home care services on a case-by-case basis.  The 
palliative care team typically consisted of 5 teams comprised of 16 care coordinators.  All care 
coordinators received 1 day in class training and received follow-up refresher training as needed.  Care 
coordinators included Registered Nurses, Social Workers, Occupational Therapists, Physiotherapists, 
Speech Language Pathologists, as well as relief staff when necessary.  Data was collected from 2006 to 
2010 using paper-based assessments.  Assessments were de-identified, then scanned and entered into the 
data repository at the University of Waterloo. 
5.2.1.1.4 Mississauga-Halton CCAC 
The Mississauga-Halton CCAC prioritizes the delivery of quality integrated health care in the client’s 
home (Mississauga Halton CCAC, 2013a).  The Mississauga-Halton CCAC serves the sub areas of South 
Etobicoke, Oakville, Northwest and Southeast Mississauga, Halton Hills, and Milton (Figure 5.1., Area 
#6).  In 2012-2013, the Mississauga Halton CCAC served more than 41,000 clients.  Mississauga Halton 
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CCAC is comprised of an ethnically diverse population with the immigrant population representing 
43.2% in comparison to a 28.3% provincial average (Mississauga Halton CCAC, 2013a).  In 2012/2013 
the over 1,700 clients received palliative home care services representing a 6.2% increase in clients 
(Mississauga Halton CCAC. 2013a).  Supporting clients to wish to die at home with dignity is one of the 
eight service specialties prioritized by the Mississauga Halton CCAC (Mississauga Halton CCAC, 
2013b). 
 The interRAI PC was piloted by 10 case managers (9 registered nurses and 1 occupational 
therapist) on all home care clients with a prognosis of 12 months to live or less within the Mississauga-
Halton CCAC catchment region.  Clients were first assessed with the interRAI Contact Assessment for 
intake purposes.  At that time they could be directly referred to the palliative team and receive the RAI-
PC or they would be assessed with the RAI-HC if designated as a long-stay home care client and then 
transferred to the palliative team and assessed with the RAI-PC at a later date.  Although anyone could 
refer clients to the palliative care team, eligibility for palliative care was based on an estimated prognosis 
of 12 months to live or less as designated by a physician or nurse practitioner.  Assessors attended two-
day in-person training on how to use the RAI-PC.  Data collected from 2008 to 2011 using paper-based 
assessments were de-identified and transported to the University of Waterloo where they were scanned 
and entered into the data repository. 
5.2.1.1.5 North East CCAC 
The North East CCAC covers six regions; Cochrane, Algoma, Manitoulin/Sudbury, Timskaming, 
Nipissing, and Parry Sound (Figure 5.1., Area #13).  In 2013, the North East CCAC served over 34,000 
clients and over 15,500 clients per month (North East CCAC, 2013).  A range of end-of-life care services 
including hospice palliative care, care directives, and bereavement support programs are offered to 
address physical, emotional, spiritual and practical needs of clients and members of their informal support 
networks (NorthEasthealthline.ca, 2013).  Like the Champlain and Hamilton-Norfolk-Haldimand-Brant 
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CCAC, the North East CCAC also employs a circle of care approach to palliative care team service 
support.  The circle of care is a person specific support network comprised of a variety of health care 
professionals working together to address the person’s needs including physicians, advanced practice 
nurses, pain and symptom management consultants in addition to the CCAC care coordinator and others 
as required.   Eligibility criteria for the palliative home care program were based on physician referral and 
community case manager expert judgment.  Following initial assessment using the RAI Contact 
Assessment clients who were expected to die within three months were then referred to the palliative team 
and assessed with the interRAI PC.  Eligibility criteria were flexible and not mandated.  Referral policies 
may also have been affected by caseload intensity and demand 
The Manitoulin/Sudbury region was selected as the focus of the interRAI PC pilot.  It included a 
seventy percent urban and thirty percent rural client mix.  Six registered nurse case managers who 
comprised the regional palliative team attended a two-day in person training workshop.  Pilot data were 
collected from 2009 to 2011.  Paper based assessments were completed, copied, and de-identified and 
then sent to the Nipissing University.  Assessments were manually entered into an excel form which was 
then transferred to the University of Waterloo for entry into the data repository. 
5.2.1.1.6 North West CCAC 
The North West CCAC, covering 458, 010 km2 or 47% of the province of Ontario, is comprised of 
four districts:  Kenora, Rainy River, Thunder Bay District, and Thunder Bay City (North West CCAC, 
2013) (Figure 5.1., Area #14).  In 2011-2012, the North West CCAC served 12,792 clients.  The interRAI 
PC was piloted only in the Thunder Bay City district.  In contrast to other CCAC’s, the regional office in 
Thunder Bay employs only one end of life care coordinator.  This care coordinator managed the end of 
life caseload of approximately 60~80 persons (but up to 120~130 during peak times) and completed all 
interRAI PC assessments for persons receiving palliative home care services.  Referral for palliative care 
service was determined most often by the person’s physician or home care case manager.  Clients may be 
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referred for palliative care services and assessed with the interRAI PC directly at the point of intake or 
may have received a previous RAI-HC assessment and be referred for palliative care services during a 
follow-up assessment. Data was collected from 2006 to 2010 using paper-based assessments.  
Assessments were de-identified, then scanned and entered into the data repository at the University of 
Waterloo. 
5.2.2 Measures 
 interRAI instruments speak a common language.  They share a core group of items that enable 
comparability between client groups or across care settings, and reduce the need for separate assessments 
and further documentation. Various scales representing different clinical and risk domains embedded 
within the interRAI PC considered in Chapters 6,7, and 8 include the Changes in Health, End-stage 
disease, and Signs and Symptoms (CHESS) scale (Hirdes, Frijters, & Teare, 2003); Cognitive 
Performance Scale (CPS) (Morris et al., 1994); the Activities of Daily Living Hierarchy (ADL-H) 
(Morris, Fries, & Morris, 1999); and the Pain Scale (Fries, Simon, Morris, Flodstrom, & Bookstein, 
2001).  The CHESS scale, a measure of instability in health as a clinical outcome and predictor of 
mortality, ranges from 0 (no instability in health) to 6 (highly unstable health). Mental status is assessed 
using the CPS, a scale ranging from 0 (cognitively intact) to 6 (severe cognitive impairment).  It has been 
validated against the Mini-Mental State Examination in both institutional and community settings (Morris 
et al., 1994; Landi et al., 2000).  Physical functioning is measured using the ADL-H scale ranging from 0 
(independent) to 6 (totally dependent). Items included in the ADL-H score include personal hygiene, 
toilet use, locomotion, and eating.  The Pain Scale uses two items to measure pain and has scores ranging 
from 0 (no pain) to 4 (excruciating pain).  The Pain Scale has been validated with the Visual Analogue 
Scale (Fries, Simon, Morris, Flodstrom, & Bookstein, 2001).   
The interRAI PC combines comprehensive, multidisciplinary evaluation of an individual’s strengths, 
preferences, and needs with a series of Clinical Assessment Protocols (CAPs) to inform clinical decision-
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making as part of the care planning process (Martin, et al., 1999) and inform where more focused plans of 
care may be required.  The interRAI PC includes eight Clinical Assessment Protocols (CAPs) in three 
domains: (1) Performance (Fatigue and Sleep Disturbance); (2) Clinical Complexity (Nutrition, Pressure 
Ulcers, Pain, and Dyspnea); and (3) Cognition and Mental Health (Mood Disturbance and Delirium).  
CAPs use algorithms calculated from responses collected on various items collected as part of the 
interRAI PC assessment.  These CAPs do not require additional questions to be asked.  The CAPs are 
designed to assist clinicians to probe in-depth into areas on specific aspects of person’s function and 
quality of life, and to assess the person’s potential for change. Each CAP addresses how the clinical issue 
may impact the life of the person with a life limiting illness; outlines the overall goals of care highlighting 
what is to be achieved through intervention; includes a targeting trigger identifying who is most likely to 
benefit from an intervention; and provides best practice care guidelines that inform an appropriate 
approach to the issue. 
5.3 Proposed Research 
This research addresses the importance of using standardized comprehensive evidence to inform care 
planning for persons with a life limiting illness, using information gathered from the interRAI PC and 
specifically through in-depth analysis focused on the interRAI PC CAPs.  Three research chapters 
examine the clinical needs of palliative home care clients in Ontario, describe how clinical needs may 
vary by person and regional characteristics, and illustrate potential benefits using the interRAI PC CAPs 
may have to inform care planning.  The interRAI PC was mandated for use across Ontario in September 
2012, but to date only limited research has been done to examine the CAPs in the Canadian context.  This 
thesis examines how the interRAI PC and its associated CAPs can provide information about needs and 
enable better care planning for persons with life limiting illness’ among community dwelling persons 
receiving palliative home care services.  Hierarchical triggering structure in the CAP distributions is 
presented. 
   88 
Analyses for the three chapters are based on pilot data gathered between 2006 and 2011 using the 
interRAI PC assessment instrument.  Community dwelling persons with a life limiting illness receiving 
palliative home care services in six geographic locations across Ontario, Canada, are included in the 
analysis.  Persons with a life limiting illness residing in institutional or hospice facilities, or in 
jurisdictions outside of Ontario, were excluded.  Chapters 6, 7, and 8 have been formatted as journal 
articles suitable for publication.  Analyses are performed using SAS Version 9.2 with an alpha level of p< 
0.05 for all statistical tests unless otherwise stated.  The University of Waterloo’s Office of Research 




5.3.1 Care Planning Needs of Ontario Palliative Home Care Clients Based on the interRAI 
Palliative Care (interRAI PC) Assessment Clinical Assessment Protocols (CAPs) 
 
Chapter six provides an overview of the distributional properties of the interRAI PC CAPs adding to 
the current literature of the population level needs of persons with a life limiting illness receiving home 
care services.  This chapter describes how data gathered from the interRAI PC CAPs may be used to 
inform clinicians during the care planning process for palliative home care clients in Ontario, Canada.  
This chapter is the first to examine how the CAPs may be used among a population of persons with a life 
limiting illness recognized to be nearing the end of life and requiring palliative home care services. 
Patterns in CAP triggering and variability in triggering rates among the eight interRAI PC CAPs are 
discussed.  This is the first comprehensive study in Canada to use the interRAI PC CAPs to examine the 
care needs of a large diverse sample of palliative home care clients with multiple disease diagnoses across 
six regional jurisdictions (See Figure 5.1.).  Specifically, the goals of this chapter are to:  1) examine 
distributional properties of the eight interRAI PC CAPs with special focus given to client age, sex, 
estimated prognosis, geographic location, and disease diagnosis (Cancer vs. No-Cancer Diagnosis) and 2) 
following methods used by Morris et al., (1999), identify a hierarchical structure in CAP triggering rates 
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across the eight CAPs.  Chapter six describes an overall profile of persons with a life limiting illness 
across Ontario who received palliative home care services and examines the value and depth of 
information available to be gained by utilization of evidence from the interRAI PC assessment 
instrument. 
5.3.2 Changes in Dyspnea Symptoms Over Time Among Community Dwelling Persons with a Life 
Limiting Illness in Ontario, Canada 
 
Chapter seven focuses on the interRAI PC Dyspnea CAP and describes the depth of information 
available to inform evidence based clinical decision-making during the care planning process.  This 
chapter focuses on dyspnea as it is not only one of the most distressing symptoms at end of life, but is 
common among palliative home care clients and known to affect the QOL of both the person with a life 
limiting illness and the informal support network.  Chapter seven employs cross-sectional and 
longitudinal methods to examine predictors of the Dyspnea CAP being triggered.  Careful attention is 
given to the role of disease diagnosis and estimated prognosis.  An extensive literature review focused on 
the epidemiology of dyspnea informed the rationale for variable selection and inclusion in all analyses. 
Specifically, the goals of chapter seven are to:  1) investigate the prevalence of dyspnea among persons 
who receive palliative home care services in Ontario, Canada; b) describe how those who experience 
dyspnea differ from those who do not experience dyspnea; and c) examine changes in dyspnea over time.  
Findings from this chapter seek to expand understanding on health and clinical characteristics as well as 
levels of health service utilization associated with dyspnea and focuses upon identification of predictive 
factors affecting development of new dyspnea and recovery from dyspnea over time.  These findings may 
be clinically relevant to inform clinicians during care planning process and lead to more effective care. 
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5.3.3 A Cross-Sectional Examination of the Relationship Between Dyspnea and Distress 
Experienced Within the Caregiver-Client Unit of Care 
 
Dyspnea, selected as the symptom of the focus of chapter seven, is widely recognized to be one of 
the most troubling symptoms for the person with a life limiting illness who experiences the symptom but 
also for their caregivers (Ng &von Gunten, 1998; Potter, Hami, Bryan, & Quigley, 2003; Dellon et al., 
2010; Kroenke, Johns, Theobald, Wu, & Tu 2013). Chapter eight expands understanding of the negative 
characteristics associated with dyspnea for both the care recipient (person with a life limiting illness) and 
their informal caregiver emphasizing the importance for clinicians to prioritize care of dyspnea during the 
care planning process.  There is a lack of palliative care research that examines the ‘family unit’, which 
includes both the person with a life limiting illness and their family caregivers together as an ‘interactive 
system’ (Mehta et al., 2009).  The psychosocial wellbeing of persons at end of life and their caregivers are 
interrelated (Hodges, Humphris, & Macfarlane, 2005)) this chapter examines the relationship between 
presence of dyspnea and the presence of distress experienced by both the caregiver and care recipient by 
focusing on the caregiver-client unit of care. 
As persons nearing the end of life experience multiple complex conditions and the main criteria to 
evaluate dyspnea is subjective it remains unclear how strong dyspnea is as a predictive factor affecting 
distress within the caregiver-client unit of care.  Therefore, the current study examines the relationship 
between distress within the caregiver-client unit of care and dyspnea to investigate the role of dyspnea as 
an independent variable to predict distress experienced by the person or his/her caregivers.  The specific 
objective of this study is to determine whether dyspnea is associated with distress in either the person 
receiving palliative care or members of their informal network.  It is postulated that findings will 
emphasize the importance for clinicians to consider the caregiver-client unit of care when care planning 
for persons who are experiencing dyspnea.   
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6.  Care Planning Needs of Ontario Palliative Home Care Clients Based on the 
interRAI Palliative Care (interRAI PC) Assessment Clinical Assessment 
Protocols (CAPs)  
6.1 Introduction 
Palliative care is a person-centered approach to care that prioritizes the highest level of pain and 
symptom management available to improve quality of life at the end of life for persons faced with a life 
limiting illness.  Moreover, palliative care may enhance the health and well-being of the person’s 
informal support network including family and caregivers.  Palliative care may be “achieved through 
prevention and relief of suffering by means of early identification, comprehensive assessment, and 
treatment of pain and physical, psychosocial, or spiritual problems” (World Health Organization [WHO], 
2010).   
Standardized assessment provides a systematic way to identify need at the person level.  
Accumulation of assessments may create an evidence base to inform community, regional, and national 
standards and policies at an aggregate level.   The interRAI Palliative Care (interRAI PC) assessment 
instrument is part of the larger interRAI suite of instruments.  interRAI, an international collaborative of 
researchers, clinicians, and health professionals, share a united vision that implementation of standardized 
measurement systems and integration of comprehensive assessments into clinical practice may promote 
evidence informed decision making to improve care of vulnerable persons.   The interRAI PC, designed 
for use among persons faced with a life limiting illness, is a standardized comprehensive assessment tool 
providing person-specific information to inform the care planning process.  Moreover, information 
gathered from the interRAI PC enables tracking change over time, and may inform future development of 
a case mix system for persons receiving palliative care (Steel et al., 2003).  The interRAI PC has been 
newly implemented in Ontario, Canada, joining other mandated interRAI instruments including the RAI-
HC and MDS 2.0 (CHCA, 2008; Hirdes, Mitchell, Maxwell, & White, 2011).   
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 The interRAI PC assists front line care providers to address aspects of physical and cognitive 
functioning, mental health and wellbeing, as well as social supports and end of life preferences.  Uptake 
of evidence gathered from the interRAI PC into clinical decision-making facilitates interpersonal 
communication between clients and their care providers, and when appropriate their informal support 
network.  Effective communication leads to higher quality of care at the person level through better 
targeting of care services to meet their needs at the right time in the right place.  
The interRAI PC Clinical Assessment Protocols (CAPs) focus on specific aspects of person’s 
function and quality of life and assess the needs, strengths, preferences, and potential for change of the 
person. Using algorithms embedded within the interRAI PC, the CAPs alert the assessor to specific 
problems and indicate either risk or potential for improvement, that should be addressed in the care plan 
(Carpenter, 2006).  Each CAP contains 4 main components:  issue statement, goals of care, triggers, and 
guidelines.  The issue statement provides a clear rationale for why the specific CAP domain should be 
considered an important part of the palliative care services approach and examines the impact of the 
clinical issue on the person’s life.  The goals of care highlight the benefits of potential intervention and 
focus on what may be achieved through care (Brandeis, Berlowitz, Hossian, & Morris, 1995; Martin et 
al., 2009; Zhu et al., 2007; and Resnick et al., 1996).  These vary by CAP but each may include:  
resolving the problem, reducing risk of deterioration or reducing side effects, or increasing the 
opportunity to improve or maintain function where possible.  Targeting triggers identify which persons 
are most likely to benefit from intervention.  Detailed technical information on the statistical code for the 
CAP triggers may be accessed via www.interRAI.org.  Best practice care guidelines summarize 
appropriate responses to the issue.  By outlining approaches to the problem clinicians are able to consider 
underlying issues and treatment alternatives when creating a person-specific plan of care.  The CAP 
manual includes additional resources and reference materials enabling clinicians’ quick access to detailed 
information on issues addressed by the CAPs. 
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The first suite of eight interRAI PC CAPs released in 2013 address three key domains: 
Performance- Fatigue CAP and Sleep Disturbance CAP; Clinical Complexity – Nutrition CAP, Pressure 
Ulcers CAP, Pain CAP, and Dyspnea CAP; and Cognition and Mental Health- Mood Disturbance CAP 
and Delirium CAP (Steel, et al., 2013e).  These CAPs are distinct from other CAPs such as those 
accompanying the interRAI home care, long-term care, and mental health instruments, in that they 
specifically account for changing client needs as individuals progress towards death and recognize that 
clinicians may choose to whether to prioritize care planning to address the issue depending on the 
person’s prognosis.  The CAP’s highlight, when appropriate, areas of need that may benefit from 
treatment/care even in the final stages of life.  Mathias, Hirdes, and Pittman (2010) and Neufeld, Perlman, 
and Hirdes (2012) illustrated the benefits of the CAPs for both risk assessment and care planning in the 
community and institutional mental health settings.  Neufeld, Freeman, Hirdes, and Joling (2014) 
highlighted the benefits for clinicians to use the CAPs to assist in identifying at-risk residents residing in 
long-term care facilities.   
This is the first time to describe the strengths and limitations of the interRAI PC Clinical 
Assessment Protocols (CAPs) and illustrate its ability to identify persons at risk thereby providing 
valuable information during the care planning stage.  Integration of evidence from the CAPs into the 
clinical decision making process clearly supports comprehensive assessment, as emphasized by the WHO 
(2010), be an integral component of quality palliative care. An overview of the CAPs development 
process will be provided and an examination of how the CAPs function in relation to physical, social, 
psychological, and clinical characteristics at an aggregate level will be shown.  The detailed profile of 
home care clients diagnosed with a life limiting illness in six regions of Ontario assessed to receive 
palliative home care services will show the value and depth of information to be gained by utilization of 
the interRAI PC assessment instrument.  
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6.2 CAP development process 
 CAP development entailed a three phase multi-year process conducted by an international 
committee with members from nine countries, involved consideration of evidence from peer-reviewed 
literature; international best practice guidelines; and provided by a collective of national and international 
experts (Steel, 2013e). Phase one focused on an extensive literature review of international best practice 
guidelines for each CAP domain area, gathered from at least three global regions.  These guidelines were 
used to identify and prioritize the CAP domain focus.  If guidelines were unavailable then relevant peer-
reviewed publications were identified. Phase two involved widespread consultation, focus groups, and 
formal in person reviews with subject-matter experts from around the world to gather feedback on the 
CAPs.  Direct evaluation of the CAPS by clinicians was paramount to ensure face validity.  Responses 
from both interRAI and outside experts supported that each CAPs captured accurate and clinically 
relevant information applicable to care providers.  Recommendations during the consultation process 
were incorporated into the CAP frameworks. Phase three focused on creation of triggering algorithms 
created based on analysis of Canadian pilot data. The interRAI PC CAP manual was developed, detailing 
information on trigger rates; factors associated with triggering; and best practice guidelines (Steel et al. 
2013e).  
6.2.1 Data Source 
The interRAI PC includes more than 280 items, covering 75 key areas, grouped into 17 key 
domains including demographic and intake information, medical diagnoses and conditions, physical and 
cognitive functioning, and psycho-social and emotional wellbeing (Steel, 2003).  It may be employed in 
multiple care settings such as community-based, hospice, or residential care facility.  Assessments, 
completed by trained assessors with professional backgrounds, including nursing and social work, 
consolidate information from direct observation, medical records, and communication with the person, 
their health team, and their informal support network.  Information gathered from the interRAI PC assists 
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clinicians in their evaluation of individual care needs. The breadth of information collected provides a 
comprehensive description of the person.  Items contained in the interRAI PC have shown excellent inter-
rater and test-retest reliability (Steel et al, 2003, Hirdes et al, 2008).  Data gathered from interRAI PC 
assessments provide an evidence base, which when combined with clinical judgment, is useful to inform 
the development and implementation of care plans tailored to the unique needs of each person. 
6.2.2 Clinical Assessment Protocols (CAPs) 
The Dyspnea CAP and Delirium CAP both have binary triggers in comparison to the other six 
CAPs that have two triggering levels.  The Dyspnea CAP identifies persons experiencing shortness of 
breath and highlights strategies to recognize the onset and severity of symptoms (Steel, Morris, & Leff, 
2013a).  Persons who are currently experiencing delirium trigger the Delirium CAP that highlights 
clinical strategies not only to identify and treat symptoms but also to prevent foreseeable complications 
and to improve quality of life (Steel, Inouye, Morris, Murphy, & Marcantonio, 2013b).  The Fatigue CAP 
is the most frequently triggered.  It differentiates the risk for persons currently or at risk to experience 
fatigue (medium risk-trigger level 1, high risk-trigger level 2) and outlines key considerations to address 
both causes and symptom reduction (Olsen, Steel, Ljunggren, Steel, & Smith, 2013). Based on the Pain 
Scale, the Pain CAP prioritizes persons experiencing pain (medium-trigger level 1, high-trigger level 2) 
and provides best practice guidelines for assessment and management strategies (Won et al., 2010).   The 
Mood Disturbance CAP differentiates levels of risk of depression by symptom frequency (single-trigger 
level 1, multiple-trigger level 2) with a goal to improve psychological well-being (Smith, Rabinowitz, 
Hirdes, Morris, Stewart, Constantino, & Steel, 2013).  It outlines best practice approaches that address the 
symptoms, investigate further the type of disorder, and lists key considerations for potential treatment and 
monitoring of the disorder.  The Sleep CAP differentiates the potential to improve (moderate-trigger level 
1 or high-trigger level 2) among persons experiencing a sleep disturbance. Based upon the presence of a 
list of reversible issues, the Sleep CAP focuses on strategies to reduce the disturbance, increase comfort, 
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and improve functioning (Ljunggren, Olson, Smith, Steel, Hirdes, & Morris, 2013).  The Nutrition CAP 
identifies persons who may benefit from education and interventions to optimize energy and protein 
intake, reduce anxiety about not eating, or who could benefit from interventions addressing hunger (Steel, 
Morris, Sorby, & Steel, 2013d).   Trigger levels focus on persons with a low body mass index and 
differentiates levels based on absence (trigger level 1) or presence (trigger level 2) of weight loss.  The 
Pressure Ulcers CAP emphasizes importance of appropriate treatment and identifies potential for 
improvement (moderate-trigger level 1, high-trigger level 2) for persons with pressure ulcers (Steel et al., 
2013c). 
6.2.3 Study Population  
De-identified cross-sectional pilot data from 6,769 interRAI PC assessments gathered between 
2006 and 2011 from palliative home care clients in Ontario, Canada were included for analysis.  When 
follow-up assessments were available, only the first assessment was included.  Sample characteristics of 
the study population are shown in Table 6.1.  Age ranged greatly from 18 to 107 years with a mean age of 
70.0 years (SD ±13.4 years), of whom more than 80% reported a diagnosis of cancer (n=5,875).  The 
majority of persons had an estimated prognosis of greater than 6 weeks, with more than 40% (n=2,310) 
having an estimated prognosis of greater than six months at time of assessment.  In contrast only 2% 
(n=110) had a prognosis of death being imminent. 
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Table 6.1. Sample Characteristics of Clients Receiving Palliative Home Care Services 2006-2011, 




Age Groups   
18-44 4.3 (288) 
45-64 29.9 (2,025) 
65-74 25.4 (1,718) 
75-84 28.7 (1,943) 
85 + 11.7 (795) 
  
Gender   
Male 49.1 (3,303) 
Female 50.9 (3,418) 
  
Estimated Prognosis   
Greater than 6 months 41.5 (2,310) 
6 weeks to 6 months 48.1 (2,677) 
Less than 6 weeks 8.4 (468) 
Death Imminent 2.0 (110) 
  
CCAC Site Location   
Site 1 4.0 (270) 
Site 2 47.7 (4,581) 
Site 3 14.6 (991) 
Site 4 7.5 (510) 
Site 5 2.1 (142) 
Site 6 4.1 (275) 
  
Diagnosis   
Have Cancer Diagnosis 86.8 (5,875) 
Metastatic 40.0 (2,710) 
Not Metastatic 46.8 (3,165) 
Do not have Cancer 9.8 (666) 
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6.2.4 Analysis 
The univariate distributional properties were examined for all eight interRAI PC CAPs and cross 
tabulations were used to examine the hierarchical triggering structure of the CAPs.  Associated covariates 
including age, gender, estimated prognosis, geographic location, and disease diagnosis, were examined 
using chi-square to determine significant relationships.  The hierarchical analysis also employed chi-
square analysis to examine covariates among CAPs. All analyses were performed using SAS Version 9.2 
with an alpha level of p< 0.05 for all statistical tests. 
6.3 Results 
Each CAP contains individualized triggers occurring at different rates from 74% (Fatigue CAP) 
to less than 15% (Delirium and Pressure Ulcers CAPs) (Figure 6.1).  Spearman’s rank correlations 
suggested that the majority of CAPs were reasonably independent from each other.  Modest correlations 
were evident between the Fatigue and Delirium CAPs (0.20) and Fatigue and Mood CAPs (0.26).   
Figure 6.1. Triggering Rates by CAP of Clients Receiving Palliative Home Care Services 2006-2011, 
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Nearly 9 in 10 persons triggered at least one CAP (87.9%, n=5,950) and approximately two thirds 
triggered more than two CAPs (Figure 6.2.).   
Figure 6.2. Number of CAPs Triggered by Clients Receiving Palliative Home Care Services 2006-
2011, Ontario, Canada (N=6,769). 
  
 Variable distribution differs across the four clinical complexity CAPs (Table 6.2. and 6.3.). 
Dyspnea CAP and Pressure Ulcers CAP triggering rates increased with age but the Pain CAP triggering 
rate decreased with age.  A curvilinear relationship was observed among persons who triggered the 
Nutrition CAP where the youngest (aged 18-44) and the oldest old (85+) age groups were more likely to 
trigger at level 1. Small gender differences were evident between CAPs.  Males were more likely to 
trigger the Dyspnea CAP in contrast to females who were more likely to trigger the Nutrition CAP.  
Triggering of the clinical complexity CAPs increased as the length of estimated prognosis decreased.  
Persons over the age of 65 exhibited higher rates of persons who triggered the Pressure Ulcers CAP and 
were most likely to trigger as difficult to improve.  With the exception of the Pain CAP where persons 
with a cancer diagnosis triggered most frequently, the clinical complexity CAPs were most often 
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Triggering rates differed by geographic location. CCAC Site 5 reported substantially lower rates 
of persons who triggered the Dyspnea CAP than other CCAC sites (23.6% for CCAC site 1 vs. range 
from 37.5% in CCAC site 2 to 46.75 in CCAC site 2).  For the Nutrition CAP, although overall triggering 
prevalence were comparable across sites, persons from the CCAC Site 5 reported the highest triggering 
rates at level one but the lowest prevalence at level two.  In contrast, CCAC Site 1 exhibited the lowest 
triggering rates for the Nutrition CAP at level one and the highest prevalence of Nutrition CAP triggering 
rates at level two.  
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Table 6.2. Distribution of Background Characteristics by Dyspnea and Nutrition Clinical Complexity CAPs of Clients Receiving Palliative 
Home Care Services 2006-2011, Ontario, Canada (N=6,769). 
 Dyspnea Nutrition 























Age Groups                 
18-44 68.6 (192) 31.4 (88) 31.8 (4) <.0001 76.4 (155) 12.3 (25) 11.3 (23) 28.4 (8) 0.0004 
45-64 57.1 (1,140) 42.9 (858)    78.7 (1,044) 6.3 (84) 14.9 (198)    
65-74 54.4 (919) 45.6 (769)    76.5 (855) 8.4 (94) 15.1 (169)    
75-84 52.0 (994) 48.0 (919)    73.1 (882) 10.3 (124) 16.7 (201)    
85 + 54.0 (420) 45.9 (356)    71.9 (330) 12.2 (56) 15.9 (73)    
Gender             
Male 53.1 (1,727) 46.9 (1,526) 9.6 (1) 0.002 78.9 (1,645) 6.3 (132) 14.8 (308) 38.1 (2) <.0001 
Female 56.9 (1,908) 43.1 (1,446)    72.5 (1,591) 11.4 (251) 16.1 (353)    
Estimated Prognosis             
Death Imminent 37.4 (40) 62.6 (67) 105.2 (3) <.0001 64.7 (33) 2.0 (1) 33.3 (17) 78.4 (6) <.0001 
Less than 6 weeks 43.8 (203) 56.3 (261)    65.2 (193) 6.8 (20) 28.0 (83)    
6 weeks to 6 months 53.4 (1,413) 46.6 (1,235)    73.5 (1,407) 9.2 (176) 17.3 (331)    
Greater than 6 months 63.7 (1,454) 36.3 (829)    79.4 (1,355) 9.4 (161) 11.2 (191)    
Geographic Location             
Site 1 62.6 (167) 37.5 (100) 41.5 (5) <.0001 74.1 (172) 4.7 (11) 21.1 (49) 38.9 (10) <.0001 
Site 2 53.3 (2,389) 46.7 (2,091)    77.1 (1,945) 8.2 (208) 14.7 (371)    
Site 3 58.1 (574) 41.9 (414)    71.3 (627) 10.8 (95) 17.9 (157)    
Site 4 54.0 (273) 46.1 (233)    75.6 (272) 10.8 (39) 13.6 (49)    
Site 5 76.4 (107) 23.6 (33)    72.8 (75) 17.5 (18) 9.7 (10)    
Site 6 56.6 (155) 43.4 (119)    81.4 (175) 5.6 (12) 13.0 (28)    
Diagnosis             
Have Cancer Diagnosis 57.8 (2,295) 42.2 (1,678) 98.9 (3) <.0001 76.1 (1,912) 8.71 (219) 15.2 (383) 39.5 (6) <.0001 
Have Cancer and Non-Cancer 
Diagnosis 56.5 (1,023) 43.5 (789)    77.8 (1,047) 6.76 (91) 15.5 (208)    
Have Non-Cancer Diagnosis Only 37.8 (245) 62.3 (404)   67.5 (241) 16.8 (60) 15.7 (56)    
Diagnosis unspecified 46.2 (103) 53.9 (119)   68.8 (66) 13.5 (13) 17.7 (17)    
Note:  df denotes degrees of freedom  
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Table 6.3. Distribution of Background Characteristics by Pain and Pressure Ulcers Clinical Complexity CAPs of Clients Receiving 
Palliative Home Care Services 2006-2011, Ontario, Canada (N=6,769).  


























Age Groups                   
18-44 47.4 (120) 20.6 (52) 32.0 (81) 156.7 (8) <.0001 91.2 (239) 5.34 (14) 3.4 (9) 87.8 (8) <.0001 
45-64 51.9 (955) 23.1 (425) 25.0 (460)   91.6 (1,708) 3.9 (73) 4.5 (84)    
65-74 59.9 (948) 21.2 (336) 18.8 (298)   89.4 (1,414) 5.6 (88) 5.1 (80)    
75-84 67.4 (1,191) 16.2 (286) 16.3 (288)   88.3 (1,573) 8.0 (143) 3.7 (66)    
85 + 70.8 (499) 16.1 (113) 13.1 (92)   83.3 (600) 13.3 (96) 3.3 (24)    
Gender                
Male 59.5 (1,775) 19.9 (593) 20.6 (614) 2.8 (2) 0.25 88.6 (2,684) 6.7 (204) 4.7 (141) 2.7 (2) 0.26 
Female 61.4 (1,913) 19.5 (608) 19.1 (594)   89.6 (2,811) 6.6 (208) 3.8 (120)    
Estimated Prognosis                
Death Imminent 51.5 (51) 24.2 (24) 24.2 (24) 53.2 (6) <.0001 76.0 (73) 22.9 (22) 1.0 (1) 139.4 (6) <.0001 
Less than 6 weeks 50.5 (218) 23.6 (102) 25.9 (112)   80.0 (348) 15.9 (69) 4.1 (18)    
6 weeks to 6 months 57.3 (1,454) 22.1 (562) 20.6 (522)   87.9 (2,222) 7.5 (190) 4.6 (115)    
Greater than 6 months 65.2 (1,424) 18.2 (398) 16.6 (363)   92.7 (2,022) 3.5 (76) 3.8 (83)    
Geographic Location                
Site 1 50.2 (133) 23.8 (63) 26.1 (69) 195.2 (10) <.0001 87.6 (232) 7.9 (21) 4.5 (12) 34.7 (10) 0.0001 
Site 2 59.3 (2,382) 20.9 (838) 19.8 (795)   89.5 (3,653) 6.1 (248) 4.4 (181)    
Site 3 77.1 (745) 10.0 (97) 12.9 (125)   87.5 (853) 9.6 (94) 2.9 (28)    
Site 4 48.9 (244) 20.0 (100) 31.1 (155)   87.8 (430) 5.7 (28) 6.5 (32)    
Site 5 58.4 (80) 24.8 (34) 16.8 (23)   88.2 (119) 8.9 (12) 3.0 (4)    
Site 6 49.4 (129) 30.7 (80) 19.9 (52)   93.6 (247) 4.2 (11) 2.3 (6)    
Diagnosis           
Have Cancer Diagnosis 57.9 (2,124) 21.1 (774) 21.0 (772) 56.3 (6) <.0001 91.0 (3,375) 4.5 (166) 4.6 (169) 215.9 (6) <.0001 
Have Cancer & Non-
Cancer Diagnosis 61.7 (1,044) 18.5 (313) 19.8 (335)   90.0 (1,541) 6.3 (108) 3.7 (64)    
Have Non-Cancer 
Diagnosis Only 73.2 (429) 13.0 (76) 13.8 (81)    75.6 (445) 20.5 (121) 3.9 (23)   
Diagnosis unspecified 59.2 (116) 25.0 (49) 15.8 (31)   86.9 (173) 9.6 (19) 3.5 (7)   
Note:  df denotes degrees of freedom 
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Males were more likely to trigger the Sleep Performance CAPs (Table 6.4.) Not only does the 
proportion who trigger the Fatigue CAP increase as length of estimated prognosis lessens, the number 
who trigger it at high risk nearly triples between those with an estimated prognosis of greater than six 
months compared to those where death is imminent.  A similar pattern emerges for the Sleep CAP; 
however, it is much less frequently triggered than the Fatigue CAP.  Geographic variation is pronounced 
among the performance CAPs.  Prevalence of Fatigue CAP triggering ranged greatly by site.  CCAC Site 
3 stands out with lower rates for Fatigue CAP triggering (72% CCAC Site 3 compared to high of 84% 
CCAC Site 4) and the highest rate of triggering for the Sleep CAP (32% CCAC Site 3 compared to low of 
24% CCAC Site 1).
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Table 6.4. Distribution of Background Characteristics by Fatigue and Sleep Performance CAPs of Clients Receiving Palliative Home Care 
Services 2006-2011, Ontario, Canada (N=6,769). 





























Age Groups                   
18-44 31 (62) 40.0 (80) 29.0 (58) 23.2 (8) 0.003 62.8 (135) 12.1 (26) 25.1 (54) 74.7 (8) <.0001 
45-64 26.3 (396) 36.3 (547) 37.4 (564)   66.2 (1,055) 12.1 (192) 21.7 (346)    
65-74 27.5 (351) 31.8 (406) 40.7 (520)   73.6 (1,015) 11.5 (159) 14.9 (206)    
75-84 25.7 (364) 34.4 (487) 39.9 (565)   76.8 (1,187) 10.0 (154) 13.3 (205)    
85 + 24.5 (136) 30.6 (170) 44.9 (249)   74.5 (462) 13.1 (81) 12.4 (77)    
Gender                
Male 25.3 (607) 33.9 (815) 40.9 (982) 4.7 (2) 0.09 69.5 (1,813) 13.3 (346) 17.2 (449) 20.2 (2) <.0001 
Female 27.6 (693) 34.2 (860) 38.2 (960)   74.3 (2,014) 9.7 (263) 16.0 (433)    
Estimated Prognosis                
Death Imminent 2.5 (2) 8.9 (7) 88.6 (70) 856.8 (6) <.0001 68.8 (53) 9.1 (7) 22.1 (17) 23.1 (6) 0.0008 
Less than 6 weeks 3.8 (15) 25.3 (99) 70.8 (277)   75.3 (289) 5.0 (19) 19.8 (76)    
6 weeks to 6 months 14.1 (337) 41.9 (1,000) 44.0 (1,052)   71.5 (1,635) 11.2 (257) 17.3 (394)    
Greater than 6 months 45.6 (955) 27.9 (584) 26.6 (557)   72.0 (1,483) 12.5 (258) 15.5 (320)    
Geographic Location                
Site 1 19.5 (50) 35.2 (90) 45.3 (116) 202.3 (10) <.0001 76.5 (199) 6.9 (18) 16.5 (43) 31.6 (10) 0.0005 
Site 2 28.9 (868) 28.7 (860) 42.4 (1,273)   73.1 (2,499) 11.5 (393) 15.5 (529)    
Site 3 28.5 (262) 45.1 (415) 26.5 (244)   67.1 (633) 13.8 (130) 19.09 (180)    
Site 4 15.8 (70) 40.3 (178) 43.9 (194)   70.8 (312) 7.9 (35) 21.32 (94)    
Site 5 18.0 (20) 64.0 (71) 18.0 (20)   73.9 (68) 12.0 (11) 14.13 (13)    
Site 6 17.4 (39) 33.9 (76) 48.7 (109)   72.6 (143) 12.7 (25) 14.72 (29)    
Diagnosis                
Have Cancer Diagnosis 28.1 (823) 34.7 (1,016) 37.2 (1,090) 94.2 (6) <.0001 73.6 (2,360) 11.3 (362) 15.1 (484) 19.8 (6) 0.003 
Have Cancer and Non-
Cancer Diagnosis 26.2 (375) 37.1 (530) 36.7 (525)   68.8 (1,038) 11.9 (180) 19.28 (291)    
Have Non-Cancer 
Diagnosis Only 17.2 (79) 24.8 (114) 58.0 (266)   71.2 (349) 9.8 (48) 18.98 (93)    
Diagnosis unspecified 23.4 (32) 21.9 (30) 54.7 (75)    71.8 (107) 14.8 (22) 13.4 (20)    
Note:  df denotes degrees of freedom
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Triggering rates of the cognition/mental health CAPs are shown in table 6.5.  A general increase 
in Delirium CAP triggering is shown by age. Persons aged 85 or greater exhibited the highest triggering 
rate nearly double the rate of those aged 18-44.  The inverse was generally seen for the Mood CAP where 
triggering frequency decreased with age with the exception for youngest age group.  However, among 
those who triggered the Mood CAP, younger persons were more likely to trigger at a level two.  The 
Delirium CAP is most commonly triggered by persons with shorter prognosis, with over two thirds 
triggering the Delirium CAP when death is imminent.  In contrast, the Mood CAP was most commonly 
triggered by persons with an estimated prognosis of less than 6 weeks.  Site variations in Delirium CAP 
triggering ranged greatly from 6.4% in the CCAC Site 5 (n=9) to over 20% in CCAC Site 1 (n=55) while 
the difference in Mood CAP triggering rates was less than 8% between CCACs (59.0%, n=134 in CCAC 
Site 6 to 66.9%, n=2,666 in CCAC Site 2).   Those with a non-cancer diagnosis were more likely to 
trigger the Delirium CAP than those with cancer.  Persons with a cancer and non-cancer diagnoses 
triggered the Mood CAP more frequently than those with only a cancer or only a non-cancer diagnosis.   
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Table 6.5. Distribution of Background Characteristics by Delirium and Mood Cognition/Mental Health CAPs of Clients Receiving 
Palliative Home Care Services 2006-2011, Ontario, Canada (N=6,769). 

























Age Groups                 
18-44 91.3 (240) 8.8 (23) 12.9 (8) 0.02 63.4 (156) 14.2 (35) 22.4 (55) 45.2 (8) <.0001 
45-64 86.8 (1,601) 13.2 (244)    61.4 (1,105) 17.5 (315) 21.2 (381)    
65-74 86.1 (1,348) 13.9 (217)    63.8 (953) 18.0 (269) 18.2 (272)    
75-84 87.1 (1,540) 12.9 (228)    68.1 (1,161) 16.2 (276) 15.7 (267)    
85 + 83.1 (580) 16.9 (118)    71.7 (492) 16.0 (110) 12.2 (84)    
Gender             
Male 86.0 (2,567) 14.0 (417) 1.3 (2) 0.25 66.1 (1,904) 16.6 (479) 17.2 (496) 2.2 (2) 0.33 
Female 87.0 (2,706) 13.0 (403)    64.3 (1,933) 17.4 (522) 18.3 (551)    
Estimated Prognosis             
Death Imminent 30.5 (25) 69.5 (57) 510.5 (6) <.0001 65.1 (54) 19.3 (16) 15.7 (13) 73.3 (6) <.0001 
Less than 6 weeks 62.1 (267) 37.9 (163)    51.3 (205) 18.5 (74) 30.3 (121)    
6 weeks to 6 months 85.5 (2,171) 14.5 (368)    62.1 (1,492) 18.3 (440) 19.6 (470)    
Greater than 6 months 93.3 (2,036) 6.7 (146)    69.6 (1,490) 15.3 (328) 15.1 (324)    
Geographic Location             
Site 1 79.6 (214) 20.5 (55) 85.1 (10) <.0001 62.3 (167) 15.3 (41) 22.4 (60) 34.9 (10) 0.0001 
Site 2 89.1 (3,560) 10.9 (437)    66.9 (2,666) 17.2 (684) 16.0 (638)    
Site 3 81.6 (791) 18.5 (179)    62.0 (591) 15.3 (146) 22.8 (217)    
Site 4 80.9 (402) 19.1 (95)    62.9 (251) 18.3 (73) 18.8 (75)    
Site 5 93.6 (131) 6.4 (9)    61.1 (58) 17.9 (17) 21.1 (20)    
Site 6 79.3 (211) 20.7 (55)    59.0 (134) 19.4 (44) 21.6 (49)    
Diagnosis             
Have Cancer Diagnosis 88.0 (3,221) 12.0 (438) 42.5 (6) <.0001 66.8 (2,336) 16.2 (566) 17.0 (595) 31.4 (6) <.0001 
Have Cancer and Non-Cancer 
Diagnosis 86.0 (1,482) 14.0 (241)    60.5 (1,017) 18.4 (309) 21.1 (355)    
Have Non-Cancer Diagnosis Only 78.1 (449) 21.9 (126)    67.5 (382) 18.7 (106) 13.8 (78)    
Diagnosis unspecified 86.3 (157) 13.7 (25)    70.6 (132) 12.8 (24) 16.6 (31)    
Note:  df denotes degrees of freedom
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Through examination of the count of triggered CAPs a hierarchical structure in CAP triggering 
emerged (Figure 6.3.).  Fatigue is the most commonly triggered CAP, triggered by 38.9% of persons who 
triggered only one CAP to over 90% of persons who triggered three to five CAPs and 100% of persons to 
triggered six or more CAPs.  Captured in the percentage of persons who trigger only one CAP, the 
Fatigue CAP, Pain CAP, Nutrition CAP, and Dyspnea CAP emerged as early-triggered CAPs.  In 
contrast, the Delirium and Pressure Ulcer CAPs emerged as late-triggered CAPs. Consequently, persons 
who triggered only one CAP, they were most likely to trigger the Fatigue CAP, Pain CAP, Nutrition 
CAP, and Dyspnea CAP and were least likely to trigger the Delirium CAP and Pressure Ulcer CAP. 
Among those who triggered seven CAPs, all persons triggered the Fatigue CAP and Mood CAPs and over 
90% triggered the Dyspnea CAP, Nutrition CAP, and Pain CAP.  In contrast, the Sleep CAP, Delirium 
CAP, and Pressure Ulcers CAP were triggered less frequently triggered. When all but one CAP were 
triggered, the Sleep CAP, Delirium CAP, and Pressure Ulcers CAP remained least likely to be triggered. 
 Figure 6.3. Comparison of CAP Triggering Rates by Number of CAPs Triggered of Clients 
Receiving Palliative Home Care Services 2006-2011, Ontario, Canada (N=6,769). 
 























% of Persons who Trigger One CAP % of Persons who Trigger Seven CAPs
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6.4 Discussion 
Analyses of interRAI PC CAP triggering rates in Ontario, Canada illustrate the depth of 
information to be gained from the interRAI PC, a comprehensive standardized assessment instrument.  
Covering clinical complexity, performance, and mental health/cognition domains, the eight interRAI PC 
CAPs emphasize need for care planning in key areas of palliative care.  The majority of persons triggered 
two or more CAPs reflecting high levels of clinical need within the palliative home care population. 
Variation in CAP triggering was evident based on the age, estimated prognosis, geographic location and 
diagnosis of the person. Older persons and those with a shorter estimated prognosis are most likely to 
trigger multiple CAPs.  
As emphasized by the WHO, comprehensive assessment is an integral component of quality 
palliative care.  White, McMullan, and Doyle (2009) found that two thirds of symptoms experienced by 
persons receiving palliative care services were not self-reported.  Instead, the majority of symptoms were 
only detected through systematic questioning during assessment.  As fatigue and dyspnea emerged as 
early-triggering CAPs, it is suggested that systematic questioning of these symptoms be prioritized during 
all clinical assessments.  Treatment of symptoms at end of life can be effective and improve the QOL of 
the person and their informal support network (Lorenz, 2008).  The increased health complexity of 
persons requiring palliative care necessitates individualized care planning.  Decision making strategies 
informed by evidence from the interRAI PC CAPs assist clinicians to develop a person-centered care 
plan, identify areas of need, and prioritize treatment options.  
Evidence of a hierarchical structure in CAP triggering may be useful to predict health complexity 
and change over time.  For persons with multiple health concerns, the high frequency in Fatigue CAP, 
Dyspnea CAP, Pain CAP, Nutrition CAP, and Mood CAP triggering, warrant increased awareness.  
Fatigue CAP and Dyspnea CAP emerge as pervasive issues common among the overall palliative home 
care population. When persons seem relatively stable with few major health concerns, the hierarchical 
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nature of CAP triggering suggests clinicians continue to investigate fatigue and dyspnea as potential areas 
of focus.  In contrast, Delirium CAP and Pressure Ulcers CAP trigger at higher frequency for persons 
nearing end of life.  The Delirium CAP and Pressure Ulcers CAP, late-triggering CAPs, rarely trigger in 
isolation and may highlight increased client need.  The late-triggering of the Delirium CAP and Pressure 
Ulcers CAP suggest they are indicative of later stages of need in palliative care.  Further investigation into 
the role of CAP triggering and symptom clusters is needed.  The ability of the CAPs to identify symptoms 
also requires further assessment. 
Consistent with previous research, the majority of persons in this study (86.8%, n=5875) reported 
a diagnosis of cancer. Seow, King, & Vaitonis, (2008) note that although persons with cancer receive 80-
85% of palliative care services in Ontario they account for only one third of persons who die.  Research 
used to inform current palliative care practice focuses almost exclusively on the needs of persons with a 
cancer diagnosis (McClement, 2006).   “At the moment, there is only one model for palliative care in 
Canada: The cancer model” (S. Baxter, personal communication, March 1, 2010).   Benefits of palliative 
care for persons with a cancer diagnosis and their informal support network during the rapid decline phase 
preceding death are well recognized, palliative care has been best known to benefit persons with cancer 
during these last few months of life (Shugarman, Lorenz, & Lynn, 2005; Lorenz, Shugarman, & Lynn, 
2006).  However, findings from this study stress increased need to broaden understanding of how persons 
without cancer receiving palliative care may differ.  Disease diagnosis, more specifically the presence or 
absence of a cancer diagnosis, was a strong predictor of health characteristics and CAP triggering among 
persons at end of life.  Persons reporting only a cancer diagnosis were more likely to trigger the Pain 
CAP.  This may be expected, as there is increased awareness of the benefits of palliative care to address 
pain for persons with cancer and addressing uncontrolled pain is often a reason for referral. Therefore, 
persons with cancer who are experiencing challenges with pain may be more likely to be referred for 
palliative care services.  In contrast, those reporting only non-cancer diagnoses such as heart failure, 
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stroke, COPD, or dementia, were significantly more likely to trigger the Dyspnea CAP, Nutrition CAP, 
Pressure Ulcers CAP, Fatigue CAP, and Delirium CAP.  This suggests that persons with non-cancer 
diagnoses who access palliative care services in Ontario, are more likely to exhibit increased health 
complexity and exhibit recognized need for person-specific tailoring of interventions to address multiple 
symptoms.  Persons who reported both a cancer and non-cancer diagnosis were most likely to trigger the 
Mood and Sleep CAPs.  For the Mood CAP, the prevalence of triggering with a single symptom was 
equally as high for those with non-cancer and cancer diagnosis and for those with non-cancer diagnosis 
only.  However, those with both a cancer and non-cancer diagnosis were much more likely to trigger at a 
level 2.  The level of psychosocial distress may comparable between persons with non-cancer and cancer 
diagnoses (Edmonds, 2001); however the present results suggest this burden may be amplified from 
additional disease diagnoses.  This is also reflected in the CAP triggering hierarchical structure.  Mood 
was not commonly triggered alone.  However, when almost all CAPs were triggered, all persons triggered 
the Mood CAP.  This suggests that triggering the Mood CAP may be related to increased symptom 
burden.  It may also be possible that symptom characteristics such as length since onset, intensity, and 
frequency in relation to disease diagnosis may also affect the degree the symptoms impact on the person’s 
health and QOL.   
 Palliative care needs to respond to the needs of persons for all ages. Findings from this study 
suggest that older persons are not only more complex and likely to exhibit the highest needs but that with 
the exception of the Pain CAP and Mood CAP, they trigger CAPs more frequently.  Age-related barriers 
to palliative care referral, resource allocation, and service utilization in Canada have been reported 
elsewhere (Burt & Raine, 2006, Burge, Lawson, Critchley, & Maxwell, 2005; Burge, Lawson, Jonston, & 
Grunfeld, 2008; NELS ICE, 2008) and may be compounded by other challenges such as disease 
diagnosis, and geographic location of care (Freeman, Heckman, Naus, & Marston, 2013).  Therefore, 
greater investigation into how age affects patterns in CAP triggering is warranted.  
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While the majority of CAPs were more likely to be triggered among older cohorts, two 
exceptions are the Mood CAP and Pain CAP where younger persons were most likely to trigger. A 
primary reason for these discrepancies may not be that mood and pain are less prevalent by age groups 
but instead that challenges exist for clinicians to recognize these symptoms (Proctor & Hirdes, 2000; 
Życzkowska, Szczerbińska, Jantzi, & Hirdes, 2007).  Difficulties with mood and in particular symptoms 
of depression may also be under recognized in the older adult population due to their atypical presentation 
(Szczerbińska, Hirdes, & Życzkowska, 2012; Neufeld, Freeman, Joling, & Hirdes, 2014).  Older adults 
are less likely to meet the DSM-IV-TR’s diagnostic criteria resulting in failure to diagnose or more 
importantly failure to recognize the existence of a mood related problem.  Mood disturbances and 
depression among older adults is often expressed as physical rather than psychological symptoms such as 
fatigue, weight loss, or gastro-intestinal problems in contrast to direct communications of feelings of 
sadness or expressions of depressed mood.  This presents unique age-associated challenges for clinicians 
to recognize the signs of depression and mood disturbance in an older adult population. 
The Pain CAP is commonly triggered for those aged 18-44. There are many possible explanations 
for this.  First, younger persons experiencing severe pain or challenges in pain management may feel 
more confident to voice their concerns over pain management and therefore be referred more often than 
older adults who may be more hesitant to discuss pain symptoms (Bernabei et al., 1998).  The ageist myth 
that older adults are used to pain and do not need treatment may also cause failure to refer.  Older adults 
may be hesitant to express feelings of pain due to beliefs it is a natural part of the aging process (Bernabei 
et al., 1998). Rao (2004) notes that lack of recognition of pain symptoms and severity, as well as a lack of 
understanding of the benefits of pain treatment and management, exist for older persons.  Cognitive 
impairment may affect the ability to communicate pain, challenge the clinician’s ability to recognize signs 
that pain is present, and result in the underreporting of pain (Brazil, 2012).  However, it may also reflect 
challenges for clinicians to recognize symptoms of pain among older adults. The prevalence of persons 
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exhibiting cognitive impairment increases with age and thereby may result in elevated risk for under-
recognition and under-treatment of pain for older adults.  
 It is commonly accepted that as persons near the end of life, the number of health issues and 
challenges also increases.  CAP triggering rates differ greatly by age and estimated prognosis. The CAPs 
do not to provide a set treatment plan, but help guide the clinician to consider relevant issues, assist in 
prioritization of treatment feasibility, and to inform best practice guidelines for further information and 
guidance.  In consultation with the person and when appropriate members of their informal support 
network, decisions on whether or not issues raised by the CAPs should be addressed should be made on a 
case-by-case basis.  Wishes expressed by the person should be reflected when assessing treatment burden-
benefit and determining whether or not to treat. It is important to remember that even in the final stages of 
life, persons may respond to and benefit from treatments that decrease symptom burden thereby 
improving QOL at the end of life. 
6.5 Conclusion 
 Data gathered from the interRAI PC may inform understanding of the complex needs of palliative 
home care clients in Ontario.  Patterns in CAP triggering suggest increased attention should be given to 
address the increasing complex needs of both older adults and of persons with a limited estimated 
prognosis. Future research should investigate variation by geographic location and further elucidate 
reasons for age-associated disparities in CAP triggering.  Integration of evidence gathered from the 
interRAI PC CAPs into the care planning process may allow for higher quality of care through better 
tailoring of resources at address person-specific need. 
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7.  Changes in Dyspnea Symptoms Over Time Among Community Dwelling 
Persons with a Life Limiting Illness in Ontario, Canada 
7.1 Introduction 
Dyspnea, also referred to as shortness of breath or breathlessness, is one of the most frequently 
reported and highly distressing symptoms affecting persons nearing end of life (Ng &von Gunten, 1998; 
Potter, Hami, Bryan, & Quigley 2003; Kroenke, Johns, Theobald, Wu, & Tu, 2013).  It has been defined 
as “a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that 
vary in intensity” (American Thoracic Society (ATS), 1999, page 322).  Persons may describe dyspnea in 
different ways including:  ‘tightness in their chest’, ‘feelings of suffocation’, ‘air hunger’, increased 
difficulty to breath’, or ‘increased effort to breath’ (Wilkins, Dexter, & Heuer, 2009).  Dyspnea affects 
multiple aspects of daily life from physical functioning to psychosocial well-being.  It can cause anxiety 
and fear, which in turn increase the risk of social isolation and adverse outcomes (Bredin et al., 1999; 
Parshall et al., 2012). It is distressing for not only the person experiencing dyspnea, but also can cause 
intense feelings of anxiety and helplessness among the members of their informal support network (e.g. 
family, caregivers) (Booth, Silvester, & Todd, 2003).  Gysels and Higginson (2009) note that dyspnea 
may be difficult for caregivers to cope with and serve as an ongoing threat to the ability to continue 
providing informal care.  Some caregivers perceive the worst symptom to handle is dyspnea (Gysels 
&Higginson, 2009). Estimated prevalence rates for dyspnea vary greatly from 3 to 25% in the general 
population (Michelson & Hollrah, 1999) to 16 to 80% among persons with a life limiting illness (Ng 
&von Gunten 1998; Watson, Lucas, Hoy & Wells, 2009).  In the last six weeks of life it is estimated that 
70% of persons receiving palliative care experienced dyspnea and this increases to 90% during the active 
dying phase (Tarzian, 2000).  Despite the high prevalence of dyspnea and the severity of distress it can 
cause, attention to dyspnea in the literature is lacking (Dudgeon & Rosenthal, 1996; Currow, Smith, 
Davidson, Newton, Agar, & Abernethy, 2010).   
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 The philosophy underpinning most palliative care programs places priority on persons nearing 
end of life to receive the highest quality of care possible to relieve pain and distressing symptoms such as 
dyspnea.  The World Health Organization (WHO) (2010) advocates that comprehensive assessment is 
essential to provision of person-centered care for the ‘total person’ or ‘whole self’.  The goal of high 
quality of pain and symptom management is to improve the quality of living and dying for all persons 
faced with a life-limiting condition and to provide care and support for members of the persons informal 
support network.  Palliative care services have been found to lead to improved survival, (Connor, 
Pyenson, Fitch, Spence, & Iwasaki, 2007) and increased satisfaction with care for both the persons faced 
with a life limiting illness and their informal support network (Kane, Bernstein, Wales, Leibowitz, & 
Kaplan, 1984) and with appropriate timing of referral, may lead to a reduction of unnecessary health care 
resource utilization (Tulskyc & Steinhauserc, 2007; Kamal, Currow, Ritchie, Bull, & Abernethy, 2012). 
The subjective nature of dyspnea can make diagnosis of its underlying causes challenging for 
clinicians.  The level of severity in dyspnea symptoms shows no clear relation to pulmonary functioning 
or disease status (Booth, Moosavi, & Higginson, 2008).  Moreover, the complex multifaceted 
pathophysiology of dyspnea remains not fully understood, leaving its origins open to multiple 
interpretations.  Dyspnea may result from interactions involving physiological, psychological, social, and 
environmental factors (American Thoracic Society, 1999).  Currently, there is no clearly accepted ideal 
measurement scale for dyspnea for persons nearing end of life (Dorman, Byrne & Edwards, 2007) and no 
universally recognized evaluation criteria (Bruera, Sweeney, & Ripamonti, 2002).  Viola et al,  (2007) 
found the patient-rated visual analogue scale or the Borg scale were most commonly used measures of 
dyspnea.  In a systematic review of measurement tools for dyspnea that identified 33 tools (11 
breathlessness-specific, 18 disease specific and 4 unidimensional), Bausewein, Farquhar, Booth, Gysels, 
& Higginson (2007) found no measurement tool for dyspnea assessed all dimensions of the symptom.  It 
is important that selection of the measurement tool for dyspnea consider both context and purpose (for 
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example, to assess the overall severity of dyspnea, to assess the functional impairment caused by dyspnea, 
or to assess the quality of the dyspnea symptom) (Dorman, Byrne & Edwards, 2007).   
Cancer Care Ontario recommends that identification of dyspnea, based on self-report by the person 
and where possible upon physical assessment, include consideration of the onset and frequency of the 
experience, absence/presence of anxiety, and level of difficulty breathing (Cancer Care Ontario, 2010).  
Self-report is important to assess the severity of the dyspnea and to determine any subjective effect it may 
have on the person’s health status and QOL (Mahler et al., 2010).  The consensus statement on the 
measurement of patient-reported dyspnea by the American College of Chest Physicians stated that 
clinicians should routinely ask and document patient self-reported frequency and intensity of dyspnea and 
that assessment of dyspnea investigate not only the distress but also meaning, and unmet needs that 
accompany the symptoms of dyspnea (Mahler et al., 2010). 
Care planning for persons nearing end of life is not a one size fits all process.  Across the dying 
trajectory, persons nearing end of life often experience a plethora of complex health issues.  High quality 
palliative care to address distressing symptoms such as dyspnea depends on the clinician’s ability to 
recognize and prioritize those symptoms.  In the absence of detailed assessment, distressing symptoms, 
like dyspnea, may remain undetected (Homsi et al., 2006; White, McMullan, & Doyle, 2009).  During the 
care planning process, it is useful for clinicians to combine clinical judgment with a comprehensive, 
standardized assessment to identify distressing symptoms affecting both the person with the life limiting 
illness and their informal support network (Morrison & Meier, 2004).  Reliance on self-report is not 
adequate since White, McMullan, & Doyle (2009) found that nearly two thirds of all symptoms 
experienced at the end of life were not reported by patients.  Among persons receiving palliative care, the 
number of symptoms detected using systematic assessment was ten times higher than those volunteered 
during the initial patient interview (White, McMullan, & Doyle, 2009). Therefore, comprehensive clinical 
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assessment is a useful support to: inform the care planning process; support a person-driven goal setting 
process; and improve care team communication with the person and their informal support network. 
The objectives of this chapter are to: a) investigate the prevalence of dyspnea among persons who 
receive palliative home care services in Ontario, Canada; b) describe how those who experience dyspnea 
differ from those who do not experience dyspnea; and c) examine changes in dyspnea over time.  This 
chapter sheds light on health and clinical characteristics as well as levels of health service utilization 
associated with dyspnea and focuses upon identification of predictive factors affecting development of 
new dyspnea and recovery from dyspnea over time. 
7.2 Methods 
7.2.1 Study Population 
The current study used de-identified interRAI Palliative Care (interRAI PC) assessment data, for 
6,655 unique persons completed between 2006 and 2011 from adult palliative home care clients aged 18 
years or older who resided in Ontario, Canada.  Follow-up assessments were available for 959 persons. 
7.2.2 Data Source 
The interRAI PC is a comprehensive, standardized assessment instrument that addresses 17 key 
domains, including demographic/intake information, diagnoses, health conditions, physical and 
psychological functioning, and social and emotional well-being, based on 280 unique assessment items 
(Steel et al., 2003).  In a pilot implementation, trained assessors, the majority being nurse case managers, 
completed the assessments based on information from various sources including:  communication with 
and direct observation of the person; consultation with members of the informal support network (family, 
caregivers) when appropriate; discussions with the health team; and attention to personal health records.  
Previous studies have shown the interRAI PC has excellent inter-rater and test-retest reliability (Steel 
et al., 2003, Hirdes et al., 2008).  Initial field testing of the interRAI PC conducted by Steel et al., (2003) 
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involved 144 persons in the USA and Europe, across multiple care settings including community, 
institutional, hospice, and acute care settings.  All seven domains reported showed excellent inter-rater 
reliability with average kappa values ranging from 0.77 (preferences) to 0.95 (functional status) (Steel et 
al, 2003).  Steel et al. (2003) found reliability for pain and other symptoms ranged from a low of 0.59 
(change in sleep pattern) and 0.61 (other pain) to a high of 0.90 (diarrhea) and 0.91 (constipation).   
In follow-up to reliability testing by Steel, Hirdes et al. (2008) conducted inter-rater reliability testing 
of the interRAI PC as part of an international multi-instrument reliability study of the suite of interRAI 
assessment instruments. Hirdes et al. (2008) found substantial overall instrument reliability of the 
interRAI PC (average weighted kappa reported was between 0.61 and 0.80 when interpreted using kappa 
values according to criteria outlined by Landis and Koch (1977)).  The inter-rater reliability testing of the 
interRAI PC by Hirdes et al. (2008) involved 126 participants from 5 study sites across Europe and the 
United States.  They found “almost perfect” strength of agreement based on Landis and Koch’s (1977) 
thresholds  (Kappa statistic 0.81 – 1.00) for seven of the thirteen item domains and “substantial” strength 
of agreement for the remaining five. 
7.2.3 Measure of Dyspnea 
The interRAI PC measures four levels of dyspnea: Absence of symptom; absent at rest but present 
when performed moderate activities; absent at rest, but present when performed normal day-to-day 
activities; and present at rest.  Trained assessors used client self-report to assess dyspnea.  In the case that 
the client was unable to self-report whether or not they were experiencing dyspnea during assessment, 
assessors were instructed to review available clinical records and consult with the client’s health care 
team, family and informal caregivers (Smith et al., 2010). The interRAI PC also includes numerous other 
clinical measures that might be related to dyspnea (e.g., functional impairment), but does not require that 
those other clinical issues be causally attributed to dyspnea only.  
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The newly released interRAI PC Clinical Assessment Protocols (Steel et al., 2013e) include the 
Dyspnea CAP designed to assist clinicians to recognize persons with a life limiting illness experiencing 
dyspnea when performing regular activity (Steel, Morris, & Leff, 2013d).  The two levels of the Dyspnea 
CAP: Trigger vs. not trigger, will be used in this chapter to indicate presence (trigger) and absence (did 
not trigger) of symptoms of dyspnea.  Persons who trigger the Dyspnea CAP report dyspnea to either be 
present at rest or absent at rest but present when performing normal daily activities (Smith et al., 2010). 
Persons who do not trigger the Dyspnea CAP report dyspnea is absent or is only present when performing 
more strenuous than normal activities.  Persons with a life limiting illness who trigger the Dyspnea CAP 
exhibit moderate or worse dyspnea at rest or when performing normal daily activities.  The Dyspnea CAP 
also focuses on severe symptoms of dyspnea that may require potential need for emergency intervention. 
Steel, Morris, & Leff (2013a) estimate that nearly 45% of palliative home care clients trigger the Dyspnea 
CAP.  The Dyspnea CAP guidelines provide strategies to identify the onset and severity of dyspnea 
symptoms and to investigate possible causes of the symptoms.  In addition it provides information on 
treatment options and educational strategies. 
7.2.4 Other Measures 
Clinical summary scales, representing different clinical and risk domains embedded within the 
interRAI PC that are included in the present analysis are: the Changes in Health, End-stage disease, and 
Signs and Symptoms (CHESS) scale (Hirdes, Frijters, & Teare, 2003); the Cognitive Performance Scale 
(CPS) (Morris et al., 1994); the Activities of Daily Living Hierarchy (ADL-H) (Morris, Fries, & Morris, 
1999); and the Pain Scale (Fries, Simon, Morris, Flodstrom, & Bookstein, 2001).  The CHESS scale 
measures health instability as a clinical outcome and predictor of mortality.  It ranges from 0 (no 
instability in health) to 6 (highly unstable health). The CPS measures level of cognitive functioning using 
a scale ranging from 0 (cognitively intact) to 6 (severe cognitive impairment).  It has been validated 
against the Mini-Mental State Examination in both institutional and community settings (Morris et al., 
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1994; Landi et al., 2000).  The ADL-H measures physical functioning using a scale ranging from 0 
(independent) to 6 (totally dependent). Items used to score the ADL-H include: personal hygiene, toilet 
transfer, locomotion, and eating (Morris, Fries, & Morris, 1999).  The Pain Scale uses two items to 
measure pain and has scores ranging from 0 (no pain) to 4 (excruciating pain).  The Pain Scale has been 
validated with the Visual Analogue Scale (Fries, Simon, Morris, Flodstrom, & Bookstein, 2001).   
7.2.5 Analysis 
Analysis was performed in three phases.  Phase one described the relationship between status of 
dyspnea and related factors at baseline assessment. Phase two examined health and service utilization 
characteristics and their associations with status of dyspnea at baseline and with change in status of 
dyspnea at time of follow-up assessment. Bivariate analyses were done using chi-square and t-tests 
depending on variable type to determine the significance of relationships with co-variates. 
Phase three employed complete case logistic regression analysis to create two distinct profiles of risk 
and protective factors.  Model A aimed to predict presence of a new dyspnea at follow-up among persons 
who did not experience dyspnea at baseline (predict triggering the Dyspnea CAP at follow up among 
persons who did not trigger the Dyspnea CAP at baseline assessment).  Model B aimed to predict 
recovery from (absence of) dyspnea at follow-up among persons who exhibited dyspnea at baseline 
(predict not triggering the Dyspnea CAP at follow-up among persons who triggered the Dyspnea CAP at 
baseline assessment). The dependent variable for both models was presence or absence of dyspnea at time 
two.  Persons included in Model A were restricted to those who did not experience dyspnea at baseline 
(did not trigger the Dyspnea CAP), while Model B was restricted to those who had dyspnea present at 
baseline (triggered the Dyspnea CAP).  Model A was ordered descending to model the presence of the 
event occurring or the person having dyspnea.  In contrast, Model B was not ordered descending so that it 
modeled the event not occurring or the person not having dyspnea.  Logistic regression analysis was 
conducted using four stages for the analysis.  In stage one, all variables that had emerged as significant in 
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bivariate analysis or important as indicated in the literature review and available in the interRAI PC were 
included (See Appendix A).  The second stage used model selection tool score and command best =10 
were used to identify any unforeseen relationships among the list of variables used in stage one.  The 
quantitative model selection tool score identified the best subsets of co-variates for each model from the 
total list of variables included for analysis.  The best=10 command specified that only ten models be 
selected for display for each model size to allow increased flexibility for model identification.  Finally, to 
minimize the chance that a better model was available, three automatic model selection techniques were 
used to search for any further models in the third phase.  First, the forward automatic selection tool was 
used with an alpha of 0.1 for variable entry.  Next, the backward automatic selection tool was used with 
an alpha of 0.1 for variable exit.  Finally, the stepwise automatic selection tool was used with an alpha of 
0.1 for both variable entry and exit criteria.  A relaxed alpha level of 0.1 was selected to allow for 
inclusion of a larger range of variables.  Stage three automatic model selection techniques did not 
elucidate additional models than had not already been considered during stages one and two.  In the final 
fourth stage, the best model was selected and any potential unexplained alternatives to the best model 
were tested.  
All analyses were performed using SAS Version 9.2 with an alpha level of p< 0.05 for all statistical 
tests unless otherwise noted above.  Validity of the final logistic regression model was assessed using the 
Hosmer and Lemeshow Goodness-of-Fit test with a small statistic with a large p value indicating 
acceptable model fit (Hosmer and Lemeshow, 2013, p. 167); while the c-statistic was used to assess the 
discrimination strength of the model (Bewick, Check, & Ball, 2005).  
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7.3 Results 
 At baseline, nearly half of the population (44.9%, n=2,990) exhibited dyspnea compared to 
55.1% (n=3,665) who did not exhibit dyspnea (Table 7.1.). With the exception of the oldest old, the 
prevalence of dyspnea increases with age.  Males were more likely to experience dyspnea than females.  
The prevalence of dyspnea among persons whose death was imminent was nearly twice as high compared 
to those with an estimated prognoses of six months or greater (62.6% vs. 36.3%; p <0.0001).  The 
prevalence of dyspnea also varied by CCAC site ranging from a low of 23.6% in Site 5 to a high of 46.7% 
in Site 2.  Persons with a non-cancer diagnosis were more likely to exhibit dyspnea 
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Table 7.1. Sample Distributions and Presence of Dyspnea by Selected Demographic and Clinical Variables of Clients Receiving Palliative 




Total Sample (%, N=6,655) 
No Dyspnea at 
Baseline 
(55.1%, n=3,665) 










18-44 4.2 (280) 68.6 (192) 31.4 (88) 31.8 (4) <0.0001 
45-64 30.0 (1,998) 57.1 (1,140) 42.9 (858)   
65-74 25.4 (1,688) 54.4 (919) 45.6 (769)   
75-84 28.8 (1,913) 52.0 (994) 48.0 (919)   
85 + 11.7 (776) 54.1 (420) 45.9 (356)   
Gender   
 
   
Male 49.2 (3,253) 53.1 (1,727) 46.9 (1,526) 9.6 (1) 0.002 
Female 50.8 (3,354) 56.9 (1,908) 43.1 (1,446)   
Estimated Prognosis   
 
   
Death Imminent 1.9 (107) 37.4 (40) 62.6 (67) 105.2 (3) <0.0001 
Less than 6 weeks 8.4 (464) 43.8 (203) 56.3 (261)   
6 weeks to 6 months 48.1 (2,648) 53.4 (1,413) 46.6 (1,235)   
Greater than 6 months 41.5 (2,283) 63.7 (1,454) 36.3 (829)   
Geographic Site   
 
   
1 4.0 (267) 62.6 (167) 37.5 (100) 41.5 (5) <0.0001 
2 67.3 (4,480) 53.3 (2,389) 46.7 (2,091)   
3 14.9 (988) 58.1 (574) 41.9 (414)   
4 7.6 (506) 54.0 (273) 46.1 (233)   
5 2.1 (140) 76.4 (107) 23.6 (33)   
6 4.1 (274) 56.6 (155) 43.4 (119)   
Diagnosis   
 
   
Have Cancer Diagnosis 59.7 (3,973) 57.8 (2,295) 42.2 (1,678) 98.9 (3) <0.0001 
Have Cancer and Non-Cancer Diagnosis 27.2 (1,812) 56.5 (1,023) 43.5 (789)   
Diagnosis unspecified 3.3 (221) 46.2 (102) 53.9 (119)   
Have Non-Cancer Diagnosis Only 9.8 (649) 37.8 (245) 62.3 (404)   
Note:  df denotes degrees of freedom
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Table 7.2. shows the prevalence of clinical and health characteristics by presence of dyspnea among 
the total population at baseline.  Persons with dyspnea were more likely to exhibit functional impairment 
and moderate cognitive impairment compared to those who did not exhibit dyspnea.  No significant 
differences were observed at baseline between prevalence of dyspnea and presence of depression or 
smoking status.  Compared to those who did not exhibit signs of dyspnea at baseline, persons with 
dyspnea were more likely to experience fatigue (p<0.0001), difficulty clearing airway secretions 
(p<0.0001), weight loss (p<0.0001), edema (p<0.0001), urinary incontinence (p=0.01), and bloating 
(p=0.003).  Bowel incontinence, acid reflux, nausea, and vomiting did not differ significantly by status of 
dyspnea. 
Higher levels of health instability were also evident based on the distribution of the CHESS score 
among persons with dyspnea (Table 7.2.). This was not entirely surprising, since the presence of dyspnea 
is used in the calculation of CHESS and no persons with dyspnea present at baseline could score a zero on 
the CHESS scale.  That being considered, significantly more persons with dyspnea experienced highly 
unstable health with a CHESS Score of 4 or greater compared to persons without dyspnea (47.7% vs. 
26.9%, p<0.0001).  
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Table 7.2. Clinical and Health Characteristics by Status of Dyspnea at Baseline of Clients Receiving 










No Dyspnea  
(55.1%, n=3,665) 
Have Dyspnea  
(44.9%, n=2,990) 
ADL Impairment         
No-minimal (ADL-H = 0) 51.5 (3,239) 57.1 (1,985) 44.5 (1,254) 99.7 (2) <0.0001 
Mild-moderate (ADL-H=1-2) 21.2 (1,334) 18.5 (642) 24.6 (692)   
Severe (ADL-H > 3) 27.3 (1,720) 24.4 (848) 30.9 (872)   
Cognitive Impairment          
No-minimal (CPS = 0) 67.9 (4,272) 69.6 (2,416) 65.8 (1,856) 14.7 (2) 0.0006 
Mild-moderate (CPS = 1-2) 24.3 (1,527) 22.4 (778) 26.6 (749)   
Severe (CPS > 3) 7.9 (495) 8.1 (280) 7.6 (215)   
CHESS Scale         
0 4.6 (286) 8.4 (286) 0 (0) 703.2 (5) <0.0001 
1 12.0 (738) 17.7 (604) 4.9 (134)   
2 19.9 (1,229) 23.3 (794) 15.8 (435)   
3 27.3 (1,681) 23.8 (812) 31.6 (869)   
4 25.4 (1,567) 19.4 (661) 32.9 (906)   
5 10.7 (661) 7.5 (254) 14.8 (407)   
Depression Rating Scale         
0-2 90.9 (5,514) 91.5 (3,077) 90.2 (2,437) 3.2 (1) 0.07 
3+ 9.1 (550) 8.5 (285) 9.8 (265)   
Pain         
None/Less than daily pain  46.9 (2,912) 48.4 (1,666) 45.1 (1,246) 6.8 (1) 0.009 
Experiences pain daily  53.1 (3,297) 51.6 (1,778) 54.9 (1,519)   
Presence of Pain         
No pain 30.7 (1,947) 32.2 (1,127) 28.9 (820) 11.1 (3) 0.01 
Pain present with movement 10.3 (656) 10.6 (371) 10.0 (285)   
Pain present at res 2.5 (1,601) 2.6 (91) 2.4 (69)   
Pain present with movement and at rest 56.4 (35.8) 54.6 (1,911) 58.7 (1,668)   
Pain Scale         
No pain 27.7 (1,717) 28.9 (994) 26.2 (723) 9.8 (4) 0.04 
Less than daily pain 19.3 (1,195) 19.5 (672) 18.9 (523)   
Daily pain but not severe 35.0 (2,174) 34.6 (1,191) 35.6 (983)   
Daily severe pain 13.1 (812) 12.5 (429) 13.9 (383)   
Daily excruciating pain 5.0 (311) 4.6 (158) 5.5 (153)   
Smoking         
Non-smoker (c7a = 0) 85.6 (5,516) 86.2 (3,047) 84.9 (2,469) 2.2 (1) 0.14 
Smoker (C1a = 1,2) 14.4 (929) 13.8 (489) 15.1 (440)   
      
Sleep Problems        
Difficulty falling asleep        
No 69.9 (4,498) 73.2 (2,597) 65.8 (1,901) 40.9 (1) <0.0001 
Yes 30.1 (1,939) 26.8 (952) 34.2 (987)   
Too much sleep        
No 74.2 (4,761) 77.0 (2,729) 70.8 (2,032) 31.9 (1) <0.0001 
Yes 25.8 (1,567) 23.0 (817) 29.3 (840)   
Fatigue         
No 19.7 (1,290) 29.2 (1,056) 8.0 (234) 456.7 (1) <0.0001 
Yes 80.3 (5,253) 70.8 (2,566) 92.0 (2,687)   
Difficulty clearing airway secretions         
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No 85.4 (5,599) 91.6 (3,308) 77.7 (2,291) 251.9 (1) <0.0001 
Yes 14.6 (959) 8.4 (302) 22.3 (657)   
Weight loss         
No 54.0 (3,403) 57.8 (2,009) 49.4 (1,394) 45.0 (1) <0.0001 
Yes 46.0 (2,897) 42.2 (1,466) 50.7 (1,431)   
Peripheral Edema         
No 73.6 (4,840)  78.5 (2,848) 67.6 (1,992) 100.0 (1) <0.0001 
Yes  26.4 (1,736) 21.5 (780) 32.4 (956)   
Urinary Incontinence         
No 82.8 (5,446) 83.9 (3,040) 81.5 (2,406) 6.5 (1) 0.01 
Yes 17.2 (1,128) 16.1 (583) 18.5 (545)   
Bowel Incontinence         
No 87.9 (5,709) 88.4 (3,165) 87.4 (2,544) 1.3 (1) 0.25 
Yes 12.1 (783) 11.6 (417) 12.6 (366)   
Acid Reflux         
No 88.2 (5,795) 88.1 (3,189) 88.4 (2,606) 0.2 (1) 0.66 
Yes 11.8 (775) 12.0 (433) 11.6 (342)   
Bloating         
No 80.9 (5,299) 82.2 (2,970) 79.3 (2,329) 8.7 (1) 0.003 
Yes 19.1 (1,250) 17.8 (643) 20.7 (607)   
Nausea         
No 77.1 (5,045) 77.4 (2,789) 76.7 (2,256) 0.5 (1) 0.50 
Yes 22.9 (1,501) 22.6 (815) 23.3 (686)   
Vomiting         
No 89.6 (5,858) 89.3 (3,214) 90.1 (2,644) 1.1 (1) 0.31 
Yes 10.4 (678) 10.7 (386) 10.0 (292)   
Note:  df denotes degrees of freedom   
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Table 7.3. shows resource utilization of the total population stratified by presence of dyspnea at 
baseline.  The majority of persons received assistance from a home nurse (76.1%, n=5,064), while 
approximately one third received assistance from a personal support worker (assistance with ADL and 
IADL tasks) (32.9%, n=2,190).  One in four persons with dyspnea received oxygen therapy (27.2%, 
n=772) compared to less than one in twenty among persons not reporting dyspnea at baseline (4.8%, 
n=173). Overall, more than half reported a hospital stay in the past 90 days while less than one in four 
reported visiting the ER in the past 90 days.  Persons with dyspnea were significantly more likely to 
report a hospital stay (p=0.0006) and more likely to report an ER visit (p=0.009) during the past 90 days.  
With the exception of receiving oxygen therapy, persons experiencing dyspnea at baseline were not more 
likely to receive assistance from formal care providers (home nurse, PSW, occupational therapy, and 
physiotherapy).  In addition, no significant differences were evident by hours of informal care received.  
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Table 7.3. Health Resource Utilization Characteristics by Status of Dyspnea at Baseline of Clients Receiving Palliative Home Care 




in Total Sample 





No Dyspnea         
(55.1%, n=3,665) 
Have Dyspnea     
(44.9%, n=2,990) 
Assistance from Formal Care Providers           
Receive assistance from Home Nurse 
 
        
No 23.9 (1,591) 20.0 (733) 28.7 (858) 68.4 (1) <0.0001 
Yes 76.1 (5,064) 80.0 (2,932) 71.3 (2,132)     
      
Receive assistance from Personal Support 
Worker  
        
No 67.1 (4,465) 67.0 (2,454) 67.3 (2,011) 0.1 (1) 0.80 
Yes 32.9 (2,190) 33.0 (1,211) 32.7 (979)     
      
Receive assistance from Occupational Therapy 
 
        
No 83.0 (5,522) 83.3 (3,054) 82.5 (2,468) 0.7 (1) 0.40 
Yes 17.0 (1,133) 16.7 (611) 17.5 (522)     
      
Receive assistance from Physical Therapy 
 
        
No 94.1 (6,265) 93.9 (3,441) 94.5 (2,824) 0.9 (1) 0.33 
Yes 5.9 (390) 6.1 (224) 5.6 (166)     
  
 
        
Receive Oxygen Therapy 
 
        
No 85.4 (5,506) 95.2 (3,444) 72.8 (2,062) 641.0 (1) <0.0001 
Yes 14.7 (945) 4.8 (173) 27.2 (772)     
Hours of Informal Support (in last 3 days) 
 
        
0 - > 18 hours  53.7 (3,249) 53.2 (1,785) 54.3 (1,464) 2.4 (2) 0.30 
18-35 hours  22.8 (1,379) 22.5 (757) 23.1 (622)     
36 +  23.5 (1,425) 24.3 (816) 22.6 (609)     
Have had a Hospital Stay in past 90 days 
 
        
No 44.9 (2,851) 46.8 (1,662) 42.5 (1,189) 11.8 (1) 0.0006 
Yes 55.1 (3,495) 53.2 (1,887) 57.5 (1,608)     
Have visited ER in past 90 days 
 
        
No 79.6 (4,434) 80.8 (2,585) 77.9 (1,849) 6.8 (1) 0.009 
Yes 20.5 (1,140) 19.2 (616) 22.1 (524)     
Note:  df denotes degrees of freedom
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 Follow-up assessments were available for 959 persons (14.4%).  Clinical and health 
characteristics reported at baseline by status of dyspnea at follow-up stratified by status of dyspnea at 
baseline are shown in Table 7.4.  At follow-up, 47.1% (n=452) exhibited dyspnea compared to 52.9% 
(n=507) who did not.  Of persons who did not experience dyspnea at baseline, 31.0% (n=169) reported 
new dyspnea symptoms at follow-up while 69.1% (n=377) continued not to experience dyspnea.  Among 
persons who experienced dyspnea at baseline, 68.5% (n=283) continued to experience dyspnea at follow-
up.  In contrast, 31.5% (n=130) had recovered from dyspnea and no longer reported symptoms of dyspnea 
at follow-up.   
Of persons who did not exhibit dyspnea at baseline, those who smoked at time of baseline assessment 
were more likely to exhibit a new dyspnea at follow-up (39.6% vs. 28.5%; p = 0.04).  Moreover, of those 
who did not exhibit dyspnea at baseline, persons who experienced fatigue were more likely to develop 
new dyspnea symptoms (35.2% vs. 23.1%; p = 0.003) while persons who had urinary incontinence were 
less likely (21.0% vs. 32.2%; p=0.04).  Among persons who experienced dyspnea at baseline, also having 
fatigue was predictive of continued dyspnea at follow-up.  Persons with urinary incontinence were less 
likely to report continued dyspnea at follow-up (57.6% vs. 70.4%; p=0.04). 
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Table 7.4. Clinical and Health Characteristics by Status of Dyspnea at Baseline Stratified by Status of Dyspnea at Follow-up of Clients 
Receiving Palliative Home Care Services 2006-2011, Ontario, Canada (N=959). 
 
No Dyspnea at Baseline (56.9%, n=546) Have Dyspnea at Baseline (43.1%, n=413) 
 
All persons with 






































ADL Impairment                     
No-minimal (ADL-H = 0) 73.5 (380) 67.9 (258) 32.1 (122) 1.4 (2) 0.51 64.3 (247) 30.8 (76) 69.2 (171) 1.0 (2) 0.62 
Mild-moderate (ADL-H=1-2) 12.2 (63) 71.4 (45) 28.6 (18) 
 
 
20.1 (77) 36.4 (28) 63.6 (49) 
 
  
Severe (ADL-H > 3) 14.3 (74) 74.3 (55) 25.7 (19) 
 
 
15.6 (60) 30.0 (18) 70.0 (42) 
 
  
         









No-minimal (CPS = 0) 73.3 (381) 68.5 (261) 31.5 (120) 0.8 (2) 0.66 78.7 (299) 30.4 (91) 69.6 (208) 2.0 (2) 0.36 
Mild-moderate (CPS=1-2) 21.2 (110) 70.9 (78) 29.1 (32) 
 
 
17.4 (66) 34.9 (23) 65.2 (43) 
 
  
Severe (CPS > 3) 5.6 (29) 75.9 (22) 24.1 (7) 
 
 
4.0 (15) 46.7 (7) 53.3 (8) 
 
  
         









0-2 90.0 (451) 69.2 (312) 30.8 (139) 0.2 (1) 0.68 88.5 (316) 31.0 (98) 69.0 (218) 0.2 (1) 0.68 
3+ 10.0 (50) 72.0 (36) 28.0 (14) 
 
 
11.5 (41) 34.2 (14) 65.9 (27) 
 
  
         









Less than daily  47.2 (239) 71.1 (170) 28.9 (69) 0.4 (1) 0.53 40.9 (150) 28.7 (43) 71.3 (107) 1.2 (1) 0.27 
Daily pain  52.8 (267) 68.5 (183) 31.5 (84) 
 
 
59.1 (217) 34.1 (74) 65.9 (143) 
 
  









Non-Smoker  82.6 (431) 71.5 (308) 28.5 (123) 4.3 (1) 0.04 80.1 (322) 31.7 (102) 68.3 (220) 0.1 (1) 0.77 
Smoker  17.4 (91) 60.4 (55) 39.6 (36) 
 
 
19.9 (80) 30.0 (24) 70.0 (56) 
 
  









No 36.9 (199) 76.9 (153) 23.1 (46) 8.6 (1) 0.003 12.5 (50) 44.0 (22) 56 (28) 4.3 (1) 0.04 
Yes 63.2 (341) 64.8 (221) 35.2 (120) 
 
 
87.5 (349) 29.5 (103) 70.5 (246) 
 
  











No 92.7 (498) 70.1 (349) 29.9 (149) 3.2 (1) 0.08 81.2 (328) 31.4 (103) 68.6 (225) 0.2 (1) 0.64 
Yes 7.3 (39) 56.4 (22) 43.6 (17) 
 
 
18.8 (76) 34.2 (26) 65.8 (50) 
 
  









No 60.6 (315) 72.7 (229) 27.3 (86) 3.2 (1) 0.08 60.0 (228) 33.8 (77) 66.2 (151) 0.5 (1) 0.47 
Yes 39.4 (205) 65.4 (134) 34.6 (71) 
 
 
40.0 (152) 30.3 (46) 69.7 (106) 
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No 80.0 (432) 71.0 (307) 28.9 (125) 3.3 (1) 0.07 71.7 (291) 33.3 (97) 66.7 (194) 1.2 (1) 0.28 
Yes 20.0 (108) 62.0 (67) 38.0 (41) 
 
 
28.3 (115) 27.8 (32) 72.2 (83) 
 
  









No 85.0 (459) 67.8 (311) 32.2 (148) 4.1 (1) 0.04 83.9 (344) 29.7 (102) 70.4 (242) 4.2 (1) 0.04 
Yes 15.0 (81) 79.0 (64) 21.0 (17) 
 
 
16.1 (66) 42.4 (28) 57.6 (38) 
 
  









No 90.1 (480) 68.3 (328) 31.7 (152) 0.3 (1) 0.61 91.7 (373) 31.6 (118) 68.4 (255) 0.4 (1) 0.53 
Yes 9.9 (53) 71.7 (38) 28.3 (15) 
 
 
8.4 (34) 26.5 (9) 73.5 (25) 
 
  


















No 71.0 (377) 70.8 (267) 29.2 (110) 1.8 (1) 0.18 64.7 (256) 32.4 (83) 67.6 (173) 0.04 (1) 0.84 
Yes 29.0 (154) 64.9 (100) 35.1 (54) 
 
 
35.4 (140) 31.4 (44) 68.6 (96) 
 
  









No 79.4 (416) 70.2 (292) 29.8 (124) 0.3 (1) 0.60 73.9 (291) 33.0 (96) 67.0 (195) 0.8 (1) 0.36 
Yes 20.6 (108) 67.6 (73) 32.4 (35) 
 
 
26.1 (103) 28.2 (29) 71.8 (74) 
 
  









No 87.6 (474) 69.2 (328) 30.8 (146) 0.01 (1) 0.93 88.0 (358) 32.1 (115) 67.9 (243) 0.3 (1) 0.62 
Yes 12.4 (67) 68.7 (46) 31.3 (21) 
 
 
12.0 (49) 28.6 (14) 71.4 (35) 
 
  









No 85.5 (461) 68.8 (317) 31.2 (144) 0.1 (1) 0.76 84.7 (343) 31.2 (107) 68.8 (236) 0.03 (1) 0.87 
Yes 14.5 (78) 70.5 (55) 29.5 (23) 
 
 
15.3 (62) 32.3 (20) 67.7 (42) 
 
  









No 78.2 (422) 68.5 (289) 31.5 (133) 0.6 (1) 0.46 76.3 (312) 30.1 (94) 69.9 (218) 1.7 (1) 0.20 
Yes 21.9 (118) 72.0 (85) 28.0 (33) 
 
 
23.7 (97) 37.1 (36) 62.9 (61) 
 
  









No 92.2 (495) 68.9 (341) 31.1 (154) 0.4 (1) 0.51 89.9 (364) 30.2 (110) 69.8 (254) 3.2 (1) 0.07 
Yes 7.8 (42) 73.8 (31) 26.2 (11)     10.1 (41) 43.9 (18) 56.1 (23)     
Note:  df denotes degrees of freedom
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Table 7.5. summarizes assistance received from formal care providers as well as hours of informal 
support by status of dyspnea at baseline stratified by status of dyspnea at follow-up.  Among persons who 
did not exhibit dyspnea at baseline, persons who did not receive assistance from a home nurse were more 
likely to experience a new dyspnea at follow-up.  Prevalence of assistance from other formal care 
providers for the both populations was not significantly different with the exception of receiving oxygen 
therapy.  One in five persons with dyspnea received oxygen therapy at baseline compared to one in 
twenty persons for those who did not report dyspnea at baseline.  Among persons who did not exhibit 
dyspnea at baseline, those receiving oxygen therapy were significantly more likely to be experiencing a 
new dyspnea at follow-up (62.5% vs. 29.5%, p=0.0006).  
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Table 7.5. Health Resource Utilization Characteristics by Status of Dyspnea at Baseline Stratified by Status of Dyspnea at Follow-up of 
Clients Receiving Palliative Home Care Services 2006-2011, Ontario, Canada (N=959). 
 










































Assistance from Formal Care Providers                     
Receive assistance from Home Nurse   
  
    
   
    
No 23.3 (127) 61.4 (78) 38.6 (49) 4.5 (1) 0.03 34.6 (143) 25.9 (37) 74.1 (106) 3.2 (1) 0.72 
Yes 76.7 (419) 71.4 (299) 28.6 (120)     65.4 (270) 34.4 (93) 65.6 (177)     




    
   
    
No 69.8 (381) 67.5 (257) 32.6 (124) 1.5 (1) 0.07 70.5 (291) 28.9 (84) 71.1 (207) 3.1 (1) 0.08 
Yes 30.2 (165) 72.7 (120) 27.3 (45)     29.5 (122) 37.7 (46) 62.3 (76)     




    
   
    
No 87.7 (479) 68.1 (326) 31.9 (153) 1.8 (1) 0.18 84.5 (349) 29.8 (104) 70.2 (245) 2.9 (1) 0.09 
Yes 12.3 (67) 76.1 (51) 23.9 (16)     15.5 (64) 40.6 (26) 59.4 (38)     
Receive assistance from Physical Therapy   
  
    
   
    
No 91.8 (501) 69.3 (347) 30.7 (154) 0.1 (1) 0.72 93.7 (387) 31.8 (123) 68.2 (264) 0.3 (1) 0.61 
Yes 8.2 (45) 66.7 (30) 33.3 (15)     6.3 (26) 26.9 (7) 73.1 (19)     
Receive Oxygen Therapy   
  
    
   
    
No 95.6 (518) 70.5 (365) 29.5 (153) 11.7 (1) 0.0006 80.7 (314) 33.4 (105) 66.6 (209) 1.8 (1) 0.18 
Yes 4.4 (24) 37.5 (9) 62.5 (15)     19.3 (75) 25.3 (19) 74.7 (56)     
Hours Informal Support (in last 3 days)   
  
    
   
    
0 - > 18 hours 62.2 (306) 67.0 (205) 33.0 (101) 3.4 (2) 0.19 63.5 (223) 31.4 (70) 68.6 (153) 0.2 (2) 0.93 
18-35 hours 19.5 (96) 71.9 (69) 28.1 (27)     18.2 (64) 32.8 (21) 67.2 (43)     
36 + .  18.3 (90) 76.7 (69) 23.3 (21)     18.2 (64) 29.7 (19) 70.3 (45)     
Hospital Stay in past 90 days 
  
  
    
   
    
No 46.8 (249) 69.5 (173) 30.5 (76) 0.02 (1) 0.9 44.3 (167) 34.1 (57) 65.9 (110) 0.6 (1) 0.45 
Yes 53.2 (283) 67.0 (198) 30.0 (85)     55.7 (210) 30.5 (64) 69.5 (146)     
Visited ER in past 90 days 
  
  
    
   
    
No 80.6 (381) 71.9 (274) 28.1 (107) 0.7 (1) 0.39 77.1 (232) 33.2 (77) 66.8 (155) 0.2 (1) 0.64 
Yes 19.5 (92) 67.4 (62) 32.6 (30)     22.9 (69) 36.2 (25) 63.8 (44)     
Note:  df denotes degrees of freedom
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 Model A (Table 7.6.) used logistic regression analyses to examine risk and protective factors for 
exhibiting new dyspnea symptoms at follow-up assessment.  Consistent with bivariate analysis, presence 
of fatigue (OR 2.32; 95% CI 1.51-3.56) and receipt of oxygen therapy (OR 4.51; 95% CI 1.87-10.91) 
emerged as strong risk factors predicting development of a new dyspnea at follow-up.  Interestingly, 
persons experiencing urinary incontinence were less likely to develop a new dyspnea (OR 0.51; 95% CI 
0.28-0.96).  In contrast, receiving assistance from a home nurse, which was significant at the bivariate 
level, was no longer significant in the multivariate model.  Females were less likely to develop new 
dyspnea symptoms compared to males (OR 0.65; 95% CI 0.44 – 0.96).  Age was not significant in the 
logistic regression model.  A c statistic of 0.65 indicates moderate predictive strength of Model A.  
Acceptable fit for Model A is indicated by a relatively small Hosmer and Lemeshow statistic along with a 
large p value (6.89; p=0.55).  
 Logistic regression analysis described in Model B (Table 7.7.) examined risk and protective 
factors among those who exhibited signs of dyspnea at baseline for recovering from dyspnea and no 
longer exhibiting signs of dyspnea at time of follow-up assessment.  Persons experiencing fatigue were 
less likely to recover from dyspnea (OR 0.48; 95% CI 0.26 – 0.88).  In contrast, persons who received 
support from a personal support worker were more likely to recover from dyspnea (OR 1.71; 95%          
CI 1.06 – 2.74).  Neither age nor gender was significant in the regression analysis.  A c statistic of 0.59 
indicates weaker predictive strength of this model compared with Model A.  Acceptable fit for Model B is 
indicated by a relatively small Hosmer and Lemeshow statistic along with a large p value (2.64; p=0.95). 
 Presence/absence of a cancer diagnosis, CCAC site, and assessment interval (in days) between 
baseline and follow-up assessment were forced into the models but there were no significant associations 
for these variables.  Accordingly, they were then removed from the final models.   
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Table 7.6. Final Multiple Logistic Regression Model for Development of New Dyspnea at Follow-up 
Assessment Among Persons Who Did Not Exhibit Dyspnea at Time of Baseline Assessment, 




Adjusted odds ratio  
(95% CI) 
p value 
Age  (10 year increments) 0.08 (0.08) 1.08 (0.93 - 1.25) 0.31 
    Gender (Ref = Male) 
   Female -0.43 (0.20) 0.65 (0.44 - 0.96) 0.03 
    Bladder Incontinence (Ref = Continent) 
   Bladder incontinent -0.68 (0.31) 0.51 (0.28 - 0.94) 0.03 
    Fatigue (Ref = No fatigue) 
   Have fatigue 0.84 (0.22) 2.32 (1.51 - 3.56) 0.0001 
    Oxygen Therapy (Ref = Do not receive  
oxygen therapy) 
  Receive oxygen therapy 1.51 (0.45) 4.51 (1.87 - 10.91) 0.0008 
  
   Note:  C statistic 0.65 
 
 
Table 7.7. Final Multiple Logistic Regression Model for Recovery From Dyspnea at Follow-up 
Assessment Among Persons Who Did Not Exhibit Dyspnea at Time of Baseline Assessment, 





Adjusted odds ratio  
(95% CI) 
p value 
Age  (10 year increments) 0.02 (0.08) 1.02 (0.86 - 1.20) 0.86 
    Gender (Ref = Male) 
   Female 0.14 (0.22) 1.16 (0.75 - 1.78) 0.51 
    Fatigue (Ref = No fatigue) 
   Have fatigue -0.75 (0.32) 0.48 (0.26 - 0.88) 0.02 
    Personal Support Worker (Ref = Do not  
receive support) 
  Receive support from a personal support 
worker  0.53 (0.24) 1.71 (1.06 - 2.74) 0.03 
  
   Note:  C statistic 0.59  
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7.4 Discussion 
 Dyspnea is reported to be a highly distressing symptom for both the person and caregivers 
(Booth, Silvester, & Todd, 2003), suggesting it should be of major concern. Although dyspnea affects 
nearly half of the palliative home care sample in this study it is not inevitable.  The overall prevalence of 
dyspnea remained the same over time; however a large proportion of persons exhibited change over time.  
Dyspnea CAP triggering rates clearly show that not only do some persons get worse and develop 
symptoms of dyspnea over time, but that a substantial portion of persons exhibit the potential to improve 
in symptoms over time.  Of persons with dyspnea at baseline, 1 in 3 developed a new dyspnea by time of 
follow-up.  In contrast, 1 in 4 persons with dyspnea were able to recover from their symptoms.  The high 
number of persons changing in status of dyspnea over time suggests it would be useful to seek out risk 
factors that may be modifiable.  
 Dyspnea was less common among persons with cancer diagnoses compared to those with other 
reported disease diagnoses.  This has been supported in previous findings that persons with non-cancer 
diagnoses who receive palliative home care services such as those with diagnoses including stroke, 
Alzheimer’s disease or other dementia, or Parkinson’s disease (Freeman & Hirdes, forthcoming) exhibit 
higher levels of health complexity compared to the general palliative population.   Increased health 
complexity and uncontrolled symptom prevalence may be a driving factor for referral to palliative care 
for persons with non-cancer diagnoses. 
 The higher prevalence rates for dyspnea among those with shorter prognosis for survival found in 
the cross-sectional results were not evident in longitudinal analysis.  This may be due to multiple factors, 
the most important of which is mortality.  Follow-up assessments were available for less than 20% of the 
baseline population.  High mortality levels evident among palliative end of life populations may 
contribute to this reduced sample size.  However, it may also represent the nature of a pilot dataset where 
data collection windows may not have allowed ample time to elapse for a follow-up assessment to be 
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warranted.  Persons in the sample may still be alive and residing in the community, but not yet have 
received a follow-up assessment.  Alternatively, some persons nearing the end of life are not able to 
remain in the community due to increased level of caregiver distress or unavailability of a caregiver.  
These persons may transition to community hospice or long-term care facilities for more intensive support 
and therefore would not be represented in this dataset.  The Alzheimer’s Society of Canada (2011) notes 
that most persons with Alzheimer’s disease nearing end of life receive care from a LTCF due to the heavy 
burden placed on their caregivers and informal support network.  Future analyses may examine the role of 
prognosis and time to death to be investigated with larger sample sizes now that Ontario has mandated the 
interRAI PC for use across the province.  However, at the time of writing of this thesis, data available 
after implementation were not available.  Furthermore, future data linkages between the interRAI HC, 
MDS 2.0, and interRAI PC assessment instruments would allow for greater depth of understanding 
through linking and tracking of person specific need over time across the continuum of care. 
 Persons with increased levels of functional or moderate cognitive impairment were more likely to 
exhibit dyspnea at baseline.  However, neither functional status nor cognitive impairment was 
significantly associated with changes in status of dyspnea over time in both bivariate and multivariate 
analyses.  This suggests that the relationships of cognitive and functional impairment with dyspnea may 
be related to other factors such as prognosis.  This is also evident among various health characteristics 
including difficulty clearing airway secretions, weight loss, edema, bloating, difficulty falling asleep, and 
too much sleep.  All of these characteristics were significantly more common among persons with 
dyspnea at baseline; however they were not significantly associated with changes in dyspnea over time.  It 
is possible that the lack of significant findings was a result of sample size limitations. 
 At baseline, differences in the prevalence of dyspnea were evident by site at the bivariate level, 
but not at the multivariate level.  Due to varying sample sizes between CCAC’s and limitations in the 
availability of follow-up data in various regions, it was not possible to fully investigate regional 
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differences at this time.  Future investigations should examine whether variations in the prevalence of 
dyspnea is due to differences in regional referral processes and disparities in service availability or 
whether it is due to underlying risk factors in the total population (for example, long-term exposure to 
high levels of environmental pollutants). 
 At baseline, persons who smoked were not more likely to exhibit signs of dyspnea.  However, at 
follow-up, among those who did not exhibit signs of dyspnea at baseline, persons who smoked were more 
likely to exhibit new dyspnea.  This supports previous findings by Dudgeon and Lertzman (1998) that 
smoking is significantly associated with dyspnea among an end of life population.  Therefore, it remains 
important for clinicians to discuss smoking cessation options during the care planning process. 
 As expected, fatigue was strongly associated with dyspnea and emerged as a strong factor at the 
bivariate and multivariate levels for both development of a new dyspnea and recovery from dyspnea over 
time.  Experiencing fatigue increases the risk for persons to develop a new dyspnea over time.  In 
addition, persons who experience fatigue are less likely to recover from dyspnea.  Among those 
exhibiting both fatigue and dyspnea at baseline, over 70 percent were likely to continue to exhibit 
dyspnea.  Like dyspnea, fatigue has been shown to interfere with ADLs and result in decreased quality of 
life (Richardson, 1995; Crow, & Hammond, 1996).  Although fatigue is experienced by the majority of 
persons faced with a life limiting illness and is one of the most frequently reported physical concerns 
reported, it should not be perceived as ‘normal’ or ‘untreatable’ (Kristjanson, 2006).  Attention to fatigue 
during the care planning process with a person-centered individualized focus may have a double benefit.  
Symptoms of dyspnea and fatigue share common characteristics such as variation in severity by time of 
day or by activity being performed.  Incorporation of non-pharmacological therapies such as energy 
expenditure planning or energy conservation and restoration strategies into the care plan may address 
fatigue and dyspnea together as a multidimensional construct and maximize potential benefits.  
Prioritization of activities to be completed when energy levels are highest, ensuring adequate rest and 
   138 
nutrition, and reducing stress may reduce or prevent fatigue (Radbruch, et al., 2008; NHS Lothian, 2010) 
and thereby reduce the risk to develop a new dyspnea over time or promote recovery from dyspnea.  As 
some causes of fatigue may be modifiable, it is plausible that amelioration of fatigue may in turn reduce 
symptoms of dyspnea.   Education during the care planning process is fundamental to assist the person to 
recognize aspects of dyspnea or fatigue they can control and to introduce strategies such as planned 
periods of rest, delegation of activities to others, increased physical activity where appropriate.  
Receipt of home care assistance from a personal support worker (PSW) emerged as an important 
predictor of recovery from dyspnea in multivariate analyses.  PSW home care supports services primarily 
target ADL and IADL tasks including: assistance with bathing hygiene, mobility, or toileting as well as 
meal preparation and housework.  Previous studies note the relationship between allocation of PSW 
support in Ontario, Canada to respond to worsening symptoms and increased functional impairment 
(Seow, Barbera, Howell, & Sydney, 2010a).  Receipt of more than 7 hours of PSW services per week has 
been shown to reduce demand for hospital based services with lower odds of hospital admissions, ER 
visits before death, and of dying in a hospital (Seow, Barbera, Howell, & Sydney, 2010b).  In contrast, 
although our study found persons with dyspnea were more likely to report a hospitalization and visiting 
the ER in the past 90 days at baseline, persons with dyspnea were not more or less likely to experience a 
hospitalization nor visit the ER at follow-up assessment.  Our findings support that allocation of PSW 
support results in increased potential for symptom improvements among persons with dyspnea.  As 
PSW’s focus on support with ADLs and IADL activities, persons with dyspnea who receive PSW 
assistance may no longer be performing strenuous physical activities such as bathing or performing 
regular house duties such as vacuuming or meal preparation thereby reducing opportunities to experience 
dyspnea during exertion. Communication during the care planning process and allocation of services to 
reduce or prevent dyspnea is important.  Recognition of tasks that trigger episodes of dyspnea and 
matching of PSW supports may enable better targeting of PSW services to support persons at the end of 
   139 
life.  Receipt of support from a PSW was associated with higher improvement rates of dyspnea over time 
suggesting that the symptoms of dyspnea may be modifiable through the provision of additional services 
or clinical interventions.  Future randomized clinical trials would be beneficial to test this further. 
  A finding unique to this study is the significant relationship between urinary incontinence and 
lower prevalence of dyspnea.  Developing a new dyspnea or continued experiencing of dyspnea over time 
were more common among persons who are urinary continent.  Previous studies have noted an increased 
risk for dyspnea among persons who are incontinent among populations of persons with COPD 
(Hirayama, Binns, Lee, and Senjyu, 2005) and adults with cystic fibrosis (White, Stiller, and Roney, 
2000).  Both studies linked the association for increased prevalence of dyspnea and urinary incontinence 
to coughing. Urge urinary incontinence may result from increased stress and intra-abdominal pressure, 
caused by repeated coughing (Hirayama, Binns, Lee, and Senjyu, 2005).  In contrast, McGrother et al. 
(2005) found dyspnea was associated with higher risk for stress incontinence at the bivariate level.  In 
multivariate analysis, McGrother et al. (2005) found that dyspnea was only associated with stress 
incontinence in the cross sectional model and was not associated with stress incontinence in longitudinal 
analysis.  Instead multivariate findings found consistent associations with physical non-respiratory 
characteristics, obesity, and disease diagnoses (McGrother et al., 2005).  None of these studies focused on 
an end of life population.  Persons nearing end of life with dyspnea may not experience coughing to the 
same extent someone may with chronic lung disease in its earlier stages. 
 Consultation with expert palliative care clinicians currently practicing in the palliative home care 
field raised alternative potential confounding factors including pharmaceuticals, urinary retention, 
dehydration, or other physiological contributing factors (N. Dahlen
7
, personal communication, November 
                                                     
 
7
 N. Dahlen, BSc (Pharm), is the Palliative Pharmacist Lead, Regional Palliative Care Program, Northern 
Health Authority, British Columbia, Canada. 
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29, 2013; J. Fergusen
8
, personal communication, November 28, 2013; M. Henderson-Betkus
9
, personal 
communication, November 28, 2013) which may be indicated by urinary continence.  First, urinary 
continence can be suggestive of urinary retention or dehydration.  Urinary retention is a common problem 
affecting person at the end of life that in addition to urinary continence can present numerous ways 
including confusion, restlessness, or agitation (Watson, 2005).  Dehydration may lead to decreased urine 
output that may be mistaken by clinicians as urinary continence.  Other potential confounding factors with 
urinary continence include: bowel incontinence, cachexia, edema, and insufficient fluids.  These were 
examined, but no associations were found between these characteristics and dyspnea at the bivariate and 
multi-variate levels.  Other suggested factors that may contribute to the relationship between urinary 
continence and increased risk for dyspnea include metabolic abnormalities, neuromechanical and 
metabolic imbalances, and kidney failure.  The relationship between dyspnea and urinary incontinence 
has not been widely addressed among persons nearing end of life.  Further  investigation is warranted to 
determine whether these findings are spurious resulting from having examined a large number of potential 
independent variables by replicating these analyses in another sample  to confirm the role of bladder 
continence as a risk factor for dyspnea. 
7.5 Summary 
 Dyspnea is not inevitable as persons receiving palliative care progress in the illness trajectory 
towards death.  Findings from this study describe risk factors to develop a new dyspnea and to recover 
from dyspnea over time may be useful to inform and prioritize care planning strategies.  As dyspnea is 
one of the most distressing symptoms and commonly experienced among persons at the end of life, 
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 J. Fergusen, BScN, RN, CHPCN(c) is a Hospice Palliative Care Nurse Consultant, Northern Health 
Authority, British Columbia, Canada. 
9
 M. Henderson-Betkus, RN, MSc, MBA, GNC(c) is the Lead, Clinical Program Standards, Regional 
Home and Community Care, Northern Health Authority, British Columbia, Canada.  
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resource allocation that addresses fatigue should be prioritized.  Prevention strategies for development of 
dyspnea over time need to further elucidate the role of urinary continence as a risk factor.  Allocation of 
PSW supports to meet client need may assist to support recovery from dyspnea over time.  
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8.  A Cross-Sectional Examination of the Relationship between Dyspnea and 
Distress Experienced Within the Caregiver-Client Unit of Care 
8.1 Introduction 
 Dyspnea is one of the most troubling symptoms for both persons with a life limiting illness who 
experience the symptom and for their caregivers (Ng &von Gunten, 1998; Potter, Hami, Bryan, & 
Quigley, 2003; Dellon et al., 2010; Kroenke, Johns, Theobald, Wu, & Tu 2013).  Dyspnea, highly 
prevalent among persons nearing end of life, often increases in severity as the person progresses towards 
death (Booth, Moosavi, & Higginson, 2008).  Dyspnea may trigger an intense fear of suffocation, which 
causes high levels of distress (Australian Government National Health and Medical Research Council, 
2006, p. 109).  Dyspnea directly affects the person’s functional ability and mobility and can cause anxiety 
thereby increasing the risk of social isolation (Bredin, et al., 1999; Parshall et al., 2012).  It can incite a 
cycle of panic and distress where the symptoms of dyspnea cause anxiety.  The increased level of anxiety 
may then elevate the symptoms of dyspnea thereby further increasing the psychological distress 
(Australian Government National Health and Medical Research Council, 2006, p. 109).  Conversely, it 
may also be possible that anxiety incites the cycle of dyspnea, panic and distress, such that anxiety is the 
cause of dyspnea (Lankan et al., 2008). 
Informal caregivers play an essential role in community-based care and support for persons 
nearing end of the life.  In Canada, over 8 million persons provided care to a family member or friend 
who had a long-term health condition, disability, or age-related problem in 2012 (Statistics Canada, 
2013). Even from the point of diagnosis with a life limiting illness, the lives of members of the persons 
informal support network including family, friends, caregivers, or co-workers may be affected (CHPCA, 
2005).  CHPCA notes that each death substantially affects the immediate health and well-being of an 
average of five other persons or over 1.25 million Canadians annually (CHPCA, 2012).   
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Informal care enables vulnerable persons who wish to stay at home to remain in the community 
longer (Canadian Caregiver Coalition, 2012).  Yet, it is not without cost.  Approximately half of informal 
caregivers caring for their spouses or children experience distress (Statistics Canada, 2013).  Providing 
informal care for a person nearing the end of life often involves an extensive range of complex and 
strenuous duties . The increased level of assistance necessary to provide care affects the physical, 
financial, and psychological health and wellbeing of the informal caregiver (Fletcher, Fast, & Eales, 
2011).  Informal caregivers may be unprepared for the complex health and psychosocial needs of persons 
nearing the end of life.  
 Caring for a person with dyspnea has been linked to high levels of distress, unmet needs, and 
fewer reported positive benefits experienced by caregivers during caregiving activities (Malik, Gysels, & 
Higginson, 2013).  Dyspnea has been linked to anxiety and feelings of helplessness among caregivers 
(Goodridge, Duggleby, Gjevre, & Rennie, 2008; Booth, Silvester, & Todd, 2003).  Dyspnea may be 
difficult for caregivers to cope with and serves as an ongoing threat to the ability to continue providing 
informal care (Gysels and Higginson, 2009).  As the disease progresses and the prevalence and frequency 
of dyspnea increase (Solano, Gomes, & Higginson, 2006) caregivers may experience increased feelings of 
distress and helplessness (Booth, Silvester, & Todd, 2003).  In a study of caregivers of patients dying of 
cystic fibrosis, Dellon et al. (2010) found over half (52%) of patients reported dyspnea to be the most 
distressing symptoms while 100% of caregivers reported dyspnea to be distressing during the final week 
of life.  
Palliative care aims to provide the highest quality of pain and symptom management not only to 
the persons nearing the end of life but also advocates for the provision of support and care to those family, 
friends, and other informal network members affected by the persons illness.  Expanding the unit and 
focus of care from the quality of living and dying for the person faced with a life limiting illness to 
include his or her family, friends, and caregivers (informal support network) is a cornerstone of the 
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palliative care philosophy.  The World Health Organization (WHO; 2010) takes the view that palliative 
care should prioritize self-determination for the ‘total person’ and care for the ‘whole self’ while 
simultaneously recognizing the need for a multidisciplinary team approach which also addressed the 
needs of family members and friends enabling them to function as a support system.  This involves 
helping informal caregivers to cope throughout the illness trajectory and during bereavement.  Palliative 
care services have been found to lead to increased satisfaction with care for not only the person faced with 
a life limiting illness, but also for their informal caregivers (Kane, Bernstein, Wales, Leibowitz, & 
Kaplan, 1984).  In addition, palliative home care programs have been shown to improve overall scores for 
QOL, reduce physical symptoms such as dyspnea, reduce psychological distress such as depression or 
anxiety, and improve accessibility to formal care services (Melin-Johansson, Axelsson, Gaston-
Johansson, & Danielson, 2010). 
Previous research has shown mutuality in distress experienced by the caregiver and the care 
recipient (client).  Caregiver and client physical and psychosocial wellbeing at end of life are interrelated 
(Hodges, Humphris, & Macfarlane, 2005). Anxiety disorders exhibited by caregivers may be associated 
with anxiety experienced by the client and vice-versa (Bambauer et al., 2006).  Moreover, depression is 
also a common distressing symptom for a number of caregivers and clients.  Lankan et al (2008) note that 
up to one third of caregivers of persons with advanced respiratory disease may exhibit risk for depression 
while in a meta-analysis of depression among cancer patients, Krebber et al (2014) found the mean 
prevalence of depression ranged from 8% to 24%.  Dyspnea has also been associated with increased 
levels of distress by both the person faced with a life limiting illness and their informal caregivers.  
Gysels, Bausewein, and Higginson (2007) suggest that caregivers are equally as distressed by dyspnea as 
is the person experiencing it. Malik, Gysels, and Higginson (2013) note that interventions to address 
dyspnea experienced by persons with a life limiting illness must also address the needs of the caregivers. 
The physical and psychological suffering experienced by the client has been shown to affect the 
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psychological health and wellbeing of the caregiver both during the illness trajectory and following 
during the bereavement period. 
Care planning for persons with a life limiting illness can be complex and involve issues at a time 
when added sensitivity, patience, and understanding are needed.  High quality palliative care recognizes 
the impact that caregiving and bereavement may have on members of the informal support network and 
aims to address the needs of the caregiver across the illness trajectory and during bereavement.  This 
includes access to caregiver-focused resources, counseling, and education in addition to collaboration 
with and support from health professionals to assist with care related duties.  It involves informed 
tradeoffs to achieve a burden/benefit balance, which should aim to meet the needs of both the client and 
caregiver when determining the plan of care.  This applies specifically to the allocation or non-allocation 
of interventions, treatments, or supports when considering estimated prognosis, the impact on QOL, and 
goals of care for all members of the care unit. When caring for a person nearing the end of life, these 
challenges are magnified due to the expanded unit of care focus of palliative care to address the needs of 
the person during the illness trajectory and the needs of their informal support network during and 
following the death of the person.   
 It is well recognized that a large number of persons would prefer to die at home; however, the 
feasibility of a home death is heavily dependent upon the availability and efforts of informal caregivers 
(Canadian Caregiver Coalition, 2012). Informal caregivers are needed to enable and support persons 
nearing end of life to remain in the community at achieve a home death (Gomes & Higgins, 2006). The 
level of informed decision-making and perceived choice to provide community based palliative care for 
the client vary greatly, and can have a substantial impact on caregiver health and well-being (Stajduhar & 
Davies, 2005). Therefore, caregivers’ needs should be considered of fundamental importance during the 
care planning decision-making process.  Following, it is important to have a better understanding of how 
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individual person-specific characteristics increase the likelihood for the caregiver and client (members of 
the care unit) to experience distress. 
 Previous research by Hirdes et al. (2012) used pilot data from the interRAI PC to investigate 
predictors of caregiver distress among an earlier sub-sample of the current sample palliative home care 
population.  Bivariate associations showed increased risk for caregiver distress for a large group of client 
demographic and caregiver characteristics, clinical indicators, and health service indicators (Hirdes et al., 
2012).  Moreover, multivariate logistic regression analyses found that a combination of a subset of client, 
caregiver, and service use/provider characteristics significant at the bivariate level was strongly predictive 
of caregiver distress.  Hirdes et al., (2012) did not focus on distress as experienced by the caregiver-client 
care unit.  Distress experienced by the client was not included as part the dependent variable.  Instead, 
their research focused solely on caregiver distress.  In their bivariate analysis, dyspnea was shown to be a 
significant indicator of caregiver distress (OR 1.27; SD 1.04-1.55); however, this variable was not 
included as an independent variable in the final multiple logistic regression model (Hirdes et al., 2012).  
The Changes in Health and End Stage Signs and Symptoms (CHESS) Scale, a measure of health 
instability (Hirdes, Frijters, & Teare, 2003), was included in the final regression analysis.  Since dyspnea 
is included in the CHESS scale, its predictive strength as an independent variable was not presented.  
Due to the multiple conditions experienced by persons nearing end of life and the subjective 
evaluation of dyspnea, it remains unclear how strong dyspnea is as a predictive factor affecting distress 
within the caregiver and client care unit.  Therefore, the current study examined the relationship between 
distress within the caregiver and client unit and dyspnea.  In contrast to previous work by Hirdes et al., 
(2012) which used caregiver distress only as the dependent variable of focus, current analysis aimed to 
elucidate the role of dyspnea as an independent variable to predict distress experienced by the person or 
his/her caregivers. The specific objective of this study was to determine whether dyspnea is associated 
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with distress in either the person receiving palliative care or members of their informal network among a 
sample population of persons receiving palliative home care services in Ontario, Canada. 
8.2 Methods 
8.2.1 Data Source 
This cross sectional analysis focused on de-identified interRAI PC assessment data gathered from 
6,655 unique palliative home care clients.  Pilot data were collected from 2006 to 2011 across six regional 
CCAC jurisdictions in Ontario, Canada.   
The interRAI PC is a comprehensive standardized assessment instrument, now mandated for use 
for all palliative home care clients assessed to receive care across all regional jurisdictions in Ontario, 
Canada.  The interRAI PC provides a comprehensive picture of clients heath and clinical characteristics 
encompassing physical, mental, and social domains as well as important information regarding 
demographic, health service utilization, and care preferences.  It gathers a breadth of information on client 
mood, life-completion, and self-reported spirituality.  In addition, the section on informal supports 
collects information describing the informal caregiving network including primary and secondary 
caregiver’s relationship to the client, hours and type of care provided.  Trained assessors completed 
assessments using information from the direct observation and discussion with the client, members of 
their health care team, and informal support network as well as consideration of available medical 
records, as part of regular clinical practice. The strength of inter-rater and test-retest reliability of the 
interRAI PC (Steel et al., 2003, Hirdes et al., 2008) has been described previously (see Chapter 7). 
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8.2.2 Measures of Distress 
The interRAI PC collects information on caregiver distress based on three items:  a) Informal 
helper is unable to continue caring activities; b) Primary informal helper expresses feelings of distress, 
anger, or depression; and c) Family or close friends report feeling overwhelmed by the person’s illness. 
The rate of caregiver distress, calculated based on the presence of one or more of these three items, was 
present in one quarter of caregivers (25.2%, n=1,580). 
Three self-reported mood items embedded within the interRAI PC were used to evaluate three 
dimensions of the clients’ state of mood including a) Anhedonia (little interest or pleasure in things 
normally enjoyed; b) Anxiety (anxious, restless, or uneasy); and c) Dysphoria (sad, depressed, or 
hopeless).  Together, in the current analysis, self-report of one or more of these variables indicated self-
reported distress.  One or more signs of self-reported distress was exhibited by 44.9% of clients 
(n=2,571). 
The Depression Rating Scale (DRS) has been shown to be an effective assessor-rated scale to 
indicate potential signs of depression.  It is calculated from seven mood and behaviour items embedded 
within the interRAI PC.  Each item is rated 0 (not exhibited in the last 30 days); 1 (exhibited up to five 
days a week) or 2 (exhibited daily or almost daily) and then added to comprise a summative score ranging 
from 0 indicating no depression to a maximum score of 14.  The DRS has been validated against the 
Hamilton Depression Rating Scale and the Cornell Scale for Depression in Dementia and shown to have 
greater sensitivity and specificity when compared to the 15-item Geriatric Depression Scale among a 
long-term care population (Burrows, Morris, Simon, Hirdes, & Phillips, 2000).  More recently the validity 
and reliability was demonstrated in a palliative home care population (Fisher, Seow, Brazil, Smith, & 
Guthrie, 2014c).  While a score of 3 is associated with major or minor depressive disorders (Burrows et 
al., 2000), a lower threshold score of 1 was used in the current analysis to indicate presence of any 
depressive symptom.  A DRS score of 1 or greater was reported by 30.0% of clients (n=1,816). 
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A measure of overall client distress was derived from a score of one or more on the DRS and/or 
presence of self-reported distress.  Overall client distress was reported by 47.6% of clients (n=2,957).  A 
global measure of distress affecting either the palliative care client or his/her caregivers (referred to here 
collectively as the “care unit”) was calculated using presence of any of the three indicators of caregiver 
distress or presence of any of the three client self-rated mood items or a DRS score by the client of one or 
higher. Care unit distress was present among 53.0% of client/caregiver units (n=3,491). 
8.2.3 Analysis 
Cross-sectional analyses to elucidate the relationship between dyspnea and care unit distress were 
performed in three phases.  Phase one provided an overview of the bi-variate relationship between 
presence of dyspnea and defining distress characteristics of the caregiver, client, and care unit.  Phase two 
examined the bi-variate relationship between client specific characteristics and their prevalence associated 
with status of care unit distress.  These analyses used chi-square and odds ratios to determine the 
significance and strength of relationships between co-variates. 
Phase three employed complete case logistic regression analysis to investigate the strength of 
dyspnea as a risk factor for care unit distress (Models 1-4). The dependent variable for all models was 
presence or absence of care unit distress.  The ‘descending’ statement was used to order the event to 
occurring; meaning care unit distress was present. As the purpose of this chapter was to investigate the 
role of dyspnea in relationship to care unit distress, regression analysis did not focus on all possible 
factors affecting care unit distress.  Model 1 examined the role of dyspnea as an independent predictor of 
care unit distress. Model 2 controlled for basic unmodifiable client characteristics. Based on previous 
research predicting caregiver distress among a palliative home care population (Hirdes et al, 2012), a 
comparative model (Model 3) was run to control for co-variates recognized as important.  Model 4 
combined variables from Model 2 and Model 3 to examine the predictive strength of dyspnea as a risk 
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factor for care unit distress.  As the role of dyspnea as an independent risk factor for care unit distress was 
the focus of this chapter, automatic model selection techniques focused on predicting care unit distress 
were not employed to confirm the above analyses.  Final model analysis compared the predictive model 
strength for care unit distress including dyspnea to previous findings predicting caregiver distress by 
Hirdes et al. (2012). 
All analyses were performed using SAS Version 9.2 with an alpha level of p< 0.05 for all 
statistical tests.  Validity of the logistic regression models were assessed using the Hosmer and 
Lemeshow Goodness-of-Fit test where a small statistic with a large p value indicated acceptable model fit 
(Hosmer & Lemeshow, 2013, p. 167).  The c statistics was used in the current analysis to assess the 
discrimination strength of the logistic regression model (Bewick, Cheek, & Ball, 2005) and as a basis to 
compare the different models fitted to predict care unit distress (Peng, Lee, & Ingersoll, 2002). 
8.3 Results 
Sample characteristics are shown in Table 8.1.  The majority of palliative home care clients were 
aged 65 or greater of whom nearly two thirds were married (64.5%).  Two in five clients reported a 
prognosis of greater than six months (41.5%, n=2,283) while death was expected within six weeks of 
assessment for one in ten clients (10.3%, n=571).  The vast majority (86.9%, n=5,785) reported a 
diagnosis of cancer, of whom approximately one third simultaneously reported non-cancer diagnoses 
(n=1,812).  Dyspnea was a commonly occurring symptom reported present when performing activities for 
45.9% (n=3,054) of clients and present at rest for 17.4% (n=1,155) of clients. 
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Table 8.1. Sample Characteristics of Clients Receiving Palliative Home Care Services 2006-2011, 
Ontario, Canada (N=6,655). 
 
  
   
 Total Population 
(N=6,655) 
Age Groups   
18-44 4.2 (280) 
45-64 30.0 (1,998) 
65-74 25.4 (1,688) 
75-84 28.8 (1,913) 
85 + 11.7 (776) 
Gender   
Male 49.2 (3,253) 
Female 50.8 (3,354) 
Marital Status   
Not married 35.6 (2,292) 
Married/partner 64.5 (4,155) 
Estimated Prognosis   
Death is imminent 1.9 (107) 
Less than 6 weeks 8.4 (464) 
6 weeks to 6 months 48.1 (2,648) 
Greater than 6 months 41.5 (2,283) 
Geographic Site   
1 4.0 (267) 
2 67.3 (4,480) 
3 14.9 (988) 
4 7.6 (506) 
5 2.1 (140) 
6 4.1 (274) 
Diagnosis   
Reported cancer diagnosis only 59.7 (3,973) 
Reported non-cancer diagnosis only 9.8 (649) 
Reported both cancer and non-cancer diagnosis 27.2 (1,812) 
Diagnosis unspecified 3.3 (221) 
Functional Ability   
No-minimal impairment (ADL-H = 0) 51.5 (3,239) 
Mild-moderate impairment (ADL-H = 1-2) 21.2 (1,334) 
Severe impairment (ADL-H > 3) 27.3 (1,720) 
Cognitive Ability    
No-minimal impairment (CPS = 0) 67.9 (4,272) 
Mild-moderate impairment (CPS = 1-2) 24.3 (1,527) 
Severe impairment (CPS > 3) 7.9 (495) 
Dyspnea   
No dyspnea 36.8 (2,446) 
Present when performing activities 45.9 (3,054) 
Present at rest 17.4 (1,155) 
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Table 8.2. shows sample characteristics of informal caregivers of clients receiving palliative 
home care services.  Nearly all clients reported having a primary caregiver (n=6,530, 98.1%) while 71.8% 
reported having a secondary caregiver (n=4,779).  Primary caregivers were most likely to be 
spouses/partners of the client (58.6%, n=3,823) followed by their adult children (29.1%, n=1,897).  Other 
primary caregivers including siblings of the client, other relatives, friends, and neighbours were reported 
by 12.4% of respondents (n=810).  Secondary caregivers were most likely to be adult children of the 
client (52.0%, n=3,492), followed by other primary caregivers (16.7%, n=1,109).  Few spouses of clients 
reported being secondary caregivers (1.5%, n=178).  Over three quarters of informal caregivers provided 
ADL care during the last 3 days (78.8%, n=4,483).  Almost all informal caregivers provided IADL care 
during the last 3 days (96.4%, n=5,546).  Approximately half of informal caregivers reported providing 
less than 18 hours of care assisting with IADL and ADL support over the past three days (53.7%, 
n=3,249).  In comparison, 22.8% reported providing between 18 and 35 hours of care (n=1,379) and 
23.5% (n=1,425) reported providing 36 hours or more of care.  The majority of clients reported having a 
strong and supportive relationship with their family (95.7%, n=6,277).  
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Table 8.2. Characteristics of Informal Caregivers of Clients Receiving Palliative Home Care 
Services 2006-2011, Ontario, Canada (N=6,655). 
 
Prevalence Total 
Population at Baseline 
(N=6,655) 
 Primary Caregiver Relationship to Client 
 Child 29.1 (1,897) 
Spouse/Partner 58.6 (3,823) 
Other 12.4 (810) 
Did not report having a primary caregiver 1.9 (125) 
Secondary Caregiver Relationship to Client   
Child 52.0 (3,492) 
Spouse/Partner 1.5 (178) 
Other 16.7 (1,109) 
Did not report having a secondary caregiver 28.2 (1,876) 
Informal Caregiver Provides ADL care   
No 21.2 (1,209) 
Yes 78.8 (4,483) 
Informal Caregiver Provides IADL care   
No 3.7 (210) 
Yes 96.4 (5,546) 
Caregiver Resides with Client   
No 18.6 (1,080) 
Yes 81.4 (4,736) 
Hours of Informal Care Provided (in past 3 days)   
>18 53.7 (3,249) 
18-35 22.8 (1,379) 
<36 23.5 (1,425) 
Strong and Supportive Relationship with Family    
No 4.3 (280) 
Yes 95.7 (6,277) 
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 Psychosocial characteristics indicating distress of the client, informal caregiver, and care unit are 
shown in Table 8.3.  Nearly half of clients exhibited signs of distress (47.5%, n=2,857).  Clients 
experiencing symptoms of dyspnea were more likely to also exhibit overall signs of distress (p <0.001), 
more likely to report one or more signs of self-reported distress (p<0.0001), and more likely to be at risk 
for depression indicated by increased DRS scores at all levels scoring one or higher (p=0.002) compared 
to persons who did not experience dyspnea.  A common pattern was evident for individual client self-
report mood items (anhedonia, anxiety, and dysphoria) that consistently showed that the signs of 
depression were more common among persons exhibiting dyspnea than persons who did not exhibit 
dyspnea.  One in four caregivers exhibited signs of distress (25.2%, n=1,580).  Caregivers of clients 
experiencing dyspnea were more likely to exhibit distress (p=0.005). Less than 10% of caregivers 
reported feeling unable to continue their caregiving activities (n=577), while 14.7% reported feelings of 
distress, anger, or depression (n=934) and 18.5% reported feeling overwhelmed by the person’s illness 
(n=1,166).  Similar to the pattern exhibited for client self-reported distress, the prevalence of all 
individual informal caregiver distress items showed increased prevalence of distress when caring for a 
client exhibiting dyspnea.  However, the increased prevalence of informal helpers unable to continue 
caring activities was not statistically significant.  When indicators of caregiver distress and client distress 
were combined, over half of the caregiver-client units exhibited distress (53.0%, n=3,491).  Clients who 
exhibited dyspnea were more likely to also exhibit signs of combined distress than persons without 
dyspnea (p <0.0001). 
  
   155 
Table 8.3. Bivariate Associations of Indicators of Client and Caregiver Distress by Status of 

















Client Status            
Client exhibits overall distress (Self-






No 53.5 (3,152) 56.9 (1,219) 50.6 (1,446) 48.3 (487) 27.6 (2) <0.0001 
Yes 47.5 (2,857) 43.1 (925) 49.4 (1,410) 51.7 (522)    







No 55.1 (3,152) 59.6 (1,219) 53.0 (1,446) 51.2 (487) 27.7 (2) <0.0001 





     




     
No 78.1 (4,417) 82.1 (1,658) 76.7 (2,071) 73.7 (688) 32.7 (2) <0.0001 





     
No 68.5 (3,926) 74.2 (1,525) 65.5 (1,785) 64.8 (616) 48.6 (2) <0.0001 





     
No 70.1 (3,999) 73.0 (1,495) 68.2 (1,852) 69.4 (652) 13.0 (2) 0.002 
Yes 29.9 (1,703) 27.0 (553) 31.8 (863) 30.6 (287)    




     
0 70.1 (4,248) 72.9 (1,586) 68.2 (1,978) 69.3 (684) 20.8 (6) 0.002 
1-2 20.9 (1,266) 19.2 (417) 22.5 (653) 19.9 (196)    
3-5 6.8 (415) 6.3 (138) 7.0 (202) 7.6 (75)    
6 + 2.2 (135) 1.7 (36) 2.3 (67) 3.2 (32)    
Informal Caregiver Status            
Caregiver exhibits signs of distress     
 
     
No 74.8 (4,693) 75.8 (1,733) 75.5 (2,201) 70.9 (759) 10.8 (2) 0.005 
Yes 25.2 (1,580) 24.2 (552) 24.6 (716) 29.1 (312)    
Informal helper is unable to continue in 
caring activities  





No 90.1 (5,752) 91.3 (2,107) 91.0 (2,672) 89.8 (973) 1.8 (2) 0.40 
Yes 9.1 (577) 8.8 (202) 9.0 (265) 10.2 (110)    
Primary informal helper expresses 
feelings of distress, anger, or depression  





No 85.3 (5,404) 84.9 (1,963) 86.5 (2,541) 82.6 (189) 9.6 (2) 0.008 
Yes 14.7 (934) 15.1 (348) 13.5 (397) 17.4 (189)    
Family or close friends report feeling 
overwhelmed by persons illness 





No 81.6 (5,154) 82.6 (1,906) 81.7 (2,401) 78.8 (847) 7.2 (2) 0.03 
Yes 18.5 (1,166) 17.4 (401) 18.3 (537) 21.2 (228)    
Combined Care Unit Distress            
Distress exhibited by either/both 






No 47.1 (3,102) 51.6 (1,244) 44.8 (1,360) 43.5 (498) 31.6 (2) <0.0001 
Yes 53.0 (3,491) 48.5 (1,169) 55.2 (1,675) 56.5 (647)    
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 Table 8.4. describes the bivariate associations between client demographic characteristics and 
status of distress within the care unit.  Distress within the care unit was significantly associated with client 
age, prognosis, CCAC site location, diagnosis, and status of dyspnea (p<0.0001).  Clear age differences 
emerged as both the prevalence and risk for care unit distress were significantly higher for the younger 
clients in comparison to the oldest old (p<0.0001).  No differences were evident by client gender or 
marital status.  Care unit distress is most commonly reported by persons with an estimated prognosis of 
less than six weeks (69.5%, n=321) in contrast to clients with a prognosis of greater than six months 
(48.8%, n=1,112) who reported the lowest rate of care unit distress.  Clients with an estimated prognosis 
of less than six weeks were at highest risk for distress within the care unit (OR 2.38; 95% CI 1.92-2.96) 
followed by those with a prognosis of greater than six weeks and less than six months (OR 1.43; 95% CI 
1.27-1.60) compared to clients with a prognosis of greater than six months to live.  Clients who reported 
both a cancer and non-cancer diagnosis were most likely to exhibit care unit distress (59.1%, n=1,065 
p<0.0001), followed by persons with only a non-cancer diagnosis (54.2%, n=347).  Persons with dyspnea 
were more likely to exhibit signs of unit distress than clients who did not have dyspnea (p<0.0001).  
Persons who reported dyspnea present at rest were at a slightly higher risk to exhibit unit distress (OR 
1.38; 95% CI 1.2-1.59) than those who reported dyspnea present when performing activities (OR 1.31; 
95% CI 1.18-1.46) when compared to persons who did not experience dyspnea.  
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Table 8.4. Bivariate Associations of Client Demographic Characteristics by Status of Distress 
Within the Caregiver/ Client Unit Among Clients Receiving Palliative Home Care Services 2006-
2011, Ontario, Canada (N=6,655). 
 
Neither Exhibit 
Signs of Distress 
(47.1% n=3,102) 
Either/Both Caregiver or 
Client Exhibit Signs of 







Age Groups          
18-44 40.0 (110) 60.0 (165) 25.1 (4) <0.0001 1.66 (1.25-2.19) 
45-64 43.9 (870) 56.1 (1,111)    1.41 (1.19-1.67) 
65-74 47.3 (792) 52.7 (882)    1.23 (1.04-1.46) 
75-84 48.9 (928) 51.1 (969)    1.15 (0.98-1.36) 
85 + 52.5 (402) 47.5 (364)    ref 
Gender   
 
     
Male 47.6 (1,533) 52.4 (1,687) 0.8 (1) 0.38 ref 
Female 46.5 (1,547) 53.5 (1,778)    1.04 (0.95-1.15) 
Marital Status   
 
     
Not Married 47.9 (1,086) 52.1 (1,182) 1.6 (1) 0.21 ref 
Married/Partner 46.2 (1,904) 53.8 (2,214)    1.07 (0.96-1.18) 
Estimated Prognosis   
 
     
Greater than 6 months 51.2 (1,165) 48.8 (1,112) 81.6 (3) <0.0001 ref 
6 weeks to 6 months 42.4 (1,117) 57.6 (1,519)    1.43 (1.27-1.60) 
Less than 6 weeks 30.5 (141) 69.5 (321)    2.38 (1.92-2.96) 
Death Imminent 47.6 (49) 52.4 (54)    1.16 (0.78-1.71) 
Geographic Site   
 
     
1 42.1 (112) 57.9 (154) 68.3 (5) <0.0001 1.03 (0.73-1.44) 
2 50.4 (2,228) 49.6 (2,196)    0.74 (0.57-0.94) 
3 39.7 (391) 60.3 (595)    1.13 (0.87-1.49) 
4 42.4 (214) 57.6 (291)    1.01 (0.75-1.36) 
5 29.0 (40) 71.0 (98)    1.83 (1.18-2.83) 
6 42.7 (117) 57.3 (157)    ref 
Diagnosis   
 
     
Report cancer diagnosis only 49.7 (1,955) 50.3 (1,978) 42.8 (3) <0.0001 ref 
Report non-Cancer diagnosis 
only 
45.8 (293) 54.2 (347) 
 
  1.17 (0.99-1.38) 
Report cancer and non-cancer 
diagnosis 
40.9 (737) 59.1 (1,065) 
 
  1.43 (1.28-1.60) 
Diagnosis unspecified 53.7 (117) 46.3 (101)    0.85 (0.65-1.12) 
ADL Impairment   
 
     
No-minimal (ADL-H=0) 52.5 (1,690) 47.5 (1,528) 80.0 (2) <0.0001 ref 
Mild-moderate (ADL-H=1-2) 43.5 (578) 56.5 (752)    1.44 (1.27-1.64) 
Severe (ADL-H > 3) 39.9 (678) 60.1 (1,020)    1.66 (1.48-1.88) 
Cognitive Impairment    
 
     
No-minimal (CPS = 0) 52.1 (2,212) 47.9 (2,031) 136.0 (2) <0.0001 ref 
Mild-moderate (CPS = 1-2) 35.2 (535) 64.8 (983)    2.00 (1.77-2.26) 
Severe (CPS > 3) 41.1 (202) 58.9 (290)    1.56 (1.29-1.89) 
Dyspnea   
 
     
No dyspnea 51.6 (1,244) 48.5 (1,169) 32.6 (2) <0.0001 ref 
Present when performing 
activities 
44.8 (1,360) 55.2 (1,675) 
 
  1.31 (1.18-1.46) 
Present at rest 43.5 (498) 56.5 (647)    1.38 (1.2-1.59) 
Note:  df denotes degrees of freedom  
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 Logistic regression models for care unit distress are shown in Tables 8.5.-8.8.  When only 
dyspnea was included in Model 1 (Table 8.5.), a significant relationship with care unit distress was 
evident  showing that persons with dyspnea were at increased risk for care unit distress (OR 1.18; 95% CI 
1.07-1.30n; p=0.001).  Dyspnea remained significantly associated with care unit distress (OR 1.18; 95% 
CI 1.06-1.32; p=0.003) when controlling for client level characteristics including age, gender, diagnosis, 
and prognosis (Model 2, Table 8.6.).  However, the odds ratio for dyspnea did not change substantially 
when controlling for client level variables.  Dyspnea remained significant in multivariate analysis (Model 
3, Table 8.7.) when controlling for key clinical characteristics (OR 1.14; 95% CI 1.02-1.27; p=0.02), but 
did not show an increase in predictive strength.  In Model 4 (Table 8.8.), which included both client and 
clinical characteristics, dyspnea continued to be significantly associated with care unit distress (OR 1.21; 
95% CI 1.07-1.36; p=0.002).  Acceptable fit for Model 4. is indicated by a relatively small Hosmer and 
Lemeshow statistic accompanied by a large p value (6.23; p=0.62).  A c statistic of 0.65 in Model 4 
indicated stronger predictive strength than in Models 1-3, which had smaller c statistics.  
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Table 8.5. Model 1-Logistic Regression Model of Dyspnea as an Independent Variable to Predict 
Presence of Distress Within the Caregiver/Client Unit Among Clients Receiving Palliative Home 
Care Services 2006-2011, Ontario, Canada (N=6,655). 





ratio (95% CI) 
p value 
 
Dyspnea (Ref = None) 
        Have dyspnea 0.16 (0.05) 1.18 (1.07-1.30) 0.001 
        
C statistic = 0.52 
    
 
Table 8.6. Model 2- Multiple Logistic Regression Model Using Client Characteristics to Predict 
Presence of Distress Within the Caregiver/Client Unit Among Clients Receiving Palliative Home 
Care Services 2006-2011, Ontario, Canada (N=6,655). 




Adjusted odds ratio 
(95% CI) 
p value 
    Dyspnea (Ref = None) 
     Have Dyspnea 0.17 (0.06) 1.18 (1.06-1.32) 0.003 
    
Age -0.11 (0.2) 0.90 (0.86-0.93) <0.0001 
    Gender (Ref = Male) 
     Female 0.07 (0.06) 1.07 (0.96-1.19) 0.23 
    Diagnosis (Ref = Do not have cancer) 
        Have Cancer 0.002 (0.09) 1.00 (0.85-1.18) 0.98 
    Estimated Prognosis (Ref = Greater than  
six months) 
       Six weeks to six months 0.02 (0.06) 1.44 (1.29-1.62) 0.81 
     Less than six weeks 0.54 (0.92) 2.44 (1.96-3.03) <0.0001 
     Death imminent -0.2 (0.16) 1.16 (0.78-1.73) 0.18 
        
C statistic = 0.58 
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Table 8.7. Model 3- Multiple Logistic Regression Model Using Clinical Characteristics to Predict 
Presence of Distress Within the Caregiver/Client Unit Among Clients Receiving Palliative Home 
Care Services 2006-2011, Ontario, Canada (N=6,655). 





ratio (95% CI) 
p value 
    Dyspnea (Ref = None)    
Have dyspnea 0.13 (0.06) 1.14 (1.02-1.27) 0.02 
    
Functional Ability (Ref = No-minimal 
impairment (ADL-H = 0))    
Mild-moderate impairment (ADL-H = 1-2) 0.19 (0.07) 1.21 (1.06-1.40) 0.007 
Severe impairment (ADL-H >3) 0.33 (0.07) 1.40 (1.20-1.62) <0.0001 
    
Cognitive Ability (Ref = No-minimal 
impairment (CPS = 0))    
Mild-moderate impairment (CPS = 1-2) 0.60 (0.07) 1.83 (1.60-2.07) <0.0001 
Severe impairment (CPS >3) 0.17 (0.11) 1.18 (0.95-1.48) 0.14 
 
   
Hours of Informal Care Provided in Last 3 
Days (Ref = <18) 
   
18-38 hours 0.09 (0.07) 1.10 (0.95-1.27) 0.21 
36 hours + 0.13 (0.06) 1.14 (1.02-1.27) 0.02 
    
C statistic = 0.62 
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Table 8.8. Model 4- Final Multiple Logistic Regression Model Using Client and Clinical Characteristics to Predict Presence of Distress 





ratio (95% CI) 
p value 
Dyspnea (Ref = None)    
     Have dyspnea 0.19 (0.61) 1.21 (1.07-1.36) 0.002 
Age (10 year increments) -1.15 (0.23) 0.87 (0.83-0.91) <0.0001 
Gender (Ref = Male) 
   
     Female 0.07 (0.06) 1.08 (0.96-1.21) 0.22 
Diagnosis (Ref = Do not have cancer) 
   
     Have cancer 0.19 (0.10) 1.21 (1.00-1.46) 0.05 
Estimated Prognosis (Ref = Greater than six months) 
   
    Six weeks to six months 0.19 (0.14) 0.64 (0.39-1.04) 0.07 
     Less than six weeks 0.24 (0.08) 1.90 (1.47-2.44) <0.0001 
     Death imminent 0.06 (0.11) 1.22 (1.07-1.38) 0.003 
Functional Ability (Ref = No-minimal impairment) (ADL-H  = 0) 
   
     Mild-moderate impairment (ADL-H =1, 2) 0.28 (0.08) 1.33 (1.14-1.55) 0.0003 
     Severe impairment (ADL-H >3) 0.37 (0.09) 1.45 (1.22-1.72) <0.0001 
Cognitive Ability (Ref = No-minimal impairment) (CPS = 0) 
   
     Mild-moderate impairment (CPS =1, 2) 0.61 (0.07) 1.85 (1.60-2.13) <0.0001 
     Severe impairment (CPS >3) 0.36 (0.13) 1.44 (1.12-1.85) 0.004 
Hours of Informal Care Provided in Last 3 Days (Ref = <18)     
     18-36 hours 0.45 (0.08) 1.57 (1.34-1.83) <0.0001 
     More than 36 hours -0.05 (0.08) 0.95 (0.81-1.11) 0.53 
Geographic Location (Ref = Site 2)    
    Site 1 0.19 (0.14) 1.20 (0.92-1.58) 0.17 
    Site 3 0.24 (0.08) 1.27 (1.08-1.48) 0.004 
    Site 4 0.06 (0.11) 1.06 (0.86-1.32) 0.57 
    Site 5 0.86 (0.22) 2.37 (1.56-3.61) <0.0001 
    Site 6 -0.09 (0.14) 0.91 (0.69-1.21) 0.53 
    
C statistic = 0.65 
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8.4 Discussion 
 Distress within the care unit is a major problem affecting over half of the palliative home care 
population.  Findings from this study show that client, caregiver, and care unit distress are all significantly 
associated with the presence of dyspnea:  All measures of distress are increasingly prevalent when the 
client is experiencing dyspnea.  It is important that clinicians recognize that dyspnea affects all members 
of the care unit and that care provided to address symptoms of dyspnea may have a double benefit to both 
the client and the caregiver.  During the care planning process clinicians should reflect on the presence of 
distress within the care unit and design interventions and allocate resources which address the needs of 
the client and caregiver as a collective unit (Mehta et al., 2009).  Chapter seven models predicting which 
clients exhibit elevated risk to develop a new dyspnea over time and predicting those who exhibit highest 
potential to recover from dyspnea, provide insight into potential areas for interventions to address 
dyspnea.  Following, care planning and targeted intervention strategies to treat dyspnea may not only 
address symptoms of dyspnea for the client but may also reduce distress within the care unit. 
 The philosophy of palliative care encourages clinicians to look at the ‘whole person’ when 
addressing symptoms like dyspnea and to extend the focus of care to the ‘whole care unit’.  Treatments 
for dyspnea should be part of a greater plan of care to address multiple factors recognizing the needs of 
the person and their caregiver.  Care planning to address complexity of symptoms experienced by persons 
nearing the end of life necessitates a multidimensional response to improve QOL and wellbeing for 
caregivers and clients.  Dyspnea remains a significant predictor of care unit distress in multivariate 
analyses a finding that supports prioritization of resource allocation to address symptoms of dyspnea.  As 
dyspnea is a recurring issue, analyses indicate increased need for clinicians to prioritize identification of 
factors that may trigger an exacerbation.  
The interRAI Palliative Care Dyspnea Clinical Assessment Protocol (CAP) informs organization 
of clinical observations in a systematic manner to identify factors that influence clinical and other 
outcomes.  The interRAI PC Dyspnea CAP identifies when symptoms of dyspnea, which may or may not 
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have been previously prioritized, require further investigation by the clinician.  The interRAI CAPs have 
been found to assist in the prevention of further decline, reduction of unnecessary hospital or emergency 
room visits, and assist to delay or prevent admission to LTC (Carpenter, 2006).  Integrating use of the 
Dyspnea CAP into the clinical decision making process provides clinicians with best practice guidelines 
important to address specifically in the context of persons nearing the end of life.  Most importantly, the 
Dyspnea CAP contains a summary of best practice guidelines useful to assist clinicians to reflect on 
potential underlying issues to consider during the care planning phase.  Findings from the current study 
emphasize the importance care planning to address dyspnea have not only for the client but also for the 
caregiver. 
 Although dyspnea remained a significant predictor of care unit distress in multivariate analysis it 
was not the strongest predictor.  In comparison to the predictive strength of multivariate analysis by 
Hirdes et al. (2012) indicated by a c-statistic of 0.75, Model 4, the comparable model in the current study 
using dyspnea as an independent variable in contrast to the CHESS score, showed slightly weaker 
predictive strength with a c-statistic of 0.65.  The continued strength of association of dyspnea in all 
models suggests that dyspnea remains a predictive characteristic, yet the smaller odds ratio indicates 
dyspnea may not be the most important or strongest characteristic driving care unit distress.  Oi-Ling, 
Man-Wah, and Kam-Hung (2005) also found dyspnea to be highly distressing in the last week of life, but 
not the strongest distressing symptom.  They noted this might be attributed to increased recognition and 
treatment of dyspnea as well as the availability of clinical practice guidelines (Oi-Ling et al., 2005). 
 Clients were more likely to report self-reported distress than exhibit signs of depression as 
captured in the DRS. This supports previous findings by Krebber et al. (2014) who also note the 
discrepancy between higher rates of self-reported distress compared to lower rates of diagnosed clinical 
depression may be a result of overestimation during self-report or under recognition by diagnostic 
interview.  This emphasizes the importance that open conversations between clinicians and clients may 
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have to inform the clinician and to assist them to gain a fuller picture of distress as felt by the person.  
Caregivers were more likely to feel overwhelmed by the situation than to report being unable to care.  
Being unable to continue caring activities may suggest other issues not captured within the interRAI PC 
or correlated in other items within the multivariate analysis.  
 Clients who reported multiple diagnoses including cancer were at highest risk to experience care 
unit distress.  It may be that experiences of the caregiver and client with dyspnea differ based on unique 
circumstances experienced specific to the disease diagnosis.  Findings from a qualitative study comparing 
lived experiences with dyspnea among persons with cancer, COPD, and other diseases found marked 
differences in person’s perceptions of the causes of dyspnea (Gysels & Higginson, 2011).  Persons with 
COPD were more likely to perceive dyspnea as self-inflicted, which they had brought on through their 
own actions, and thereby were more likely to feel guilt associated with symptoms of dyspnea (Gysels & 
Higginson, 2011).  In contrast, persons with cancer were likely to perceive episodes of dyspnea as 
characteristic of their illness and a reminder of their own mortality (Gysels & Higginson, 2011).  Mehta et 
al (2010) found that past caregiving experiences influenced the means in which caregivers addressed or 
perceived their current situation.  As the disease trajectories and frequency of exacerbations with dyspnea 
differ greatly by disease diagnosis and estimated prognosis, it is possible that experiences with episodes 
of dyspnea may lead to cumulative fear and distress. Limitations in sample size for numerous non-cancer 
diagnoses inhibit the ability of the current analysis to investigate further the role of disease diagnosis.  
However it is an area where further examination with a larger sample size is needed. 
A limitation of the current chapter is the use of cross-sectional data.  Cross-sectional data 
prevents inference of a causal relationship between dyspnea and distress within the care unit.  Therefore 
longitudinal studies with larger sample sizes are required to improve understanding of the temporal order 
between dyspnea and care unit distress.  A systematic review by Gysels, Bausewein, and Higginson 
(2007) investigating experiences of dyspnea found that of 19 studies examining dyspnea and COPD 
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identified internationally, four studies examined the patient’s experience of care, one examined care from 
the informal caregivers perspective, and one examined care from a health professional perspective.  They 
also noted limitations in sample size and lack of quantitative research limit current understanding about 
the relationship between the symptoms of dyspnea as a predictor of the distress faced by persons and their 
caregivers as they near the end of life.  Although current dataset challenges limit the ability to conduct 
longitudinal analysis this dataset is one of the largest non-administrative datasets currently available in 
Canada.  Challenges to sample size are a problem common in palliative care.  A scan of recently 
published full article research abstracts in three prominent palliative care journals revealed that only 2 
published studies (5%, n=2/44) consisted of sample sizes greater than 1000
10
.  Nonetheless, findings from 
this study establish the importance for clinicians to address dyspnea within the care unit.  
The Dyspnea CAP provides a summary of guidelines clinicians may consider when addressing 
dyspnea during the care planning process.  For the client, these include determining the onset and severity 
of the dyspnea symptoms as well as investigating the cause (Steel, Morris, and Leff, 2013a).  The 
Dyspnea CAP outlines general treatment strategies including positioning, medication options, and 
breathing exercises as well as the importance on educating the client and caregiver.  Clients and 
caregivers may not understand the multiple of triggers for dyspnea and be equipped with the necessary 
treatment and management strategies.  Clinicians should discuss with clients and caregivers of the role of 
prescription medications and the importance of adherence to manage everyday symptoms and 
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exacerbations.  Clients and caregivers should work together with the clinician to create a management 
plan and discuss anticipated events that may occur as the person nears death.   
For community based palliative home care clients, informal caregivers often shoulder the 
majority of responsibility for care (Taube, 2005).  Without adequate support, the magnitude and intensity 
of care provision necessary to keep the client at home in the community as they progress along the illness 
trajectory may overwhelm the client with a life limiting illness and his/her caregivers. Therefore, the care 
plan must include educational interventions to support and inform not only the person with a life limiting 
illness but also their informal support network with respect to current and projected expectations of need, 
level of care to be required, and availability of formal support services (Taube, 2005). 
8.5 Summary 
Distress within the care unit experienced by caregivers and clients should be a priority focus for 
clinicians when care planning to meets the needs of clients nearing the end of life.  To provide optimal 
palliative care, the clinician must communicate available treatment and management options tailored to 
meet the specific needs of both the client and their informal caregiver.  This must be done in a manner 
that empowers both clients and caregivers with the knowledge needed to determine whether treatments 
offered will cause added burden or assist to alleviate distress. 
The interRAI Dyspnea CAP may be an effective resource not only to identify persons 
experiencing dyspnea who may require further attention from clinicians (as discussed in chapter seven), 
but also as a resource to empower clinicians with best practice guidelines to address issues of distress 
within the caregiver/client unit.  Awareness of the needs of both caregiver and client are paramount to 
provision of high quality care palliative care.  As the Mood CAP already addresses issues specific to 
distress experienced by the person with a life limiting illness, development of a specific interRAI PC CAP 
dedicated to caregiver distress is warranted.   Results from this chapter illustrate clear associations 
between presence of dyspnea and increased client, caregiver, and care unit distress.  Effective palliative 
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care should address the symptom of dyspnea to improve the health and QOL of both the client and the 
caregiver.  
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9.  Summary 
The widely recognized benefits of palliative care including improved survival, (Connor, Pyenson, 
Fitch, Spence, & Iwasaki, 2007) increased satisfaction with care by clients and caregivers (Kane, 
Bernstein, Wales, Leibowitz, & Kaplan, 1984) and reduction of unnecessary health care resource 
utilization (Tulskyc & Steinhauserc, 2007; Kamal, Currow, Ritchie, Bull, & Abernethy, 2012), are all 
dependent upon the clinicians ability to recognize and prioritize client need, to craft a person-centered 
plan of care, and then to allocate appropriate palliative care resources to meet the needs of the client.  As 
advocated by the WHO (2010), incorporation of comprehensive clinical assessment by clinicians is a 
critical aspect of the decision making process to support an evidence-informed, person-centered approach 
to care planning.  The focus of this thesis has been to demonstrate the potential use of the interRAI 
Palliative Care assessment instrument (interRAI PC) and its associated Clinical Assessment Protocols 
(interRAI PC CAPs) to inform individualized care plan development for persons with life limiting 
illnesses.  Chapter six of this thesis gave an overview of the set of eight interRAI PC CAPs and provided 
description of the CAP development process.  The interRAI PC CAPs do not to provide clinicians with an 
automated plan of treatment.  Instead, they help the clinician to consider relevant issues, to evaluate and 
integrate these issues into their clinical decision making process and to inform best practice guidelines for 
further guidance.  While clinicians may be aware of a multitude of health issues facing the client, the 
interRAI PC CAPs may trigger in areas previously not recognized by the clinician.  The interRAI PC 
CAPs may also confirm observations by the clinician and be used as further evidence to confirm their 
clinical evaluation and best judgment.   
When any of the eight interRAI PC CAPs are triggered, clinicians in consultation with the person 
and, when appropriate, members of their informal support network can make informed, collaborative 
decisions on whether or not issues raised by the CAPs should be addressed further.  CAPs are frequently 
triggered by community-based palliative  care clients – two thirds of those assessed triggered two or more 
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CAPs.  Unique distributional characteristics of each CAP were presented in chapter six and a hierarchical 
triggering structure was described.  This evidence may be useful to predict levels of health complexity 
and change over time.  CAPs triggered at high rates such as fatigue, dyspnea, and pain warrant increased 
attention by clinicians for the majority of palliative home care clients.  Even among clients who are 
relatively stable, the CAP hierarchical triggering structure suggests that clinicians will encounter fatigue 
and dyspnea as clinical issues affecting their clients.  In contrast, CAPs that trigger later in the dying 
process (e.g., Delirium CAP and Pressure Ulcer CAP) rarely trigger in isolation.  These persons tend to 
have multiple clinical problems affecting their quality of life. When clinicians observe a client who 
triggers CAPs that tend to occur later in the dying trajectory, they may encounter more complex clinical 
needs requiring more in-depth attention as part of the care planning process.  
The eight interRAI PC CAPs released in 2013 point to needs that may require further clinical 
attention across the disease trajectory.  The interRAI PC CAPs address three key domains: Performance 
(i.e., Fatigue CAP and Sleep Disturbance CAP); Clinical Complexity (i.e., Nutrition CAP, Pressure 
Ulcers CAP, Pain CAP, and Dyspnea CAP); and Cognition and Mental Health (i.e., Mood Disturbance 
CAP and Delirium CAP) (Steel, et al., 2013e). In this dissertation, the Dyspnea CAP was selected for a 
more detailed examination, for two reasons.  First, next to the Fatigue CAP, the Dyspnea CAP is the most 
commonly triggered CAP affecting nearly half of the current sample palliative home care population. 
Second, dyspnea is reported in the literature to be one of the most distressing symptoms affecting both the 
client and their informal caregiver (Ng &von Gunten, 1998; Potter, Hami, Bryan, & Quigley, 2003; 
Dellon et al., 2010; Kroenke, Johns, Theobald, Wu, & Tu 2013). 
Although specific estimates of prevalence rates of dyspnea among the end of life population 
differ greatly, it is consistently reported to be one of the most common symptoms affecting persons 
nearing the end of life (Ng &von Gunten, 1998; Potter, Hami, Bryan, & Quigley, 2003; Dellon et al., 
2010; Kroenke, Johns, Theobald, Wu, & Tu 2013).  With prevalence rates as high as 95% for individuals 
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with COPD, 70% for persons with cancer, 85% for persons with cardiac failure and motor neuron disease 
(Solano, Gomez, & Higgenson, 2006; Oliver, 2005) it is an issue clinicians must recognize and address 
when caring for persons nearing end of life.  Chapter seven of this thesis characterized the prevalence of 
dyspnea among a sample of community dwelling palliative home care population in Ontario, Canada.  
Consistent with these previous studies, dyspnea was highly prevalent affecting nearly half of the palliative 
home care population at baseline (44.9% at baseline, 47.1% at follow-up). However, results reported in 
chapter seven demonstrate clearly that there is a strong relationship between dyspnea and prognosis as 
well as other clinical factors. Therefore, any effort to characterize rates of dyspnea across populations 
must take into account important covariates like proximity to death for those estimates to be meaningful 
and comparable. The interRAI PC assessment instrument provides the necessary data elements to support 
such comparisons.  
 In many cases, dyspnea can be preventable or modifiable such that it is not an inevitable part of 
the dying process. Although the prevalence of dyspnea over time was comparable, longitudinal analysis in 
chapter seven show that the experiences with dyspnea change over time for many persons.  Chapter seven 
showed that person-level characteristics, some of which are potentially amenable to change, affect the risk 
for dyspnea over time.  Among persons who exhibited dyspnea at initial assessment, approximately one 
third had recovered and no longer exhibited symptoms of dyspnea at the time of follow-up assessment.  
Bivariate and logistic regression analyses showed that persons experiencing fatigue and those receiving 
assistance from a personal support worker at baseline were more likely to recover from dyspnea by 
follow-up. It is not known whether this reflects an improvement in status resulting from clinical 
intervention (i.e., more PSW time leading to improved respiratory function) or a “regression to the mean” 
effect of persons who were more seriously impaired at the start of service delivery improving either 
spontaneously or as a result of good quality palliative care. Further analysis in chapter seven showed that 
among clients who did not exhibit dyspnea at baseline, approximately one third of persons had developed 
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new dyspnea symptoms at follow-up.  Logistic regression analyses showed that female clients and those 
with bladder incontinence were less likely to develop new dyspnea while those experiencing fatigue at 
baseline were more likely to develop new dyspnea by time of follow-up.  As shown by the literature 
review section of this thesis dealing with the pathophysiology of dyspnea and possible risk factors 
(Michelson & Hollrah, 1999; Kristjanson, 2006; Booth, Moosavi, & Higginson, 2008; McCusker et al., 
2009; Wilkins, Dexter, & Heuer, 2009; Porter & Kaplan, 2012), dyspnea is a complex clinical problem; 
however, there are reasonable treatment options (Bredin, et al., 1999; Sorenson, 2000; Jennings, 2002; 
Booth, Moosavi, & Higginson, 2008; Cancer Care Ontario, 2010; Parshall et al., 2012) and clinical 
strategies available to address the symptoms of dyspnea (Corner, Plant, A'hern, & Bailey, 1996; 
Kristjanson, 2006; Booth 2008).  Findings from chapter seven suggest in addition to directly addressing 
the cause and symptom of dyspnea itself, addressing issues of fatigue, and PSW service allocation may 
also have positive effects over time. This suggests that a multidisciplinary approach to care addressing 
multiple triggered CAPs would be a good strategy for responding to the dyspnea CAP (and other 
triggered CAPs).  
A hallmark of the palliative care philosophy is its aim to provide the highest quality of care and 
support for both the persons nearing the end of life and informal caregivers.  Caring for a person with 
dyspnea has been linked to high levels of distress, unmet needs, fewer reported positive benefits 
experienced during caregiving activities, and feelings of anxiety, depression and helplessness (Booth, 
Silvester, & Todd, 2003; Goodridge, Duggleby, Gjevre, & Rennie, 2008; Malik, Gysels, & Higginson, 
2013). This evidence is supported by findings in chapter eight of this thesis.  High quality palliative care 
has shown potential to increase satisfaction with care, improve global quality of life for client and their 
caregiver, reduce physical symptoms like dyspnea, decrease signs of depression or anxiety, and improve 
access to health care resources (Kane, Bernstein, Wales, Leibowitz, & Kaplan, 1984; Melin-Johansson, 
Axelsson, Gaston-Johansson, & Danielson, 2010). Chapter eight examined the association between 
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presence of dyspnea and distress experienced by members of the caregiver-client unit of care and showed 
that distress was a major problem affecting over half of the caregiver-client units of care.  Dyspnea was 
shown to be associated with a higher prevalence of distress in the client and for the caregiver.  Therefore, 
clinicians should prioritize recognition of and interventions for symptoms of dyspnea in order address 
psychosocial aspects of QOL in addition to the basic medical concerns posed by dyspnea.  The interRAI 
Dyspnea CAP is a valuable resource to assist clinicians to create a management plan.   The best practice 
guideline information available from the interRAI PC Dyspnea CAP guidelines can be a quick and 
effective resource for identifying strategies that may reduce the impact of dyspnea on the person and 
his/her caregiver(s).  Being aware of and responding to the needs of both caregiver and client are basic 
tenets of high quality care palliative care 
Although palliative care is offered in almost every sector of the Canadian health care system, 
including acute care, complex continuing care, long-term care, and home care (Dudgeon et al., 2007), it 
remains an uninsured service under the Canada Health Act (CHA).  At the federal level, Canada does not 
yet have legislation mandating provincial provision of palliative care for persons nearing the end of life.  
The Ontario Association of Community Care Access Centers (OACCAC) (2003) recognized palliative 
care lacked “coordination, integration, and consistency” that resulted in great difficulty for clients and 
their caregivers to navigate palliative care services in Ontario.  To address this on a provincial level, 
OACCAC mandated the use of the interRAI PC assessment instrument for all persons receiving palliative 
home care services across all CCACs in Ontario, Canada by 2012. 
There are multiple strategies which may be employed to encourage or improve uptake of 
information from the interRAI PC CAPs by clinicians.  One strategy may be to mandate that clinicians 
address all triggered CAPs in the subsequent care plan, as is the strategy currently employed in the long-
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term care sector in Ontario (J.P. Hirdes
11
, personal communication, April 22, 2014).  Although this would 
ensure information from the CAPs are integrated into the decision making process, it may inadvertently 
inflate the volume of work done in response to the interRAI PC if clinicians feel they must document a 
detailed plan of action for every triggered CAP as an administrative requirement. .  This strategy may not 
be recommended for the interRAI PC as persons nearing end of life may refuse a treatment perceived as 
too burdensome (e.g. a person may refuse to increased medication to treat pain if it meant they would 
become drowsy and less aware, inhibiting their ability to communicate in a perceived meaningful way 
with family).  Alternatively, information on triggered CAPs may be made available directly to the 
clinician as an integral part of their outcome report, as is the case in the OACCAC data reporting system 
software for the RAI HC CAPs (J.P. Hirdes, personal communication, April 22, 2014).  Here, information 
would be made immediately available to clinicians and they would then be given the flexibility on 
whether or not to address the CAP.  If this strategy is applied to the interRAI PC and the palliative 
homecare population it may be recommended that clinicians report reasons surrounding the decision to 
address or not address issues specific to triggered CAPs.  Integrating the CAPs into regular clinical 
practice and recording the information for easy access over time may allow for clinicians to examine 
results of their care planning activities during follow-up assessments.  There are numerous strengths of 
the interRAI PC assessment instrument and the large database amassed as a result of the pilot 
implementation phase.  First, as has been previously discussed, the interRAI PC is part of an integrated 
suite of assessment instruments, which have shown excellent inter-rater and test-retest reliability (Steel et 
al., 2003, Hirdes et al., 2008).  As part of the interRAI suite, the interRAI PC contains items common to 
other interRAI instruments, and more specifically the RAI-HC and the MDS 2.0 that are currently used in 
the majority of provinces/territories in Canada.  This allows health authorities using multiple interRAI 
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assessment instruments to integrate them into a continuous care reporting symptom.  Now that the 
interRAI PC assessment instrument has been mandated in Ontario, the OACCAC will be able to link and 
track clients as they transition across the various points in the health care (e.g., from receiving general 
home care and assessment with the RAI-HC  to receiving palliative care and assessment with the interRAI 
PC).  Second, the interRAI PC is a multi-dimensional comprehensive standardized assessment instrument 
that provides the clinician with a detailed picture of their client.  CHPCA recognizes the multifaceted role 
palliative care may take to improve the health and wellbeing of persons nearing end of life as summarized 
in eight key domains of issues associated with illness and bereavement, shown in the CHPCA domains of 
palliative care (Figure 2.8).  Consistent with efforts to address the needs of the ‘whole person’, the 
interRAI PC addresses 17 unique domains (Steel et al., 2003). With the exception of the loss and grief 
domain that includes bereavement planning, mourning and grief, all other domains (psychological, social, 
spiritual, practical, end-of-life care, disease management, and patient family characteristics) recognized 
by the CHPCA are included in the interRAI PC assessment instrument.  Third, data in the pilot 
implementation were gathered by trained assessors (mostly nurse case managers) who completed the 
assessments as a part of their regular clinical practice.  Data were gathered from all available sources 
including conversation with and direct observation of the person, interviews with informal caregivers, 
consultation with members of their health care team including doctors, nurses, and other professionals, 
and examination of available medical records.  Finally, the breadth of data gathered will allow for greater 
generalizability to the palliative home care population in Ontario Canada.  The data used in this thesis 
were gathered from six CCACs, representing urban, rural, and mixed geographic regions, northern and 
southern health regions, and areas with high, low, and mixed ethnic diversity.  The duration of the pilot 
also allowed some opportunity for repeat assessments to be collected enabling some opportunity for 
longitudinal analysis as shown in chapter seven.   
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Conversely, limitations of the interRAI PC must also be recognized.  First, with over 280 items, the 
amount of time to complete the assessment can be burdensome to not only the assessor, but more 
specifically the person.  Especially among an end of life population, likely to be experiencing fatigue, 
having a conversation about their situation and needs can be exhausting.  In this case, clinicians may need 
to complete the assessment in multiple visits or may need to rely more on reporting from family, other 
formal health care providers (e.g. Family physician or PSW) and available health records.  It is also 
imperative to avoid using redundant assessments as screening tools because these would unnecessarily 
increase the level of burden when the information is already capture din the interRAI PC.  Next, it is 
important to recognize that while assessments are completed by trained assessors, their clinical expertise 
and communication styles may vary from person to person.  This can lead to challenges for clinicians to 
assess subpopulations of persons nearing the end of life such as persons who are unable to communicate 
due to cognitive impairment.  Additional follow-up training may be required to ensure clinicians are able 
to obtain the necessary information to create a comprehensive understanding of the person and his/her 
needs.  Finally, to date, there has been a lack of studies examining the sensitivity of change of the 
interRAI PC measures.   With growth in the number of available follow-up assessments, future studies 
will be able to investigate this with greater precision. 
Future research should be undertaken to provide further evidence on the validity of the interRAI 
PC and the interRAI PC CAPs.   One such validity study might employ comparison of the well accepted 
scales (e.g. ESAS) with results from the interRAI PC.  Validity studies to examine CAPs specifically 
should also be completed.  A potential validity study focused on the Dyspnea CAP could measure 
dyspnea using the interRAI PC and compare it to other methods. Clients could complete dyspnea focused 
instruments such as the UCSD Shortness of Breath Questionnaire (SOBQ), the Borg Scale, and/or the 
Visual Analogue Scale.  Research by Eakin, Sassi-Dambron, Ries, and Kaplan (1995) showed high 
reliability and validity of the SOBQ and Baseline Dyspnea Index among a wide range of dyspnea 
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measures.   Results of these tests could be used to provide evidence for the validity of the dyspnea 
measure.  Tests would be completed by an independent clinician prior to interRAI PC assessment with a 
trained assessor.  Care in the planning of these assessments would need to account for assessment burden 
on the patient.   Completing multiple assessments on dyspnea would enable comparative measurements of 
both context and frequency of the symptom of dyspnea to be ascertained independently to determine the 
validity of the interRAI Dyspnea CAP.  It would also be useful to examine whether the subjective 
measures of the interRAI PC (e.g. dyspnea) relate to concurrent objective clinical tests of the domain of 
interest (e.g. pulmonary function testing).   
Although the interRAI PC instrument has numerous strengths as a comprehensive assessment 
instrument characterizing the needs of palliative home care clients in Ontario, Canada, limitations of the 
current research must also be recognized.  Missing data was perhaps the largest challenge faced when 
conducting the current analyses.  During the pilot implementation phase, some reasons for this became 
apparent and were addressed immediately while other issues have been addressed since full 
implementation.  First, it became evident that some clinicians did not feel comfortable discussing end of 
life issues such as estimated prognosis  (missing17.3%, n=1,153).  To address these issues during the pilot 
phase, follow-up training and education was provided to emphasize the importance of gathering this 
information and completing the full assessment as well as provision of strategies and techniques on how 
to have conversations on sensitive topics.  The initial pilot collected data using a paper-based teleform 
assessment form.  Assessors were required to mark bubbles using a black pen or marker.  Some assessors 
chose to slash bubbles instead of accurately colouring in the bubbles creating challenges when scanning 
teleform assessment and coding data electronically.  This required manual correction to correct 
unreadable bubbles for assessments already completed.  Managers at sites where this occurred were 
contacted and reminded of proper assessment marking procedures.  Additionally, in the paper based 
assessment, diagnoses were written into boxes manually by clinicians.  When scanning these boxes it was 
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challenging to recognize the handwriting of some assessors.  In this case, manual correction was 
completed.  However, disease diagnosis information could not be clearly ascertained for 3.3% of cases 
(n=221).  The de-identified nature of the assessments prohibited follow-up by researchers with clinicians 
at that time to determine accurate diagnosis information.  Therefore, to address those with missing disease 
diagnoses, a separate variable of diagnosis unspecified was used in the analyses. These errors were 
corrected following completion of the pilot as now data is directly entered in a computer system. 
Formalized reporting systems (e.g., the Home Care Reporting System managed by the Canadian Institute 
for Health Information) include standardized data quality checks to address issues of missing data, out of 
range values and logical inconsistencies in assessment records (e.g., date related errors). As the interRAI 
PC has become adopted as a provincial standard in Ontario one would expect that the new OACCAC 
managed reporting system will have a positive impact on overall data quality. Drop down menus and 
entry of ICD codes for disease diagnoses incorporated into the computerized entry system can also 
improve the accuracy of these variables.  In order to submit an interRAI PC assessment, new software 
should require all items to be answered and preclude incomplete assessments to be uploaded into the 
database system at the point of assessment. 
During statistical analysis, regression analysis in chapter seven and chapter eight were the most 
affected by the challenges related to missing data. The option chosen to address missing data in this thesis 
was to run regression analysis assuming complete cases (i.e., the records included in the regression 
analysis were those having no missing data for any variables included in the analysis). The SAS software 
defaults to complete case regression analysis and eliminates all records that have missing data for any of 
the variables included in regression analysis coding.  In a complete case analysis, as the number of 
variables entered into the model increased, the cumulative impact of missing data in the current study 
reduced the number of records included in the each regression model analysis.  This inhibited the ability 
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to use the automatic model selection technique SCORE to its fullest confirm and to compare selected 
models or to inform of alternate models.   
Although single and multiple imputation strategies exist as alternative options to address missing 
data, they were not used in this thesis.  Recent studies using the same interRAI PC dataset found that 
multiple imputation did not yield significantly different results from the complete case analysis (Fisher, 
Seow, Brazil, Freeman, Smith, & Guthrie, 2014a; Fisher, Seow, Cohen, Declercq, Freeman, Guthrie, 
2014b). For this reason, and because complete case analysis is most frequently used (and reported on) in 
epidemiological research analysis (van der Heijden, Donders, Stijnen, & Moons, 2006), this method was 
used in this thesis. As it is recognized that employing complete case analysis may increase the possibility 
that results of the regression analyses may be biased (Sterne, et al., 2009) future research is needed to 
confirm current regression analysis findings. 
Although the current dataset had challenges limiting the ability to conduct longitudinal analysis it 
should be recognized that the current dataset is one of the largest currently available with a sample size of 
6,655 unique persons receiving palliative care of whom 1,000 have a follow-up assessment.  A scan of 
abstracts of recently published full article research abstracts in three prominent palliative care journals
12
:  
The Journal of Palliative Care; The Journal of Palliative Medicine; and the BMJ of Palliative and 
Supportive Care revealed that less than 5% of published studies (n=2/44) consisted of sample sizes 
greater than 1000.  Moreover, about three quarters of published studies used sample sizes less than 500 
(n=34/44). 
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The prospects for future research using information gathered from the interRAI PC are bountiful, 
as the size of the current dataset will continue to grow in the years to come.  Even in its pilot stage 
beginnings, the breath of information from the over 280 items combined with the large sample size of 
6,655 are unprecedented making this dataset one of the richest and most comprehensive data sources of 
health and clinical information on persons receiving palliative home care in Canada.  Further integration 
of the interRAI PC into clinical practice in Ontario, and expansion to other jurisdictions across Canada, 
will enable expanded tracking of Canadians as they navigate across the care continuum.  This will open 
up new and exciting opportunities for longitudinal research.  Because the interRAI suite of instruments 
contain a core set of items it will soon be possible to examine how the health needs of persons change as 
they transition through levels of care over time and near the end of life.  Data gathered from the interRAI 
PC during this pilot and now ongoing since its integration into daily clinical practice, may inform greater 
understanding of the complex needs of palliative home care clients in Ontario.   
Patterns in CAP triggering suggest increased attention should be given to address the 
accumulative complex needs of both older adults and of persons with a limited estimated prognosis. 
Future research should investigate variations by geographic location and further elucidate reasons for age-
associated disparities in CAP triggering.  Integration of evidence gathered from the interRAI PC CAPs 
into the care planning process may allow for higher quality of care through better tailoring of resources at 
address person-specific need.  Additional investigation may use the interRAI PC CAPs and their 
hierarchical triggering structure to investigate further symptom clusters which may be associated with the 
CAPs.  Findings from this study showed that symptoms of dyspnea often occur with fatigue and are 
clearly associated with distress within the unit of care.  Further investigation into the association with care 
unit distress and other CAPs is merited.  Moreover, these findings suggest need for future intervention 
studies to examine clinical decision making strategies affecting the choice to address or not address 
triggered CAP related issues, to elucidate which aspects of the CAPs clinicians find beneficial and select 
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to integrate into the plan of care, in addition to the need to examine outcomes associated with integration 
of evidence from the interRAI PC CAPs. 
A finding unique raised in chapter seven was the significant relationship between urinary 
incontinence and lower prevalence of dyspnea.  Persons with urinary incontinence were less likely to 
develop a new dyspnea or to continue experiencing dyspnea over time.  This raises important questions 
regarding the role of bladder continence as a risk factor for dyspnea or whether it is simply a concurrent 
indicator of some other underlying clinical problem.  Literature is greatly lacking in this area and no 
studies to date have investigated this question.  Consultation with experts in the field suggests further 
research may investigate potential confounding medical conditions, effects of reduced bladder output 
from dehydration, or underreporting.   
The present thesis provided some evidence that the receipt of palliative home care assistance from 
a PSW was associated with recovery from dyspnea in chapter seven. Future research could employ an 
intervention study design to examine whether this change is caused by access to PSW services or whether 
some other explanatory factor is responsible. It may be possible that PSW services may help to reduce 
events that trigger episodes of dyspnea, but this warrants further investigation.  Further research should 
investigate whether matching of PSW supports to address identified and person-specific tasks that trigger 
episodes of dyspnea result in symptom improvements among persons with dyspnea.   
Current analysis shows that a clear relationship exists between distress among caregivers and care 
recipients and the symptoms of dyspnea.  This raises two important implications for the interRAI PC.  
First, due to the important interrelationship recognized in the current thesis and by a study by Hirdes et 
al., (2008), the development of a specific interRAI PC CAP dedicated to caregiver distress (the mood 
CAP deals with the client’s distress) should be a priority for interRAI.  Second, as recognized in chapter 
eight, the interRAI PC does not address the areas of grief and bereavement for the caregiver.  It may be 
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useful for future research to focus on development of a triggering algorithm that alerts clinicians when 
caregivers may be at elevated risk for complicated grief and bereavement.   
Implications from this thesis illustrate potential benefits using the interRAI PC CAPs to provide 
an evidence base important to inform care planning activities.  At the clinical level, when one or more 
interRAI PC CAPs are triggered clinicians should take notice.  The interRAI PC CAPs not only identify 
important problems that require further investigation by the clinician, they identify problem areas that 
may be amenable to intervention.  More specifically, the interRAI PC CAPs only trigger when there is a 
potential to improve or recover from the problem or there is an ability to prevent or slow further decline.  
In the case of the interRAI Dyspnea CAP, findings from the current study show that symptoms of 
dyspnea are not an inevitable part of the illness trajectory near the end of life.  These findings are of value 
to the general population as well, providing hope that 1 in 3 persons with dyspnea may recover over time 
and raising awareness that an equal number of persons without dyspnea may develop dyspnea over time. 
They reinforce the need for clinicians to have open dialogue with the client and their caregivers during the 
care planning process.  The next logical step building on the findings from this thesis would be to develop 
a study examining client outcomes when clinicians care plan to address issues identified by the interRAI 
PC CAPs. 
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Significant at the 
Bivariate Level 
1 Acid Reflux No No 
2 Activities of Daily Living Hierarchy (ADL-H) No <. 0001 
3 Age (in increments of 10) No <0.0001 
4 Anxious, restless or uneasy No No 
5 Bladder Incontinence No 0.01 
6 Bloating No No 
7 Bowel Incontinence No No 
8 Cachexia/wasting No No 
9 
CHESS Scale 
Yes: Dyspnea included in 
scale measure 
- 
10 Cognitive Performance Scale (CPS) No 0.0006 
11 Depression Rating Scale (DRS) No No 
12 Diagnosis of cancer vs. no cancer No <0.0001 
13 Expresses wish to die at home Yes: Missing > 20% - 
14 Expresses wish to die now Yes:  Missing > 20% - 
15 Difficulty clearing airway secretions No <0.0001 
16 Difficulty falling asleep No <0.0001 
17 Fatigue No <0.0001 
18 Gender No 0.002 
19 Have had a Hospital Stay in past 90 days No 0.0006 
20 Have visited ER in past 90 days No 0.009 
21 Home Nurse No <0.0001 
22 Nausea No No 
23 Obese Yes: Missing > 20% - 
24 Occupational Therapy or Physiotherapy No No 
25 Oxygen therapy No <0.0001 
26 Pain No 0.009 
27 Peripheral Edema No <0.0001 
28 Prognosis No <0.0001 
29 Personal Support Worker No No 
30 Receiving more or less than 6 hours of care per day No No 
31 Geographic CCAC Site No <0.0001 
32 Smoking No No 
33 Too much sleep No <0.0001 
34 Vomiting No No 
35 Weight loss No <0.0001 
 
 
